KP-4::MK-1775
LU-135::Ipatasertib
NUGC-4::EPZ004777
CAL-29::AZD8055
NCI-H1993::EHT-1864
A388::Tretinoin
NCI-H1623::SN-38
DMS-114::SGC0946
EFO-21::AZD3759
JHOS-3::Methotrexate
NALM-6::Foretinib
OCI-M1::Dactolisib
U031::Fulvestrant
EW-22::Epirubicin
LU-135::AGI-6780
NCI-H1993::AMG-319
UMC-11::LJI308
LB2241-RCC::WIKI4
HPAF-II::OF-1
KGN::VE821
LB2241-RCC::Docetaxel
EFO-21::Bortezomib
NOS-1::Entinostat
HPAF-II::Obatoclax Mesylate
NALM-6::Docetaxel
CP50-MEL-B::Dactolisib
AU565::Telomerase Inhibitor IX
HCC1143::SN-38
CPC-N::SCH772984
KP-4::Fulvestrant
HPAF-II::Rapamycin
CP50-MEL-B::Nutlin-3a (-)
MEL-HO::PCI-34051
Becker::Vinorelbine
ChaGo-K-1::5-Fluorouracil
NUGC-4::Irinotecan
LB647-SCLC::AGI-6780
EFO-21::Linsitinib
CHP-134::AZD8186
HCC1143::Wee1 Inhibitor
EFO-21::Bosutinib
LU-135::AZD5582
NCI-H1993::Niraparib
LC-2-ad::ABT737
SIMA::Cyclophosphamide
NUGC-4::AZD8186
EW-22::Talazoparib
NCI-H1993::Vinorelbine
UMC-11::Alpelisib
LN-18::Wnt-C59
LB2241-RCC::YK-4-279
TE-4::Avagacestat
JHOS-3::OF-1
SN12C::AZD6738
UMC-11::AGI-6780
AU565::MK-2206
EW-22::Gefitinib
SK-OV-3::WEHI-539
SK-OV-3::Daporinad
ESO51::JNK Inhibitor VIII
KGN::Rucaparib
LB647-SCLC::Piperlongumine
AU565::Dabrafenib
LC-2-ad::Olaparib
JHOS-3::SB216763
SK-OV-3::MK-8776
LN-18::Bortezomib
Becker::SGC0946
DMS-114::SB590885
LU-135::WIKI4
CAL-29::UMI-77
NOS-1::LCL161
NUGC-4::Sabutoclax
LC-2-ad::Dactolisib
UMC-11::Fulvestrant
NUGC-4::Pyridostatin
SN12C::AZD4547
JHOS-3::Osimertinib
RT-112::Lestaurtinib
CHP-134::EPZ5676
CP50-MEL-B::P22077
U031::Dabrafenib
JHOS-3::Pyridostatin
KGN::Avagacestat
KP-4::Nutlin-3a (-)
LB2241-RCC::Sabutoclax
JHOS-3::NVP-ADW742
TE-4::MK-1775
EW-22::MIM1
SN12C::AGI-5198
CAL-29::5-Fluorouracil
CAL-29::LJI308
LB2241-RCC::Methotrexate
CHP-134::AZD8055
LU-135::Camptothecin
NUGC-4::PLX-4720
KP-4::Sorafenib
AU565::LJI308
MEL-HO::WEHI-539
CHP-134::EPZ004777
ESO51::MK-8776
JHOS-3::PF-4708671
SK-OV-3::Afatinib
TE-4::ZM447439
LB647-SCLC::EPZ004777
CHP-134::WEHI-539
CP50-MEL-B::Irinotecan
SU-DHL-1::BMS-536924
MEL-HO::Elesclomol
A388::GSK2578215A
AU565::BIBR-1532
TE-4::Venetoclax
CAL-29::Osimertinib
KGN::MK-1775
EFO-21::WZ4003
ChaGo-K-1::Afatinib
U031::Sabutoclax
LN-18::Dinaciclib
LC-2-ad::Camptothecin
HPAF-II::Ribociclib
AU565::ZM447439
OCI-M1::Vinorelbine
LU-135::XAV939
CP50-MEL-B::JNK Inhibitor VIII
HPAF-II::SN-38
U031::SB590885
U031::RO-3306
U031::MIRA-1
EFO-21::MIRA-1
LB2241-RCC::GSK269962A
CP50-MEL-B::GW441756
LU-135::JQ1
UMC-11::Leflunomide
LN-18::Sepantronium bromide
LN-18::LY2109761
HPAF-II::SCH772984
SU-DHL-1::I-BRD9
LB2241-RCC::SN-38
KGN::Sorafenib
OCI-M1::PFI3
UMC-11::Foretinib
SK-OV-3::Lenalidomide
HCC1143::MN-64
RT-112::AZD5582
Becker::Afatinib
A388::BMS-345541
KP-4::Olaparib
KGN::BI-2536
NCI-H1623::AZD5582
MEL-HO::MIRA-1
AU565::Cyclophosphamide
EFO-21::Avagacestat
MEL-HO::Leflunomide
LB2241-RCC::AZ6102
OCI-M1::Venetoclax
LU-135::Bleomycin (50 uM)
CAL-29::EPZ004777
SU8686::PRIMA-1MET
JHOS-3::Navitoclax
LB647-SCLC::Pevonedistat
ESO51::Axitinib
NCI-H1993::Obatoclax Mesylate
DMS-114::Temsirolimus
A388::Tozasertib
NCI-H1623::Pevonedistat
DMS-114::Osimertinib
NOS-1::GSK591
LB2241-RCC::EPZ5676
EW-22::Ibrutinib
TE-4::Afuresertib
SK-OV-3::XAV939
ESO51::NU7441
LB2241-RCC::Piperlongumine
LB2241-RCC::Temsirolimus
RT-112::ZM447439
LU-135::Olaparib
NB12::Vinorelbine
DMS-114::Camptothecin
KGN::Lapatinib
LN-18::EHT-1864
CP50-MEL-B::Cyclophosphamide
OCI-M1::Motesanib
NCI-H1993::Doramapimod
CPC-N::CCT007093
NUGC-4::MN-64
ESO51::Palbociclib
CPC-N::MK-2206
HCC1143::5-Fluorouracil
CPC-N::Serdemetan
A388::Daporinad
SU8686::Sorafenib
NUGC-4::Sapitinib
CP50-MEL-B::Rucaparib
HCC1143::GSK1904529A
AU565::Ibrutinib
SU-DHL-1::Sorafenib
NOS-1::EPZ004777
RT-112::RVX-208
EFO-21::PLX-4720
KARPAS-620::Serdemetan
ESO51::Wee1 Inhibitor
SIMA::Afuresertib
NOS-1::GNE-317
LC-2-ad::I-BRD9
LU-135::LY2109761
SU-DHL-1::Niraparib
CPC-N::EPZ5676
LB647-SCLC::LGK974
ChaGo-K-1::PD0325901
NB12::NVP-ADW742
ChaGo-K-1::VX-11e
HCC1143::Alpelisib
ChaGo-K-1::MK-2206
LC-2-ad::I-BET-762
RT-112::BMS-536924
KGN::Erlotinib
Becker::SN-38
HCC1143::Docetaxel
AU565::BMS-536924
EFO-21::Alisertib
TE-4::MIRA-1
UMC-11::Nutlin-3a (-)
LU-135::Nutlin-3a (-)
TE-4::Cytarabine
EW-22::Avagacestat
LN-18::MN-64
HPAF-II::Doramapimod
EFO-21::AZD7762
UMC-11::GSK343
NCI-H1623::GSK591
JHOS-3::VX-11e
NALM-6::RO-3306
ESO51::Motesanib
KARPAS-620::Avagacestat
HCC1143::Leflunomide
NUGC-4::PRIMA-1MET
CPC-N::RVX-208
U031::I-BRD9
SIMA::Entinostat
NB12::Fulvestrant
AU565::Temsirolimus
HPAF-II::Dinaciclib
NUGC-4::Bleomycin (50 uM)
CAL-29::Afuresertib
KGN::EHT-1864
CP50-MEL-B::Camptothecin
LU-135::Wee1 Inhibitor
LB2241-RCC::5-Fluorouracil
NALM-6::MN-64
HPAF-II::EPZ004777
A388::SL0101
JHOS-3::SN-38
CAL-29::Cisplatin
HCC1143::SB216763
KP-4::SGC0946
SIMA::Pictilisib
LN-18::Rucaparib
EW-22::Alisertib
NCI-H1623::GW441756
NB12::Cisplatin
CAL-29::Picolinici-acid
SK-OV-3::Picolinici-acid
SN12C::Palbociclib
NALM-6::ML323
OCI-M1::BMS-536924
EFO-21::Doramapimod
SK-OV-3::GDC0810
SU8686::BMS-536924
ESO51::Fulvestrant
LN-18::Selumetinib
SU-DHL-1::Daporinad
KARPAS-620::Docetaxel
SU-DHL-1::Pevonedistat
CAL-29::MIRA-1
CAL-29::Gefitinib
U031::Paclitaxel
NOS-1::GW441756
NUGC-4::PFI-1
LB647-SCLC::P22077
ChaGo-K-1::Temsirolimus
KP-4::Alisertib
NCI-H1623::Dinaciclib
CPC-N::Ipatasertib
ESO51::Methotrexate
LB2241-RCC::Alisertib
A388::XAV939
SU-DHL-1::Leflunomide
KGN::Gemcitabine
MEL-HO::Alpelisib
U031::Olaparib
NOS-1::GSK343
EFO-21::Cytarabine
EFO-21::RVX-208
UMC-11::SB216763
NCI-H1993::JQ1
LB2241-RCC::PRIMA-1MET
SU8686::Docetaxel
EW-22::PCI-34051
LB2241-RCC::Wnt-C59
RT-112::Venetoclax
UMC-11::JQ1
NOS-1::OTX015
NALM-6::Sorafenib
KGN::AZD3759
LN-18::Vorinostat
LU-135::PD0325901
NOS-1::Nutlin-3a (-)
DMS-114::AZD8055
NOS-1::Cytarabine
NUGC-4::Navitoclax
NCI-H1623::IWP-2
LC-2-ad::Tamoxifen
SN12C::Bosutinib
DMS-114::Wnt-C59
KARPAS-620::GSK591
SN12C::AZD8055
NALM-6::Refametinib
CPC-N::MIM1
CPC-N::Savolitinib
SU8686::Vismodegib
KGN::Cytarabine
NCI-H1993::ZM447439
AU565::Afuresertib
HPAF-II::WEHI-539
SU-DHL-1::Irinotecan
LU-135::Linsitinib
HPAF-II::ABT737
UMC-11::Cediranib
NCI-H1623::BMS-536924
KARPAS-620::MIRA-1
RT-112::Vinorelbine
KARPAS-620::ML323
EFO-21::ZM447439
UMC-11::KRAS (G12C) Inhibitor-12
CHP-134::UMI-77
NUGC-4::NU7441
HCC1143::Epirubicin
LC-2-ad::Lapatinib
Becker::Irinotecan
NB12::Sepantronium bromide
CHP-134::MIM1
Becker::Fulvestrant
U031::PRIMA-1MET
SU8686::Tamoxifen
KP-4::MK-8776
SU8686::Lestaurtinib
SK-OV-3::Palbociclib
U031::Telomerase Inhibitor IX
U031::JQ1
EW-22::Picolinici-acid
HCC1143::GSK343
LB2241-RCC::MK-2206
ESO51::Temozolomide
SU8686::Obatoclax Mesylate
LC-2-ad::OSI-027
SIMA::Selumetinib
A388::VE821
ESO51::Selumetinib
LB647-SCLC::Leflunomide
AU565::Vinorelbine
LC-2-ad::LGK974
JHOS-3::Wnt-C59
SN12C::Linsitinib
CPC-N::Tamoxifen
CAL-29::Niraparib
U031::Vismodegib
NCI-H1623::P22077
CP50-MEL-B::AZ6102
A388::Tanespimycin
ESO51::Ribociclib
ESO51::Gemcitabine
SIMA::Vorinostat
KARPAS-620::VX-11e
LN-18::GSK343
SIMA::Rapamycin
EFO-21::Foretinib
AU565::CZC24832
LB2241-RCC::CCT007093
OCI-M1::GSK1904529A
TE-4::Bosutinib
CHP-134::Epirubicin
KP-4::Methotrexate
MEL-HO::OTX015
RT-112::PFI3
KGN::GSK1904529A
LN-18::P22077
TE-4::GNE-317
HPAF-II::LJI308
EFO-21::Luminespib
LN-18::Bleomycin (50 uM)
SU8686::Pyridostatin
SU8686::Erlotinib
LN-18::Nutlin-3a (-)
NCI-H1623::I-BET-762
Becker::Savolitinib
LC-2-ad::Nutlin-3a (-)
SIMA::Crizotinib
Becker::Niraparib
NB12::Navitoclax
OCI-M1::Osimertinib
CP50-MEL-B::SN-38
TE-4::Wee1 Inhibitor
CAL-29::AZD3759
JHOS-3::LCL161
SK-OV-3::Niraparib
LB647-SCLC::PLX-4720
UMC-11::Alisertib
NCI-H1623::VX-11e
KARPAS-620::Epirubicin
DMS-114::Ipatasertib
CP50-MEL-B::Daporinad
CAL-29::Alisertib
JHOS-3::Rucaparib
DMS-114::OSI-027
LB2241-RCC::WEHI-539
EW-22::VX-11e
SU-DHL-1::Vinorelbine
EW-22::WIKI4
KGN::Tanespimycin
NUGC-4::JQ1
DMS-114::AMG-319
KGN::Telomerase Inhibitor IX
OCI-M1::Bortezomib
ChaGo-K-1::SB505124
A388::BIBR-1532
NCI-H1993::BMS-536924
MEL-HO::NU7441
NOS-1::VE-822
SK-OV-3::NU7441
ChaGo-K-1::RVX-208
ChaGo-K-1::LY2109761
HCC1143::GSK2578215A
EW-22::PD173074
HPAF-II::Taselisib
LB647-SCLC::Alisertib
DMS-114::ABT737
JHOS-3::Paclitaxel
MEL-HO::Crizotinib
HPAF-II::Camptothecin
CHP-134::PFI3
AU565::Cisplatin
MEL-HO::AGI-5198
HCC1143::MK-1775
KGN::Axitinib
ChaGo-K-1::BMS-345541
SN12C::Alisertib
NB12::AZD6738
A388::Elesclomol
AU565::5-Fluorouracil
EFO-21::Methotrexate
HPAF-II::Niraparib
LB647-SCLC::PD0325901
CP50-MEL-B::WEHI-539
TE-4::MK-2206
CP50-MEL-B::Pictilisib
ESO51::OF-1
ESO51::LCL161
ChaGo-K-1::Cediranib
SU-DHL-1::PCI-34051
CAL-29::Oxaliplatin
AU565::JNK Inhibitor VIII
UMC-11::VE821
CAL-29::SGC0946
KARPAS-620::Ruxolitinib
A388::OSI-027
CP50-MEL-B::BIBR-1532
NCI-H1993::Tamoxifen
EW-22::Camptothecin
U031::SL0101
LU-135::PD173074
JHOS-3::Motesanib
CP50-MEL-B::XAV939
SIMA::AZD3759
SIMA::ZM447439
OCI-M1::P22077
NCI-H1993::XAV939
RT-112::AGI-6780
SU8686::AZ960
SU8686::MG-132
KGN::PD0325901
CHP-134::PRT062607
NUGC-4::Tanespimycin
NUGC-4::Erlotinib
CP50-MEL-B::MN-64
AU565::GW441756
TE-4::Rucaparib
LB647-SCLC::PFI3
KP-4::Afuresertib
DMS-114::Dinaciclib
RT-112::Vismodegib
CAL-29::LY2109761
CP50-MEL-B::Navitoclax
LN-18::Taselisib
CHP-134::Vorinostat
NB12::Docetaxel
MEL-HO::Olaparib
HPAF-II::Cytarabine
TE-4::SGC0946
HCC1143::SB590885
HPAF-II::OSI-027
LB2241-RCC::AZD6738
LC-2-ad::OTX015
NCI-H1993::MG-132
SU-DHL-1::MK-1775
LC-2-ad::BMS-536924
CPC-N::SGC0946
NOS-1::Vinblastine
MEL-HO::Vismodegib
LB2241-RCC::LGK974
KP-4::Axitinib
SU-DHL-1::Entospletinib
LU-135::SCH772984
U031::CCT-018159
KP-4::GSK2606414
LN-18::Gefitinib
LN-18::Pictilisib
OCI-M1::Dasatinib
CP50-MEL-B::EPZ5676
LC-2-ad::Docetaxel
HCC1143::Pictilisib
AU565::PLX-4720
SN12C::Ibrutinib
SN12C::AZ960
KARPAS-620::IWP-2
AU565::Nilotinib
JHOS-3::Rapamycin
CAL-29::BMS-345541
U031::AGI-6780
CPC-N::XAV939
KGN::WEHI-539
LC-2-ad::EPZ004777
HCC1143::Gefitinib
HCC1143::RVX-208
AU565::VE-822
Becker::Serdemetan
LN-18::RO-3306
CAL-29::Refametinib
KGN::Ribociclib
LU-135::Luminespib
NUGC-4::EHT-1864
Becker::BI-2536
UMC-11::WZ4003
CPC-N::Wnt-C59
CP50-MEL-B::RVX-208
NCI-H1623::Doramapimod
CAL-29::Sabutoclax
U031::EPZ5676
KARPAS-620::MK-2206
NUGC-4::Palbociclib
ESO51::Nutlin-3a (-)
SU-DHL-1::AZD5582
SU8686::Cytarabine
SN12C::Doramapimod
OCI-M1::Sorafenib
MEL-HO::YK-4-279
LU-135::Temozolomide
NALM-6::BI-2536
UMC-11::Entinostat
SN12C::Methotrexate
DMS-114::BMS-345541
DMS-114::Tanespimycin
HCC1143::Luminespib
EW-22::Entospletinib
HCC1143::Ruxolitinib
TE-4::PCI-34051
HCC1143::Navitoclax
KP-4::SB216763
LN-18::AZD3759
SIMA::Sapitinib
EW-22::AZD8055
DMS-114::Dabrafenib
AU565::PRIMA-1MET
CPC-N::Temsirolimus
UMC-11::BMS-345541
CPC-N::LCL161
NCI-H1623::Lestaurtinib
CAL-29::RVX-208
AU565::AZD8055
OCI-M1::WIKI4
LB2241-RCC::Palbociclib
LB647-SCLC::Motesanib
EW-22::SB590885
KGN::SGC0946
MEL-HO::Oxaliplatin
SIMA::PD173074
ChaGo-K-1::AZD6738
LN-18::OF-1
Becker::AZD7762
DMS-114::Nutlin-3a (-)
MEL-HO::Foretinib
NCI-H1993::Entinostat
NOS-1::RO-3306
MEL-HO::WZ4003
NB12::AMG-319
ChaGo-K-1::Temozolomide
JHOS-3::RVX-208
SU8686::P22077
AU565::Cediranib
SU8686::Dasatinib
KGN::SN-38
LC-2-ad::Tanespimycin
A388::Venetoclax
NCI-H1993::Irinotecan
TE-4::Obatoclax Mesylate
AU565::Crizotinib
CPC-N::AZD7762
CP50-MEL-B::Elesclomol
LC-2-ad::PF-4708671
A388::Doramapimod
JHOS-3::CZC24832
NALM-6::I-BET-762
ChaGo-K-1::Sapitinib
HCC1143::P22077
EFO-21::Leflunomide
A388::PFI-1
NALM-6::JNK Inhibitor VIII
LC-2-ad::Cediranib
DMS-114::Ruxolitinib
LN-18::VX-11e
CPC-N::Sabutoclax
NCI-H1993::Vorinostat
CP50-MEL-B::Wee1 Inhibitor
EFO-21::JQ1
KGN::SCH772984
NB12::Irinotecan
HPAF-II::UMI-77
SU-DHL-1::PD0325901
DMS-114::Selumetinib
ChaGo-K-1::AZD8186
SIMA::YK-4-279
OCI-M1::VE-822
NALM-6::Motesanib
EW-22::CZC24832
ChaGo-K-1::Rucaparib
SK-OV-3::PD173074
AU565::Vorinostat
NUGC-4::I-BRD9
NCI-H1623::MG-132
TE-4::SCH772984
OCI-M1::KU-55933
SU8686::LJI308
ChaGo-K-1::SCH772984
NOS-1::Crizotinib
DMS-114::LCL161
EFO-21::Trametinib
EW-22::Taselisib
LU-135::Refametinib
ChaGo-K-1::Camptothecin
SIMA::Ribociclib
HCC1143::GSK269962A
A388::PFI3
HCC1143::AZD3759
EFO-21::WEHI-539
HCC1143::Talazoparib
OCI-M1::PD0325901
AU565::VE821
TE-4::PFI-1
NCI-H1993::AZD7762
ESO51::EPZ5676
U031::Tozasertib
UMC-11::AZ6102
JHOS-3::Veliparib
CP50-MEL-B::Sorafenib
LB2241-RCC::Oxaliplatin
CPC-N::Gemcitabine
CAL-29::Vismodegib
U031::WZ4003
MEL-HO::PFI-1
LB647-SCLC::IOX2
HCC1143::AZD7762
ChaGo-K-1::MG-132
CP50-MEL-B::AZD6738
SU8686::Temsirolimus
KARPAS-620::LY2109761
U031::SN-38
EW-22::LJI308
LN-18::Talazoparib
SU8686::NU7441
SIMA::Dabrafenib
CAL-29::Pyridostatin
HPAF-II::Oxaliplatin
LB2241-RCC::MN-64
A388::Rucaparib
SIMA::SCH772984
KP-4::Docetaxel
LB2241-RCC::GSK1904529A
TE-4::Ruxolitinib
U031::Rapamycin
NCI-H1623::PLX-4720
SIMA::Camptothecin
LB647-SCLC::Entinostat
SU-DHL-1::PLX-4720
LB647-SCLC::AGI-5198
MEL-HO::Piperlongumine
RT-112::AGI-5198
CPC-N::VE821
SIMA::Bosutinib
EW-22::OF-1
SN12C::Lestaurtinib
JHOS-3::CCT-018159
NALM-6::MG-132
Becker::PLX-4720
SIMA::Bortezomib
ESO51::AZD6738
SU-DHL-1::5-Fluorouracil
A388::Methotrexate
NOS-1::Rucaparib
LB2241-RCC::Rapamycin
LB647-SCLC::IWP-2
NUGC-4::Lestaurtinib
SU8686::SB590885
NCI-H1993::BI-2536
Becker::YK-4-279
EW-22::VE821
LB647-SCLC::Tamoxifen
ChaGo-K-1::JQ1
LU-135::BIBR-1532
LC-2-ad::EPZ5676
EW-22::Rucaparib
RT-112::Cisplatin
AU565::Sapitinib
NALM-6::AZ6102
CP50-MEL-B::WZ4003
OCI-M1::AZD3759
OCI-M1::XAV939
SIMA::AZ6102
EW-22::Nutlin-3a (-)
CHP-134::WIKI4
LC-2-ad::Ipatasertib
CP50-MEL-B::Tozasertib
KGN::Lenalidomide
EFO-21::Sepantronium bromide
EW-22::Irinotecan
SIMA::XAV939
LC-2-ad::VE821
U031::Gemcitabine
NOS-1::Picolinici-acid
EFO-21::Talazoparib
Becker::AZD6738
NCI-H1993::VE-822
RT-112::Cyclophosphamide
ESO51::MG-132
SIMA::Luminespib
DMS-114::MIM1
HPAF-II::AZD4547
LB2241-RCC::VX-11e
DMS-114::MK-8776
LC-2-ad::Linsitinib
LB647-SCLC::Cyclophosphamide
LC-2-ad::Bicalutamide
CP50-MEL-B::PD0325901
AU565::GSK269962A
SU8686::Cyclophosphamide
AU565::Oxaliplatin
MEL-HO::ZM447439
A388::WIKI4
SU-DHL-1::Afuresertib
ESO51::GSK2606414
DMS-114::GSK2830371
KARPAS-620::OTX015
ESO51::AZD8186
EW-22::Telomerase Inhibitor IX
CPC-N::Afatinib
DMS-114::Alpelisib
CPC-N::WZ4003
LC-2-ad::Temozolomide
CP50-MEL-B::AMG-319
CAL-29::MIM1
SK-OV-3::BIBR-1532
TE-4::Olaparib
SN12C::MIRA-1
SK-OV-3::IWP-2
NCI-H1623::Avagacestat
KP-4::Dactolisib
KP-4::EPZ004777
SU8686::GSK1904529A
NCI-H1993::OF-1
NCI-H1623::Rucaparib
CP50-MEL-B::OF-1
RT-112::Camptothecin
OCI-M1::Leflunomide
NALM-6::GSK2578215A
CAL-29::Foretinib
RT-112::BMS-345541
HPAF-II::Linsitinib
KGN::PLX-4720
MEL-HO::SB590885
LB2241-RCC::Serdemetan
DMS-114::Telomerase Inhibitor IX
SK-OV-3::Nilotinib
SIMA::Gefitinib
SN12C::Sepantronium bromide
NALM-6::IWP-2
OCI-M1::GDC0810
NOS-1::Wnt-C59
CP50-MEL-B::Uprosertib
JHOS-3::Epirubicin
NUGC-4::PD0325901
KARPAS-620::JNK Inhibitor VIII
AU565::BMS-345541
UMC-11::Entospletinib
EFO-21::Motesanib
SN12C::Wnt-C59
NALM-6::AZD4547
SIMA::Axitinib
A388::Docetaxel
NCI-H1623::Niraparib
EW-22::Trametinib
SU8686::VX-11e
CHP-134::MK-8776
SIMA::BMS-536924
TE-4::GDC0810
SU-DHL-1::Temsirolimus
HCC1143::Tamoxifen
ChaGo-K-1::AZ960
AU565::Olaparib
KP-4::Vismodegib
SK-OV-3::Alisertib
OCI-M1::MIM1
HCC1143::Erlotinib
ESO51::PD0325901
NCI-H1993::AZD4547
LU-135::Avagacestat
ESO51::Venetoclax
LB2241-RCC::AGI-5198
MEL-HO::LJI308
LB2241-RCC::Temozolomide
LC-2-ad::Pevonedistat
HCC1143::Vinblastine
NALM-6::Entospletinib
KARPAS-620::5-Fluorouracil
SN12C::PD0325901
LB647-SCLC::Sabutoclax
SU-DHL-1::VX-11e
LC-2-ad::Wee1 Inhibitor
SIMA::PRIMA-1MET
LN-18::Vismodegib
KP-4::Crizotinib
SU-DHL-1::AZD7762
LB2241-RCC::Pevonedistat
CPC-N::NVP-ADW742
MEL-HO::PRIMA-1MET
NCI-H1623::MIRA-1
LN-18::Wee1 Inhibitor
CP50-MEL-B::PFI3
SN12C::Nilotinib
NALM-6::Cytarabine
LB2241-RCC::Vinorelbine
MEL-HO::Sabutoclax
SK-OV-3::Cyclophosphamide
SN12C::VE821
NB12::Osimertinib
ChaGo-K-1::GNE-317
KP-4::Alpelisib
TE-4::AZD4547
AU565::PD173074
CP50-MEL-B::Nilotinib
KGN::LGK974
MEL-HO::VE821
EW-22::Temozolomide
TE-4::Axitinib
DMS-114::GNE-317
MEL-HO::GSK2606414
DMS-114::RVX-208
HPAF-II::GSK2578215A
JHOS-3::Taselisib
JHOS-3::Lenalidomide
NCI-H1993::Erlotinib
A388::Afatinib
KARPAS-620::GSK343
KGN::YK-4-279
EW-22::I-BRD9
CPC-N::Trametinib
LN-18::Afuresertib
JHOS-3::Tamoxifen
CP50-MEL-B::Taselisib
CAL-29::Bosutinib
DMS-114::Vinorelbine
U031::Pictilisib
AU565::Fulvestrant
SN12C::Entinostat
LB647-SCLC::Ribociclib
SU-DHL-1::P22077
SK-OV-3::MN-64
NALM-6::WEHI-539
Becker::AZD8055
ESO51::Dinaciclib
SU-DHL-1::AGI-5198
SN12C::MK-1775
LU-135::PCI-34051
SN12C::KU-55933
LB647-SCLC::Daporinad
A388::Cyclophosphamide
OCI-M1::Wee1 Inhibitor
LB2241-RCC::Camptothecin
SIMA::Temozolomide
HCC1143::I-BET-762
ESO51::Nilotinib
AU565::Sepantronium bromide
AU565::Ribociclib
NB12::Veliparib
LC-2-ad::KU-55933
CAL-29::Veliparib
A388::PRIMA-1MET
SIMA::Palbociclib
Becker::GDC0810
NCI-H1623::JQ1
KGN::ABT737
LU-135::Vorinostat
MEL-HO::OSI-027
NOS-1::Alisertib
NCI-H1993::Picolinici-acid
CP50-MEL-B::EHT-1864
HPAF-II::Leflunomide
Becker::Axitinib
NCI-H1993::Oxaliplatin
EW-22::RVX-208
NCI-H1993::Cytarabine
NUGC-4::Wee1 Inhibitor
RT-112::Ibrutinib
SN12C::SN-38
KGN::OSI-027
EW-22::Luminespib
CP50-MEL-B::AZ960
NALM-6::PRT062607
JHOS-3::Nutlin-3a (-)
SK-OV-3::TW 37
AU565::Gefitinib
NUGC-4::Dactolisib
NCI-H1623::MK-1775
EW-22::EPZ5676
A388::Cediranib
CPC-N::EPZ004777
Becker::VE821
CAL-29::OTX015
CP50-MEL-B::KRAS (G12C) Inhibitor-12
OCI-M1::Camptothecin
Becker::SCH772984
EW-22::PRIMA-1MET
ChaGo-K-1::SGC0946
EFO-21::Picolinici-acid
KGN::Selumetinib
NOS-1::Epirubicin
JHOS-3::GSK343
EFO-21::LCL161
UMC-11::Cisplatin
HCC1143::KU-55933
TE-4::Cyclophosphamide
LN-18::AGI-5198
NB12::WIKI4
Becker::Ibrutinib
NOS-1::MIRA-1
LU-135::I-BET-762
A388::Temozolomide
NOS-1::OSI-027
KARPAS-620::OSI-027
ESO51::Picolinici-acid
SU8686::Entospletinib
CPC-N::Bortezomib
NCI-H1623::Ribociclib
NUGC-4::Dabrafenib
U031::WEHI-539
NOS-1::Afatinib
EFO-21::Ibrutinib
ESO51::GNE-317
NCI-H1623::Sepantronium bromide
LB647-SCLC::Palbociclib
A388::Ibrutinib
NOS-1::SB216763
SN12C::Serdemetan
U031::Irinotecan
KP-4::Bosutinib
NB12::GSK343
SIMA::BMS-345541
EW-22::GNE-317
LN-18::ML323
NALM-6::GSK2606414
CAL-29::CCT007093
SU8686::Bortezomib
MEL-HO::Lestaurtinib
Becker::VE-822
SU8686::XAV939
CHP-134::Leflunomide
AU565::LCL161
RT-112::Paclitaxel
NOS-1::WEHI-539
Becker::Wee1 Inhibitor
NCI-H1993::Refametinib
UMC-11::GSK591
Becker::WEHI-539
MEL-HO::Linsitinib
NCI-H1993::UMI-77
ESO51::GSK2830371
Becker::Nutlin-3a (-)
U031::PD0325901
NB12::Epirubicin
NOS-1::Leflunomide
Becker::AZD3759
OCI-M1::Sabutoclax
NB12::GSK2830371
NB12::JQ1
JHOS-3::Venetoclax
NOS-1::PCI-34051
SN12C::Temozolomide
UMC-11::Luminespib
KGN::Oxaliplatin
NALM-6::BMS-536924
CP50-MEL-B::GDC0810
MEL-HO::AZD3759
SIMA::GSK591
Becker::Sorafenib
MEL-HO::AZD7762
MEL-HO::Methotrexate
CAL-29::PRIMA-1MET
LC-2-ad::Tretinoin
CHP-134::Selumetinib
LN-18::CCT007093
NALM-6::Ribociclib
KGN::Rapamycin
ChaGo-K-1::Navitoclax
MEL-HO::IWP-2
JHOS-3::Crizotinib
NUGC-4::BMS-345541
JHOS-3::GSK269962A
EW-22::Vismodegib
HPAF-II::ML323
NCI-H1623::Vismodegib
LB647-SCLC::MN-64
SK-OV-3::Ipatasertib
KGN::JQ1
SIMA::Ibrutinib
DMS-114::Sorafenib
UMC-11::Temsirolimus
CPC-N::Axitinib
SK-OV-3::Leflunomide
CP50-MEL-B::Ibrutinib
SIMA::Gemcitabine
LN-18::BMS-345541
LB647-SCLC::Refametinib
TE-4::Vismodegib
MEL-HO::Dabrafenib
CP50-MEL-B::Alpelisib
NUGC-4::Wnt-C59
NUGC-4::Cediranib
ChaGo-K-1::WEHI-539
UMC-11::Gefitinib
KP-4::UMI-77
LU-135::Sapitinib
DMS-114::Tamoxifen
JHOS-3::LJI308
SU-DHL-1::BX795
ChaGo-K-1::VE-822
KGN::Ipatasertib
HCC1143::Lapatinib
DMS-114::Irinotecan
KP-4::NVP-ADW742
DMS-114::Temozolomide
ESO51::XAV939
KARPAS-620::Savolitinib
SU8686::I-BRD9
OCI-M1::SCH772984
ChaGo-K-1::Crizotinib
NCI-H1623::AGI-5198
NCI-H1993::AZD5582
NOS-1::Cediranib
OCI-M1::GW441756
TE-4::WIKI4
Becker::BMS-536924
NUGC-4::Camptothecin
LU-135::Epirubicin
SU8686::JNK Inhibitor VIII
RT-112::NVP-ADW742
SK-OV-3::GSK2830371
MEL-HO::Taselisib
KP-4::AZD3759
JHOS-3::BMS-536924
CP50-MEL-B::Temozolomide
HPAF-II::Methotrexate
CPC-N::Crizotinib
Becker::AZ6102
NCI-H1993::P22077
EW-22::Venetoclax
EFO-21::Irinotecan
U031::AZD6738
HPAF-II::Sepantronium bromide
NUGC-4::Foretinib
LB2241-RCC::Rucaparib
Becker::MG-132
HPAF-II::LGK974
LN-18::GNE-317
SK-OV-3::BMS-536924
CP50-MEL-B::PD173074
TE-4::Uprosertib
LC-2-ad::Methotrexate
LC-2-ad::XAV939
CP50-MEL-B::Olaparib
DMS-114::Uprosertib
MEL-HO::Serdemetan
LB2241-RCC::CZC24832
UMC-11::Methotrexate
OCI-M1::Erlotinib
OCI-M1::AZD8186
CPC-N::PLX-4720
U031::Cyclophosphamide
DMS-114::OTX015
KARPAS-620::MK-8776
CHP-134::Cyclophosphamide
ESO51::CZC24832
RT-112::EHT-1864
CPC-N::Selumetinib
NALM-6::Vismodegib
ChaGo-K-1::PF-4708671
UMC-11::MK-2206
RT-112::Axitinib
JHOS-3::AZD8186
NOS-1::Selumetinib
CP50-MEL-B::Rapamycin
SU-DHL-1::IOX2
EFO-21::MK-1775
SK-OV-3::Temsirolimus
LU-135::BMS-536924
EW-22::Olaparib
EW-22::Uprosertib
LB2241-RCC::LY2109761
NOS-1::Telomerase Inhibitor IX
CAL-29::Cediranib
NB12::Daporinad
NUGC-4::ML323
LB2241-RCC::Afatinib
NALM-6::VE821
ESO51::Talazoparib
U031::GSK2578215A
EW-22::Afatinib
TE-4::I-BRD9
HPAF-II::WZ4003
SU8686::Dactolisib
HCC1143::Olaparib
NCI-H1623::Epirubicin
LB647-SCLC::AMG-319
MEL-HO::OF-1
HCC1143::PD0325901
CPC-N::Pyridostatin
DMS-114::Gemcitabine
NCI-H1993::Serdemetan
AU565::SGC0946
ESO51::5-Fluorouracil
UMC-11::AZD8186
NCI-H1993::Paclitaxel
NUGC-4::Ruxolitinib
NOS-1::Vinorelbine
LB647-SCLC::Savolitinib
AU565::Nutlin-3a (-)
CPC-N::GNE-317
MEL-HO::BMS-345541
AU565::Tamoxifen
LN-18::AZD6738
CP50-MEL-B::SB216763
SU-DHL-1::Ribociclib
NOS-1::KRAS (G12C) Inhibitor-12
NCI-H1623::AZD6738
NUGC-4::BMS-536924
OCI-M1::MK-8776
A388::AZD6738
SU8686::Ipatasertib
LU-135::Lenalidomide
CAL-29::GSK591
EW-22::TW 37
LN-18::AZD8186
KP-4::Leflunomide
NCI-H1993::AGI-5198
EW-22::LCL161
LU-135::5-Fluorouracil
NUGC-4::GSK1904529A
OCI-M1::SB590885
LU-135::Pyridostatin
NB12::Trametinib
SIMA::Trametinib
DMS-114::Paclitaxel
OCI-M1::IWP-2
SK-OV-3::I-BET-762
HPAF-II::VX-11e
TE-4::GSK343
AU565::PFI3
NALM-6::Vinorelbine
DMS-114::Savolitinib
SK-OV-3::Oxaliplatin
NOS-1::Gefitinib
ESO51::GW441756
NCI-H1993::Taselisib
NB12::Motesanib
SU8686::PLX-4720
ChaGo-K-1::YK-4-279
CP50-MEL-B::PF-4708671
ESO51::BIBR-1532
OCI-M1::Oxaliplatin
NOS-1::ZM447439
NALM-6::Dactolisib
SK-OV-3::GSK343
UMC-11::KU-55933
NCI-H1993::Wee1 Inhibitor
TE-4::CCT007093
MEL-HO::Cyclophosphamide
NUGC-4::Luminespib
MEL-HO::Fulvestrant
RT-112::Temozolomide
SIMA::Linsitinib
SU-DHL-1::Foretinib
SU-DHL-1::JQ1
SU8686::RO-3306
AU565::SCH772984
Becker::CCT007093
EFO-21::Cediranib
JHOS-3::Trametinib
NCI-H1993::Sorafenib
OCI-M1::Dinaciclib
EFO-21::Tamoxifen
LB2241-RCC::Navitoclax
MEL-HO::LGK974
U031::P22077
A388::Uprosertib
RT-112::Docetaxel
A388::PD0325901
NCI-H1623::MK-8776
LB647-SCLC::KRAS (G12C) Inhibitor-12
ChaGo-K-1::GSK1904529A
A388::Afuresertib
OCI-M1::Epirubicin
MEL-HO::Sepantronium bromide
NCI-H1993::Sabutoclax
MEL-HO::Rapamycin
LC-2-ad::Afuresertib
SIMA::Taselisib
KP-4::RVX-208
CAL-29::EPZ5676
NALM-6::SB216763
DMS-114::MK-2206
RT-112::CCT007093
SN12C::Vismodegib
KP-4::JQ1
SIMA::Leflunomide
LU-135::Savolitinib
KGN::AZ6102
ChaGo-K-1::Ibrutinib
UMC-11::AGI-5198
LB2241-RCC::PFI3
SU-DHL-1::Sapitinib
CP50-MEL-B::BMS-536924
LU-135::Palbociclib
KP-4::Doramapimod
EW-22::AZ6102
NCI-H1993::Lapatinib
NUGC-4::Afuresertib
EFO-21::CCT007093
SU-DHL-1::Methotrexate
U031::Axitinib
LN-18::YK-4-279
ChaGo-K-1::OF-1
SU8686::ABT737
KP-4::AZD7762
LC-2-ad::AZD6738
CPC-N::BMS-345541
TE-4::Alisertib
CPC-N::Dabrafenib
UMC-11::PRT062607
KARPAS-620::WZ4003
KP-4::ZM447439
TE-4::Selumetinib
DMS-114::CZC24832
CHP-134::I-BRD9
TE-4::PRIMA-1MET
AU565::Temozolomide
LB647-SCLC::Wnt-C59
ChaGo-K-1::Doramapimod
NCI-H1993::LGK974
LN-18::I-BET-762
SU8686::Navitoclax
SU8686::GSK343
NB12::Ipatasertib
ChaGo-K-1::IWP-2
ChaGo-K-1::RO-3306
NALM-6::Navitoclax
Becker::Daporinad
CPC-N::AZ6102
JHOS-3::Lapatinib
LU-135::Bortezomib
SK-OV-3::AMG-319
Becker::MK-8776
NCI-H1623::PCI-34051
Becker::Afuresertib
UMC-11::AZD5582
LN-18::SN-38
HPAF-II::Selumetinib
RT-112::GSK2830371
A388::GSK2606414
ESO51::Sapitinib
SN12C::ABT737
LB647-SCLC::Trametinib
NB12::GW441756
TE-4::Niraparib
LC-2-ad::Venetoclax
SU8686::OSI-027
CAL-29::Pevonedistat
JHOS-3::Dinaciclib
LB2241-RCC::AZD8186
LN-18::GSK1904529A
UMC-11::Lestaurtinib
RT-112::VE821
LN-18::SGC0946
A388::AZD6482
NOS-1::Sepantronium bromide
ChaGo-K-1::AZD6482
UMC-11::Erlotinib
KGN::Bleomycin (50 uM)
SK-OV-3::Cytarabine
CP50-MEL-B::Lestaurtinib
JHOS-3::Pevonedistat
U031::GSK343
NCI-H1623::LCL161
LB2241-RCC::Dinaciclib
CAL-29::EHT-1864
DMS-114::Entinostat
SU-DHL-1::Savolitinib
TE-4::Temsirolimus
KARPAS-620::EHT-1864
HCC1143::AGI-6780
LB2241-RCC::Erlotinib
SN12C::Dactolisib
NUGC-4::VX-11e
A388::SB216763
SN12C::XAV939
SU-DHL-1::SN-38
SU8686::VE821
TE-4::LCL161
CPC-N::Cediranib
RT-112::GSK591
LB2241-RCC::JQ1
RT-112::Linsitinib
SU8686::OF-1
NCI-H1623::Wee1 Inhibitor
UMC-11::WIKI4
CAL-29::Selumetinib
RT-112::Dinaciclib
LU-135::SB590885
CPC-N::Camptothecin
SN12C::Telomerase Inhibitor IX
NUGC-4::MIRA-1
NB12::Alpelisib
LB2241-RCC::SB216763
CHP-134::CZC24832
NCI-H1623::Afuresertib
NCI-H1993::Osimertinib
NUGC-4::ZM447439
SK-OV-3::VE-822
LU-135::Tanespimycin
JHOS-3::Afuresertib
LU-135::Gefitinib
EFO-21::UMI-77
AU565::RVX-208
CHP-134::Sapitinib
NCI-H1993::GSK2830371
U031::Pyridostatin
CAL-29::YK-4-279
NALM-6::AGI-5198
CPC-N::PRT062607
EW-22::WZ4003
NCI-H1623::LJI308
KARPAS-620::OF-1
LC-2-ad::PRIMA-1MET
UMC-11::JNK Inhibitor VIII
LB2241-RCC::AZD6482
UMC-11::Sorafenib
AU565::Pictilisib
UMC-11::Pictilisib
HCC1143::Dactolisib
UMC-11::Ibrutinib
AU565::GSK2830371
NALM-6::Niraparib
LN-18::SCH772984
SU-DHL-1::Palbociclib
SK-OV-3::WIKI4
CP50-MEL-B::PFI-1
HPAF-II::Sorafenib
LB647-SCLC::VX-11e
SU-DHL-1::GDC0810
SK-OV-3::LGK974
KGN::TW 37
CHP-134::Wee1 Inhibitor
NCI-H1623::AZ6102
KARPAS-620::MIM1
TE-4::Palbociclib
A388::Ribociclib
ChaGo-K-1::AGI-5198
LC-2-ad::Navitoclax
HPAF-II::Telomerase Inhibitor IX
ChaGo-K-1::NVP-ADW742
CHP-134::Picolinici-acid
NALM-6::AMG-319
KARPAS-620::SN-38
NCI-H1993::GSK2578215A
NCI-H1623::Cisplatin
UMC-11::PD173074
NALM-6::P22077
KP-4::Wee1 Inhibitor
NB12::RO-3306
JHOS-3::MIRA-1
KGN::Dactolisib
ESO51::AZ6102
SN12C::Nutlin-3a (-)
U031::Picolinici-acid
A388::Piperlongumine
CAL-29::Bortezomib
NCI-H1623::Wnt-C59
KP-4::Vinorelbine
LB647-SCLC::Uprosertib
Becker::Wnt-C59
EW-22::Fulvestrant
SK-OV-3::GSK2578215A
NCI-H1623::Ibrutinib
DMS-114::PFI-1
CAL-29::Navitoclax
ESO51::Ibrutinib
CPC-N::BI-2536
NCI-H1993::Fulvestrant
NALM-6::RVX-208
U031::SB216763
NOS-1::VX-11e
KGN::LJI308
SK-OV-3::UMI-77
LN-18::ZM447439
KARPAS-620::Dinaciclib
SU-DHL-1::VE-822
LB2241-RCC::OTX015
AU565::EPZ004777
Becker::Trametinib
SIMA::Picolinici-acid
LU-135::Doramapimod
HCC1143::Osimertinib
Becker::P22077
CHP-134::Cytarabine
RT-112::AZD6738
ChaGo-K-1::Lapatinib
UMC-11::Sapitinib
CP50-MEL-B::Wnt-C59
LB647-SCLC::WEHI-539
A388::CCT007093
RT-112::Tamoxifen
LU-135::OF-1
KP-4::ABT737
SU-DHL-1::CCT007093
DMS-114::Nilotinib
LN-18::Serdemetan
HCC1143::Sepantronium bromide
CPC-N::Docetaxel
KP-4::PFI-1
NCI-H1623::AMG-319
EFO-21::VX-11e
SIMA::I-BRD9
CPC-N::GW441756
RT-112::LCL161
NOS-1::MIM1
HPAF-II::GSK591
CHP-134::5-Fluorouracil
ChaGo-K-1::MN-64
SU8686::Afuresertib
KARPAS-620::PCI-34051
EW-22::Doramapimod
NCI-H1993::Pictilisib
ChaGo-K-1::BX795
KARPAS-620::AZ6102
SK-OV-3::OF-1
DMS-114::Cytarabine
OCI-M1::Lenalidomide
Becker::Olaparib
SU8686::Taselisib
EFO-21::SGC0946
LN-18::Uprosertib
ESO51::VX-11e
EFO-21::Gefitinib
U031::Tretinoin
NCI-H1993::YK-4-279
CAL-29::P22077
SN12C::BIBR-1532
NCI-H1993::PRIMA-1MET
ChaGo-K-1::AZD5582
NALM-6::Epirubicin
NB12::AZD8186
DMS-114::Navitoclax
CPC-N::MN-64
LU-135::Oxaliplatin
SN12C::Talazoparib
HPAF-II::Docetaxel
NALM-6::Dabrafenib
SK-OV-3::AGI-6780
SN12C::Gemcitabine
NALM-6::Vinblastine
NCI-H1623::Luminespib
CPC-N::Paclitaxel
JHOS-3::Ibrutinib
ChaGo-K-1::Pictilisib
SK-OV-3::AZD7762
CHP-134::SN-38
LB2241-RCC::Foretinib
NCI-H1993::Rucaparib
SN12C::Oxaliplatin
NCI-H1623::WEHI-539
OCI-M1::JNK Inhibitor VIII
RT-112::Vinblastine
SN12C::Sapitinib
NALM-6::OF-1
OCI-M1::Paclitaxel
LC-2-ad::AZ960
KARPAS-620::Sorafenib
LB2241-RCC::Refametinib
NUGC-4::IWP-2
Becker::Cytarabine
NOS-1::MK-2206
SN12C::RVX-208
NCI-H1993::GSK1904529A
TE-4::AZ960
NALM-6::PRIMA-1MET
TE-4::AZD6738
UMC-11::GW441756
SN12C::Pevonedistat
Becker::KU-55933
SU-DHL-1::AZD3759
NOS-1::Temozolomide
NALM-6::AZD7762
A388::MN-64
TE-4::Vinblastine
LB2241-RCC::WZ4003
CHP-134::GSK2606414
DMS-114::Dasatinib
SK-OV-3::Afuresertib
SN12C::I-BRD9
SU8686::AZD4547
LC-2-ad::CCT007093
CP50-MEL-B::PLX-4720
SU8686::AZD6738
A388::Savolitinib
LC-2-ad::Niraparib
OCI-M1::Trametinib
LN-18::Osimertinib
NUGC-4::Obatoclax Mesylate
UMC-11::AZD3759
DMS-114::Gefitinib
CP50-MEL-B::Oxaliplatin
KP-4::Lestaurtinib
UMC-11::Olaparib
SU8686::YK-4-279
DMS-114::LJI308
U031::Gefitinib
CP50-MEL-B::BI-2536
NALM-6::LCL161
LC-2-ad::PFI3
HPAF-II::Cyclophosphamide
LU-135::GSK2578215A
OCI-M1::Rucaparib
SU8686::MIM1
SU8686::MK-2206
KGN::MK-8776
UMC-11::BMS-536924
RT-112::LGK974
A388::ML323
HPAF-II::Fulvestrant
A388::Nutlin-3a (-)
KARPAS-620::Selumetinib
KP-4::AZ6102
SU-DHL-1::Piperlongumine
CP50-MEL-B::PRT062607
A388::Bosutinib
DMS-114::Methotrexate
JHOS-3::MG-132
NUGC-4::VE821
EFO-21::Axitinib
TE-4::Foretinib
SIMA::Afatinib
A388::PRT062607
SU-DHL-1::Telomerase Inhibitor IX
LN-18::GSK2578215A
HPAF-II::Picolinici-acid
NALM-6::Cisplatin
CHP-134::LCL161
NOS-1::GSK2830371
CPC-N::Pictilisib
MEL-HO::I-BET-762
ESO51::Irinotecan
ChaGo-K-1::LGK974
SU-DHL-1::Talazoparib
LB2241-RCC::I-BET-762
LB647-SCLC::Telomerase Inhibitor IX
NOS-1::VE821
CPC-N::PFI-1
HCC1143::VE821
NOS-1::Camptothecin
KARPAS-620::Pyridostatin
HPAF-II::Trametinib
KGN::Luminespib
KP-4::AZD6738
KARPAS-620::Vismodegib
SN12C::AZD8186
ChaGo-K-1::MIRA-1
SN12C::RO-3306
HCC1143::OTX015
LB647-SCLC::NU7441
SK-OV-3::AZD6738
NUGC-4::Fulvestrant
LN-18::UMI-77
U031::Ibrutinib
HPAF-II::MN-64
HCC1143::SGC0946
RT-112::GDC0810
A388::AZ960
CP50-MEL-B::SB590885
TE-4::JQ1
CAL-29::Cytarabine
RT-112::IWP-2
SIMA::Wee1 Inhibitor
EW-22::KRAS (G12C) Inhibitor-12
HPAF-II::GSK343
KARPAS-620::Axitinib
NALM-6::Ruxolitinib
LU-135::Leflunomide
Becker::RO-3306
DMS-114::ML323
ESO51::KU-55933
EFO-21::NVP-ADW742
CPC-N::AZD6738
LU-135::Sabutoclax
A388::Sabutoclax
NALM-6::Avagacestat
SIMA::AGI-5198
MEL-HO::AZD8186
SU-DHL-1::Motesanib
EW-22::AZD3759
EW-22::Tamoxifen
OCI-M1::Nutlin-3a (-)
UMC-11::PFI3
KP-4::JNK Inhibitor VIII
TE-4::AZD3759
NALM-6::SGC0946
NALM-6::Oxaliplatin
ChaGo-K-1::Pyridostatin
SK-OV-3::Refametinib
MEL-HO::KU-55933
LC-2-ad::Temsirolimus
SU-DHL-1::Rucaparib
LB2241-RCC::Leflunomide
CP50-MEL-B::CCT007093
OCI-M1::AZ6102
NALM-6::GSK343
SK-OV-3::GW441756
NUGC-4::CCT007093
OCI-M1::Afuresertib
LB2241-RCC::Uprosertib
A388::GW441756
LC-2-ad::Foretinib
SIMA::AZD8186
NOS-1::I-BRD9
LB647-SCLC::LJI308
NUGC-4::Cisplatin
U031::LGK974
NUGC-4::AZD6738
ESO51::VE821
NOS-1::GDC0810
LU-135::ABT737
EW-22::GW441756
LB2241-RCC::BI-2536
ChaGo-K-1::Trametinib
EFO-21::TW 37
HPAF-II::YK-4-279
HCC1143::BMS-536924
HPAF-II::Dasatinib
A388::Trametinib
ESO51::Alisertib
Becker::Pyridostatin
SU8686::Alisertib
CHP-134::Docetaxel
NALM-6::JQ1
RT-112::RO-3306
U031::PFI-1
ChaGo-K-1::Linsitinib
CHP-134::ML323
SU-DHL-1::Rapamycin
ChaGo-K-1::Rapamycin
LB2241-RCC::MG-132
A388::Alisertib
Becker::Selumetinib
CAL-29::BMS-536924
NCI-H1993::MK-1775
NB12::SN-38
OCI-M1::AMG-319
NCI-H1993::Alisertib
EW-22::Pevonedistat
UMC-11::AZD6738
JHOS-3::Luminespib
SK-OV-3::VE821
MEL-HO::Dactolisib
NOS-1::Fulvestrant
EW-22::GSK2606414
EFO-21::RO-3306
A388::AZD3759
NOS-1::AZD3759
LB2241-RCC::ABT737
SK-OV-3::Motesanib
SU8686::Vorinostat
LU-135::GDC0810
NCI-H1623::Ipatasertib
EW-22::Niraparib
CPC-N::Erlotinib
OCI-M1::Ipatasertib
SU8686::VE-822
LU-135::Telomerase Inhibitor IX
RT-112::Sepantronium bromide
LB2241-RCC::Sepantronium bromide
SU-DHL-1::GSK591
KARPAS-620::Rucaparib
OCI-M1::MIRA-1
U031::GNE-317
EW-22::PFI3
RT-112::Nilotinib
KGN::BMS-536924
LU-135::Talazoparib
NCI-H1623::Palbociclib
HCC1143::Dasatinib
LB647-SCLC::PF-4708671
LC-2-ad::MIRA-1
CP50-MEL-B::LCL161
SK-OV-3::GNE-317
NOS-1::Tanespimycin
SN12C::I-BET-762
A388::CHIR-99021
SIMA::GNE-317
SN12C::LGK974
ChaGo-K-1::Veliparib
SN12C::Navitoclax
LN-18::PD173074
SU-DHL-1::Tozasertib
EFO-21::Entinostat
SK-OV-3::Pevonedistat
KGN::Methotrexate
NOS-1::Sabutoclax
NCI-H1993::Rapamycin
KP-4::BMS-536924
NCI-H1623::SGC0946
NCI-H1623::Dactolisib
OCI-M1::Luminespib
KARPAS-620::PLX-4720
KARPAS-620::GSK2606414
JHOS-3::PRIMA-1MET
Becker::Avagacestat
LC-2-ad::IWP-2
KGN::NU7441
U031::OF-1
A388::Taselisib
CAL-29::Wnt-C59
ChaGo-K-1::Alisertib
KP-4::Bleomycin (50 uM)
NALM-6::LGK974
LC-2-ad::GSK343
LB647-SCLC::CZC24832
CPC-N::Cisplatin
JHOS-3::Afatinib
SU8686::EPZ5676
NCI-H1623::Rapamycin
LB2241-RCC::Osimertinib
ChaGo-K-1::PRT062607
EFO-21::BMS-345541
CAL-29::Vinblastine
LB647-SCLC::MG-132
NUGC-4::AZ6102
JHOS-3::ABT737
NOS-1::AZD6738
OCI-M1::Uprosertib
MEL-HO::Tretinoin
SIMA::IWP-2
U031::OTX015
DMS-114::SB216763
AU565::XAV939
UMC-11::Osimertinib
ChaGo-K-1::LJI308
UMC-11::Vinblastine
LU-135::EPZ5676
UMC-11::Taselisib
LU-135::NU7441
NB12::Cediranib
OCI-M1::MG-132
DMS-114::Cisplatin
A388::OTX015
NUGC-4::MK-8776
NALM-6::EPZ5676
SU-DHL-1::Tanespimycin
Becker::Cisplatin
SU8686::PFI3
Becker::Ipatasertib
CPC-N::JNK Inhibitor VIII
KP-4::LJI308
UMC-11::Rucaparib
EW-22::YK-4-279
RT-112::Osimertinib
SN12C::GSK591
LN-18::NU7441
ChaGo-K-1::ML323
AU565::Wnt-C59
EFO-21::Savolitinib
SK-OV-3::Sorafenib
NUGC-4::I-BET-762
AU565::Doramapimod
OCI-M1::Doramapimod
SU-DHL-1::CCT-018159
CP50-MEL-B::Bosutinib
JHOS-3::MK-2206
MEL-HO::IOX2
NOS-1::Sorafenib
CP50-MEL-B::Doramapimod
NALM-6::MK-1775
Becker::Foretinib
CHP-134::Gemcitabine
CHP-134::Entospletinib
DMS-114::PRT062607
NCI-H1623::Alisertib
Becker::Cyclophosphamide
SN12C::MK-2206
DMS-114::Crizotinib
KP-4::WZ4003
NALM-6::Erlotinib
ESO51::Veliparib
AU565::KRAS (G12C) Inhibitor-12
NALM-6::Afatinib
KGN::Cediranib
SU8686::AZD7762
NUGC-4::GSK343
DMS-114::LY2109761
NCI-H1623::OTX015
TE-4::KRAS (G12C) Inhibitor-12
KP-4::PD173074
EFO-21::Dactolisib
ChaGo-K-1::Luminespib
JHOS-3::Entinostat
CAL-29::Linsitinib
EW-22::Paclitaxel
U031::Elesclomol
EFO-21::Nilotinib
LN-18::MIRA-1
HCC1143::Ibrutinib
UMC-11::OF-1
NOS-1::UMI-77
JHOS-3::GNE-317
SU8686::Dinaciclib
LB647-SCLC::Afatinib
HPAF-II::MIM1
CPC-N::AGI-6780
LC-2-ad::Pyridostatin
LB647-SCLC::WZ4003
RT-112::AZ6102
A388::Erlotinib
LC-2-ad::SL0101
CP50-MEL-B::VE-822
CAL-29::Ipatasertib
NOS-1::EHT-1864
OCI-M1::Lapatinib
EFO-21::AZD5582
OCI-M1::PFI-1
KP-4::AZD5582
U031::LJI308
U031::Lenalidomide
OCI-M1::NU7441
LB647-SCLC::Cediranib
DMS-114::Alisertib
LU-135::RO-3306
NCI-H1623::AZD7762
AU565::AZD6738
CPC-N::Epirubicin
HPAF-II::MIRA-1
EFO-21::Temozolomide
NB12::Gefitinib
SIMA::GSK1904529A
DMS-114::NU7441
LB647-SCLC::GSK2606414
CPC-N::MK-1775
LN-18::WZ4003
SU8686::SN-38
KGN::5-Fluorouracil
NUGC-4::Axitinib
LU-135::Motesanib
CP50-MEL-B::AZD3759
OCI-M1::RVX-208
JHOS-3::Bicalutamide
CHP-134::Oxaliplatin
LB2241-RCC::Picolinici-acid
ChaGo-K-1::Nilotinib
JHOS-3::XAV939
ChaGo-K-1::AZD7762
JHOS-3::Temsirolimus
NB12::LGK974
HCC1143::AZ960
EW-22::Dasatinib
CAL-29::Obatoclax Mesylate
EW-22::Afuresertib
LB2241-RCC::MK-8776
U031::Erlotinib
CAL-29::SCH772984
KARPAS-620::Ribociclib
Becker::5-Fluorouracil
JHOS-3::JQ1
NB12::Lapatinib
JHOS-3::GDC0810
LN-18::Linsitinib
JHOS-3::Erlotinib
UMC-11::Bleomycin (50 uM)
KP-4::Irinotecan
OCI-M1::GSK591
CPC-N::Bleomycin (50 uM)
SU8686::Rucaparib
KARPAS-620::Alpelisib
KARPAS-620::PFI3
SIMA::OSI-027
Becker::KRAS (G12C) Inhibitor-12
LC-2-ad::Trametinib
AU565::Trametinib
ESO51::Olaparib
SIMA::Wnt-C59
EW-22::GSK591
KARPAS-620::Leflunomide
A388::Lestaurtinib
ESO51::AZ960
MEL-HO::Camptothecin
A388::Dasatinib
A388::LY2109761
UMC-11::Sabutoclax
LB647-SCLC::Talazoparib
SK-OV-3::CZC24832
KARPAS-620::Olaparib
ESO51::AZD3759
NCI-H1993::Nutlin-3a (-)
NCI-H1623::GSK2606414
KARPAS-620::Bortezomib
LB647-SCLC::Foretinib
TE-4::GSK591
Becker::PRT062607
HCC1143::AZD5582
KARPAS-620::AGI-6780
DMS-114::ZM447439
UMC-11::BIBR-1532
CHP-134::PD0325901
LC-2-ad::Leflunomide
SIMA::Vismodegib
LU-135::AZD6738
Becker::Gemcitabine
NALM-6::VE-822
SK-OV-3::Methotrexate
SIMA::MG-132
NALM-6::CCT007093
CPC-N::SN-38
NCI-H1623::KU-55933
KGN::Dasatinib
MEL-HO::JNK Inhibitor VIII
NUGC-4::Leflunomide
CAL-29::Temozolomide
UMC-11::Palbociclib
ESO51::Vorinostat
NOS-1::Afuresertib
CP50-MEL-B::PRIMA-1MET
Becker::IWP-2
UMC-11::Epirubicin
UMC-11::SGC0946
SN12C::Rapamycin
LC-2-ad::AMG-319
EW-22::PLX-4720
LC-2-ad::Sepantronium bromide
SN12C::LJI308
ChaGo-K-1::CCT007093
LN-18::Savolitinib
HPAF-II::Sabutoclax
EW-22::BI-2536
LC-2-ad::Entospletinib
DMS-114::GDC0810
SU8686::GSK2606414
DMS-114::AGI-5198
NB12::Temozolomide
NCI-H1993::Savolitinib
CPC-N::SB216763
KARPAS-620::KRAS (G12C) Inhibitor-12
CHP-134::Afuresertib
RT-112::Entospletinib
ChaGo-K-1::EHT-1864
CHP-134::Rapamycin
AU565::AZD4547
KP-4::Sabutoclax
NALM-6::EPZ004777
EW-22::Bosutinib
MEL-HO::Bosutinib
JHOS-3::BX795
LB2241-RCC::Savolitinib
SU-DHL-1::Vorinostat
MEL-HO::P22077
CP50-MEL-B::I-BRD9
EW-22::Sapitinib
EFO-21::MIM1
TE-4::WZ4003
RT-112::Crizotinib
HPAF-II::Ibrutinib
U031::PLX-4720
LB647-SCLC::EPZ5676
RT-112::I-BRD9
U031::Oxaliplatin
NALM-6::Wee1 Inhibitor
NOS-1::OF-1
EFO-21::ABT737
SK-OV-3::RVX-208
JHOS-3::Talazoparib
LB647-SCLC::ABT737
UMC-11::MN-64
NOS-1::IWP-2
LU-135::GSK2606414
ChaGo-K-1::Tretinoin
JHOS-3::Sabutoclax
ChaGo-K-1::Sepantronium bromide
OCI-M1::Selumetinib
NOS-1::PRIMA-1MET
NCI-H1623::Selumetinib
Becker::XAV939
LN-18::WEHI-539
SN12C::Lenalidomide
HCC1143::SCH772984
SU8686::MK-8776
A388::PLX-4720
RT-112::Sorafenib
CPC-N::Olaparib
SN12C::Olaparib
HPAF-II::Lapatinib
NUGC-4::UMI-77
ESO51::BMS-345541
LC-2-ad::GDC0810
NOS-1::Lestaurtinib
Becker::Alpelisib
LU-135::Foretinib
OCI-M1::AZD7762
HPAF-II::BMS-345541
SU-DHL-1::GSK2606414
NOS-1::Taselisib
EFO-21::WIKI4
NALM-6::Sapitinib
HPAF-II::Axitinib
SIMA::PD0325901
NB12::Cytarabine
NUGC-4::SB216763
Becker::Leflunomide
CPC-N::Daporinad
HPAF-II::MG-132
KP-4::Camptothecin
RT-112::Niraparib
HCC1143::GSK591
NCI-H1623::GSK343
DMS-114::Epirubicin
LB647-SCLC::Gefitinib
EFO-21::LY2109761
CAL-29::WIKI4
U031::Bosutinib
LU-135::Methotrexate
LN-18::Pevonedistat
RT-112::Gefitinib
LC-2-ad::AZD5582
AU565::PRT062607
KGN::SB216763
SK-OV-3::EPZ004777
SU-DHL-1::Navitoclax
SK-OV-3::PLX-4720
ChaGo-K-1::Talazoparib
SIMA::PFI3
SU8686::GW441756
Becker::GW441756
ChaGo-K-1::Fulvestrant
LC-2-ad::Fulvestrant
MEL-HO::Pevonedistat
U031::Crizotinib
KARPAS-620::Bosutinib
Becker::Talazoparib
ESO51::Leflunomide
NOS-1::Lapatinib
LU-135::Veliparib
SU-DHL-1::Ruxolitinib
NALM-6::Trametinib
KARPAS-620::AZD4547
ESO51::ABT737
CAL-29::Nilotinib
NCI-H1993::Cediranib
LN-18::AMG-319
NCI-H1623::Dabrafenib
SU8686::PD0325901
KGN::GNE-317
CPC-N::Lestaurtinib
NOS-1::Refametinib
AU565::ML323
EW-22::MN-64
KP-4::KRAS (G12C) Inhibitor-12
SU8686::Palbociclib
MEL-HO::5-Fluorouracil
SIMA::Fulvestrant
SU-DHL-1::Sabutoclax
SN12C::NU7441
JHOS-3::AZD4547
NCI-H1993::Gemcitabine
MEL-HO::VE-822
CAL-29::Lestaurtinib
AU565::Dactolisib
NUGC-4::Tamoxifen
CHP-134::Bortezomib
RT-112::ML323
NUGC-4::Lapatinib
SN12C::Dabrafenib
DMS-114::JNK Inhibitor VIII
HPAF-II::Paclitaxel
SU-DHL-1::Gefitinib
NCI-H1623::UMI-77
ChaGo-K-1::Refametinib
ESO51::Camptothecin
CPC-N::AZD4547
SN12C::Picolinici-acid
LN-18::PLX-4720
CAL-29::PD0325901
NCI-H1623::Talazoparib
NB12::MIM1
LN-18::Leflunomide
TE-4::Epirubicin
HPAF-II::Olaparib
NCI-H1993::PD173074
KGN::Pevonedistat
EFO-21::Refametinib
ESO51::Erlotinib
JHOS-3::GSK2606414
UMC-11::Dabrafenib
SK-OV-3::Savolitinib
CP50-MEL-B::Entospletinib
MEL-HO::AZD6482
LB647-SCLC::Tozasertib
EW-22::Serdemetan
EW-22::Axitinib
NALM-6::MK-8776
TE-4::Cediranib
A388::BMS-536924
SU-DHL-1::Olaparib
JHOS-3::Niraparib
LB647-SCLC::GSK343
KARPAS-620::P22077
LB2241-RCC::Cediranib
NUGC-4::ABT737
A388::Gemcitabine
ESO51::MN-64
EFO-21::Sorafenib
LC-2-ad::Rucaparib
LB647-SCLC::Axitinib
UMC-11::PRIMA-1MET
HCC1143::Selumetinib
SK-OV-3::Serdemetan
SK-OV-3::Bosutinib
NCI-H1623::Fulvestrant
Becker::GSK2606414
SU-DHL-1::AZD4547
NOS-1::Navitoclax
LB2241-RCC::NVP-ADW742
A388::5-Fluorouracil
ESO51::Oxaliplatin
CHP-134::Sepantronium bromide
A388::SB505124
CHP-134::Dinaciclib
CHP-134::GDC0810
NB12::Camptothecin
MEL-HO::PRT062607
NB12::PD173074
SK-OV-3::Dabrafenib
KGN::MG-132
Becker::Uprosertib
AU565::OSI-027
LB647-SCLC::Sepantronium bromide
UMC-11::Vismodegib
Becker::Oxaliplatin
NCI-H1623::CZC24832
NALM-6::Fulvestrant
SN12C::Foretinib
CAL-29::Luminespib
DMS-114::Serdemetan
KGN::Vinorelbine
LB647-SCLC::SB590885
HPAF-II::Vinorelbine
UMC-11::NVP-ADW742
CAL-29::Entospletinib
NALM-6::NVP-ADW742
ChaGo-K-1::Irinotecan
NALM-6::AZD8186
JHOS-3::Dabrafenib
SIMA::P22077
CPC-N::GSK591
A388::SCH772984
EW-22::AZD8186
CP50-MEL-B::VX-11e
SU8686::AGI-5198
LB2241-RCC::Ipatasertib
DMS-114::Bleomycin (50 uM)
SIMA::CCT007093
SU-DHL-1::SCH772984
LU-135::VE-822
CAL-29::ML323
JHOS-3::Tretinoin
OCI-M1::Gemcitabine
NCI-H1993::Linsitinib
NALM-6::Camptothecin
SN12C::WIKI4
KP-4::BMS-345541
CAL-29::PD173074
LU-135::KRAS (G12C) Inhibitor-12
SN12C::Avagacestat
CAL-29::Sorafenib
SIMA::Vinorelbine
Becker::AZD5582
RT-112::Taselisib
KP-4::Cyclophosphamide
LB647-SCLC::AZD8186
CP50-MEL-B::Dinaciclib
HPAF-II::MK-8776
KARPAS-620::Lenalidomide
SN12C::PLX-4720
NOS-1::Trametinib
ESO51::Taselisib
NOS-1::Olaparib
TE-4::AMG-319
KGN::Venetoclax
DMS-114::I-BRD9
DMS-114::Cediranib
AU565::AZD6482
HCC1143::LJI308
LU-135::Afatinib
MEL-HO::AZ6102
SN12C::WEHI-539
EW-22::Pictilisib
SU8686::CZC24832
ChaGo-K-1::PFI-1
Becker::Bleomycin (50 uM)
CP50-MEL-B::Tanespimycin
KARPAS-620::Linsitinib
SU8686::GSK2578215A
NCI-H1993::AZ6102
SU-DHL-1::MK-8776
ESO51::Vismodegib
OCI-M1::Dabrafenib
U031::Sepantronium bromide
LC-2-ad::Dasatinib
EFO-21::Nutlin-3a (-)
SIMA::Tamoxifen
TE-4::GSK1904529A
HPAF-II::I-BRD9
HPAF-II::PCI-34051
ESO51::Alpelisib
KARPAS-620::Dasatinib
JHOS-3::Axitinib
DMS-114::KU-55933
SIMA::LY2109761
RT-112::VE-822
SIMA::CZC24832
HCC1143::WEHI-539
CAL-29::Docetaxel
SK-OV-3::PRIMA-1MET
TE-4::MN-64
LC-2-ad::VX-11e
ESO51::SGC0946
LB647-SCLC::Methotrexate
SU-DHL-1::BIBR-1532
NUGC-4::JNK Inhibitor VIII
OCI-M1::Cisplatin
LB2241-RCC::Motesanib
Becker::Luminespib
ESO51::Wnt-C59
NCI-H1993::Vismodegib
SU-DHL-1::Wee1 Inhibitor
Becker::ZM447439
EW-22::Ipatasertib
Becker::GSK2578215A
DMS-114::EHT-1864
NB12::Vinblastine
HCC1143::GSK2606414
EFO-21::Wee1 Inhibitor
NALM-6::PCI-34051
Becker::ML323
SK-OV-3::Sapitinib
SU-DHL-1::Gemcitabine
LB647-SCLC::JQ1
LN-18::Cediranib
A388::Fulvestrant
Becker::Entospletinib
LB647-SCLC::Alpelisib
NALM-6::AZD8055
CP50-MEL-B::Pevonedistat
SIMA::Lenalidomide
U031::AZD4547
AU565::Avagacestat
LN-18::Navitoclax
ESO51::Telomerase Inhibitor IX
EFO-21::Dabrafenib
ESO51::IWP-2
CPC-N::VE-822
SIMA::Alpelisib
NCI-H1623::I-BRD9
NB12::MIRA-1
NCI-H1993::NU7441
KP-4::Foretinib
NALM-6::PD173074
A388::Serdemetan
NCI-H1993::AZD8055
KGN::MK-2206
NCI-H1993::Dasatinib
CPC-N::Talazoparib
ChaGo-K-1::OTX015
KGN::Vorinostat
NCI-H1993::Camptothecin
NCI-H1623::SCH772984
SK-OV-3::JQ1
KGN::Doramapimod
LU-135::Alisertib
CAL-29::I-BET-762
U031::Lestaurtinib
CP50-MEL-B::Niraparib
HCC1143::UMI-77
NOS-1::Bleomycin (50 uM)
SK-OV-3::MK-2206
TE-4::Fulvestrant
HPAF-II::GW441756
HCC1143::ABT737
SU-DHL-1::WEHI-539
EW-22::NU7441
MEL-HO::Erlotinib
SK-OV-3::RO-3306
RT-112::MK-8776
SIMA::Epirubicin
SK-OV-3::GSK591
KP-4::Dabrafenib
HCC1143::Picolinici-acid
SK-OV-3::KU-55933
KP-4::OTX015
NOS-1::Vismodegib
SN12C::GSK2578215A
KGN::AMG-319
OCI-M1::Irinotecan
AU565::MN-64
CAL-29::GSK2830371
LB647-SCLC::BX795
LC-2-ad::Rapamycin
AU565::ABT737
LB2241-RCC::PCI-34051
CHP-134::Pyridostatin
HPAF-II::Luminespib
ESO51::Cediranib
JHOS-3::Dactolisib
NCI-H1623::Veliparib
UMC-11::Irinotecan
SU-DHL-1::Doramapimod
TE-4::Vorinostat
LB2241-RCC::Selumetinib
UMC-11::AZD7762
SN12C::WZ4003
Becker::Motesanib
NB12::VE821
CPC-N::Entospletinib
NB12::Sapitinib
HCC1143::Dabrafenib
RT-112::Foretinib
TE-4::WEHI-539
SU-DHL-1::Alpelisib
CHP-134::Obatoclax Mesylate
CP50-MEL-B::I-BET-762
CP50-MEL-B::Gefitinib
NUGC-4::AGI-6780
NOS-1::Dactolisib
TE-4::LGK974
NUGC-4::WIKI4
UMC-11::Niraparib
NCI-H1623::Ruxolitinib
ChaGo-K-1::SB590885
KARPAS-620::Palbociclib
ESO51::EPZ004777
U031::Temsirolimus
HCC1143::AZD4547
TE-4::ML323
HCC1143::Linsitinib
AU565::AZD5582
CHP-134::PCI-34051
ChaGo-K-1::Lenalidomide
LN-18::Paclitaxel
EFO-21::Ruxolitinib
JHOS-3::Foretinib
TE-4::VE-822
NCI-H1623::PRIMA-1MET
NOS-1::CZC24832
DMS-114::GSK591
AU565::Savolitinib
A388::YK-4-279
EW-22::Wnt-C59
NALM-6::Sabutoclax
LB647-SCLC::Linsitinib
CAL-29::Temsirolimus
SIMA::BI-2536
NALM-6::Luminespib
CP50-MEL-B::GNE-317
SU8686::LY2109761
LB647-SCLC::Dabrafenib
LN-18::Cyclophosphamide
RT-112::Fulvestrant
LB2241-RCC::GNE-317
A388::AZD8186
SN12C::Pictilisib
SIMA::Foretinib
SU-DHL-1::Temozolomide
Becker::SB590885
CAL-29::PLX-4720
NALM-6::GW441756
DMS-114::YK-4-279
NCI-H1623::Entospletinib
LB647-SCLC::Osimertinib
LN-18::MIM1
JHOS-3::Vorinostat
TE-4::SB216763
NB12::Sorafenib
CP50-MEL-B::Afuresertib
EW-22::Palbociclib
DMS-114::VE-822
LB2241-RCC::AGI-6780
RT-112::EPZ004777
SN12C::Uprosertib
MEL-HO::EPZ5676
ESO51::Temsirolimus
CHP-134::AZD6738
AU565::MIM1
SK-OV-3::Sabutoclax
EFO-21::LJI308
LN-18::SB216763
DMS-114::Sepantronium bromide
SN12C::Motesanib
LB2241-RCC::PD0325901
HCC1143::AZD8055
SU8686::OTX015
NOS-1::Ipatasertib
NCI-H1993::Leflunomide
ESO51::NVP-ADW742
SIMA::Irinotecan
Becker::Doramapimod
OCI-M1::LY2109761
KP-4::CZC24832
NB12::GSK1904529A
NB12::KU-55933
OCI-M1::Olaparib
CHP-134::Foretinib
HCC1143::EPZ004777
UMC-11::MIRA-1
NCI-H1623::GDC0810
CP50-MEL-B::Dabrafenib
OCI-M1::EPZ5676
KP-4::Sepantronium bromide
HPAF-II::Vorinostat
HCC1143::Avagacestat
SK-OV-3::Taselisib
U031::Bicalutamide
NALM-6::BMS-345541
NALM-6::Leflunomide
KARPAS-620::Tanespimycin
NCI-H1623::Pyridostatin
SK-OV-3::Cediranib
CHP-134::GSK343
Becker::Palbociclib
SN12C::5-Fluorouracil
TE-4::Erlotinib
A388::RO-3306
NOS-1::PFI-1
LB647-SCLC::EHT-1864
NCI-H1993::KRAS (G12C) Inhibitor-12
SK-OV-3::Rapamycin
A388::Motesanib
U031::PFI3
Becker::AZ960
LB647-SCLC::Crizotinib
TE-4::Entospletinib
MEL-HO::LCL161
KARPAS-620::Afatinib
NOS-1::Bortezomib
UMC-11::GSK1904529A
SU8686::LCL161
CHP-134::Olaparib
ChaGo-K-1::Paclitaxel
SU-DHL-1::GW441756
OCI-M1::CZC24832
RT-112::AZD8055
ESO51::Ruxolitinib
LC-2-ad::Palbociclib
DMS-114::Bosutinib
SU8686::AZD8186
NCI-H1993::Epirubicin
SIMA::Savolitinib
Becker::AZD4547
SU8686::Motesanib
EW-22::AZD4547
SN12C::Savolitinib
EW-22::PD0325901
EFO-21::Dinaciclib
JHOS-3::Wee1 Inhibitor
LC-2-ad::CCT-018159
NCI-H1993::5-Fluorouracil
TE-4::Sabutoclax
U031::MK-1775
NCI-H1623::Bleomycin (50 uM)
MEL-HO::GSK1904529A
KGN::Foretinib
TE-4::Navitoclax
NUGC-4::BI-2536
TE-4::Nutlin-3a (-)
U031::Bortezomib
RT-112::OF-1
NB12::Rapamycin
SN12C::MIM1
TE-4::LJI308
NCI-H1993::Sapitinib
KARPAS-620::GDC0810
ESO51::PRT062607
KP-4::PRT062607
HCC1143::VE-822
EFO-21::OF-1
KGN::AZD7762
LB647-SCLC::Nilotinib
TE-4::Osimertinib
MEL-HO::Temsirolimus
HCC1143::Trametinib
CP50-MEL-B::Ipatasertib
LN-18::XAV939
A388::VE-822
DMS-114::WZ4003
AU565::Serdemetan
CP50-MEL-B::Luminespib
AU565::AZ960
CPC-N::Entinostat
Becker::GSK2830371
NOS-1::BMS-536924
SK-OV-3::Trametinib
SU-DHL-1::Tamoxifen
TE-4::Sapitinib
MEL-HO::Gefitinib
RT-112::JQ1
NCI-H1993::CCT007093
JHOS-3::EHT-1864
SK-OV-3::Nutlin-3a (-)
A388::EHT-1864
JHOS-3::Daporinad
LC-2-ad::Ribociclib
LC-2-ad::AGI-6780
LB647-SCLC::Rapamycin
KGN::Uprosertib
LN-18::Lapatinib
A388::NVP-ADW742
EFO-21::LGK974
HCC1143::ML323
NCI-H1623::BI-2536
SK-OV-3::Fulvestrant
CP50-MEL-B::Dasatinib
SK-OV-3::Entinostat
LB647-SCLC::OTX015
LB2241-RCC::Lapatinib
NCI-H1993::EPZ004777
U031::Sorafenib
SN12C::Wee1 Inhibitor
U031::Niraparib
A388::MK-8776
UMC-11::EPZ004777
KP-4::Cediranib
SIMA::Bleomycin (50 uM)
NCI-H1623::ML323
TE-4::Telomerase Inhibitor IX
JHOS-3::IOX2
HCC1143::VX-11e
NOS-1::GSK1904529A
LB647-SCLC::Afuresertib
A388::Entinostat
CHP-134::Luminespib
OCI-M1::Cediranib
TE-4::EPZ5676
MEL-HO::GSK2578215A
KP-4::Ipatasertib
NALM-6::5-Fluorouracil
EW-22::Methotrexate
NB12::Talazoparib
NALM-6::Irinotecan
Becker::Sabutoclax
CPC-N::LJI308
JHOS-3::Cediranib
KP-4::Telomerase Inhibitor IX
NCI-H1993::WIKI4
SIMA::MK-1775
ChaGo-K-1::KU-55933
ChaGo-K-1::Ruxolitinib
LB647-SCLC::Pictilisib
SU-DHL-1::ML323
ESO51::AGI-5198
U031::BI-2536
A388::LJI308
CAL-29::SN-38
KARPAS-620::Wee1 Inhibitor
NALM-6::Cediranib
U031::Nilotinib
CPC-N::LY2109761
NCI-H1993::GNE-317
AU565::AGI-5198
CHP-134::BIBR-1532
CPC-N::Ribociclib
RT-112::Ipatasertib
NCI-H1993::GSK2606414
RT-112::OSI-027
LC-2-ad::Gefitinib
OCI-M1::LGK974
CP50-MEL-B::Ruxolitinib
LC-2-ad::Sorafenib
CAL-29::AGI-5198
CP50-MEL-B::AGI-5198
NALM-6::VX-11e
EFO-21::AZD6738
U031::JNK Inhibitor VIII
A388::Camptothecin
HPAF-II::Wee1 Inhibitor
SIMA::Venetoclax
SK-OV-3::PRT062607
AU565::Axitinib
EFO-21::NU7441
KARPAS-620::Irinotecan
A388::Niraparib
MEL-HO::PD173074
NB12::Temsirolimus
TE-4::BMS-536924
NUGC-4::MK-2206
NALM-6::Bosutinib
UMC-11::OSI-027
CAL-29::Gemcitabine
NB12::Selumetinib
SK-OV-3::KRAS (G12C) Inhibitor-12
EFO-21::JNK Inhibitor VIII
A388::AGI-5198
SN12C::EHT-1864
U031::Palbociclib
EW-22::Lenalidomide
NCI-H1623::EPZ5676
SU-DHL-1::Entinostat
SN12C::Rucaparib
RT-112::GSK1904529A
LC-2-ad::BX795
OCI-M1::Vismodegib
EFO-21::Vorinostat
SN12C::MG-132
A388::IWP-2
NB12::Serdemetan
NUGC-4::Bortezomib
JHOS-3::AZ960
CAL-29::CZC24832
SIMA::I-BET-762
ChaGo-K-1::Gefitinib
MEL-HO::SL0101
ESO51::AZD8055
CP50-MEL-B::Temsirolimus
NUGC-4::PFI3
ESO51::SCH772984
AU565::LGK974
JHOS-3::OTX015
NOS-1::JNK Inhibitor VIII
ESO51::Osimertinib
KP-4::I-BET-762
LB647-SCLC::Veliparib
CHP-134::Ibrutinib
ESO51::Niraparib
OCI-M1::Entospletinib
LB2241-RCC::Nilotinib
TE-4::Crizotinib
JHOS-3::Dasatinib
HPAF-II::OTX015
KGN::Bortezomib
U031::5-Fluorouracil
SU8686::BIBR-1532
LB2241-RCC::Crizotinib
SU-DHL-1::Docetaxel
UMC-11::SB590885
LB647-SCLC::PCI-34051
SN12C::Irinotecan
RT-112::Doramapimod
NALM-6::Serdemetan
SU-DHL-1::EHT-1864
CP50-MEL-B::Lenalidomide
DMS-114::PLX-4720
LC-2-ad::GSK269962A
OCI-M1::Niraparib
KARPAS-620::Vinorelbine
SIMA::Ipatasertib
UMC-11::Veliparib
KP-4::OF-1
EFO-21::Ribociclib
Becker::UMI-77
A388::Alpelisib
A388::AZD5582
SU8686::Rapamycin
RT-112::SGC0946
SU8686::Axitinib
SU8686::AZD3759
AU565::Venetoclax
EW-22::MK-8776
KP-4::Veliparib
AU565::Motesanib
RT-112::AZD8186
LN-18::Veliparib
UMC-11::Refametinib
KARPAS-620::Tamoxifen
LB647-SCLC::MK-8776
LB2241-RCC::Nutlin-3a (-)
NOS-1::Foretinib
RT-112::Trametinib
CHP-134::OF-1
SU8686::Alpelisib
SN12C::AZD7762
DMS-114::Linsitinib
NCI-H1993::MIM1
ESO51::AMG-319
JHOS-3::Cyclophosphamide
HCC1143::Vorinostat
LU-135::Taselisib
KARPAS-620::Lestaurtinib
NUGC-4::Olaparib
U031::BMS-536924
HPAF-II::Tamoxifen
NOS-1::MK-8776
CHP-134::Camptothecin
NCI-H1993::AZD6738
RT-112::Alpelisib
CHP-134::SCH772984
TE-4::Wnt-C59
LB2241-RCC::Sorafenib
NOS-1::Bosutinib
NUGC-4::Linsitinib
Becker::LY2109761
EFO-21::PD0325901
ChaGo-K-1::CHIR-99021
SU-DHL-1::PF-4708671
OCI-M1::PLX-4720
OCI-M1::GSK343
SN12C::Tamoxifen
NALM-6::LY2109761
EFO-21::Pevonedistat
CHP-134::RVX-208
RT-112::SB590885
HCC1143::Bortezomib
A388::AZD4547
SU-DHL-1::Luminespib
CHP-134::Temozolomide
AU565::Cytarabine
NCI-H1623::VE821
EFO-21::MK-2206
HCC1143::PF-4708671
MEL-HO::AZD4547
SK-OV-3::Olaparib
KGN::Gefitinib
RT-112::Cediranib
OCI-M1::AGI-6780
UMC-11::OTX015
LU-135::GW441756
U031::GSK269962A
HCC1143::IWP-2
LB647-SCLC::Temsirolimus
U031::Wnt-C59
SU-DHL-1::NVP-ADW742
OCI-M1::Axitinib
CPC-N::Nilotinib
U031::Methotrexate
LU-135::PRT062607
CPC-N::Lenalidomide
CHP-134::Nilotinib
Becker::Obatoclax Mesylate
AU565::Entinostat
HPAF-II::Uprosertib
NOS-1::Erlotinib
ChaGo-K-1::Wee1 Inhibitor
CHP-134::Tamoxifen
TE-4::NU7441
NUGC-4::LY2109761
CAL-29::JNK Inhibitor VIII
KP-4::Venetoclax
LU-135::Crizotinib
EW-22::Tanespimycin
LN-18::GW441756
SU8686::Uprosertib
CHP-134::MK-2206
SN12C::Vorinostat
CP50-MEL-B::CZC24832
DMS-114::TW 37
HPAF-II::Gefitinib
SK-OV-3::AZD3759
NCI-H1623::SB590885
SU8686::Dabrafenib
NOS-1::Luminespib
SN12C::NVP-ADW742
KARPAS-620::KU-55933
ChaGo-K-1::JNK Inhibitor VIII
SIMA::Dasatinib
KGN::EPZ5676
EFO-21::OTX015
NOS-1::NU7441
CAL-29::GSK343
DMS-114::WEHI-539
OCI-M1::Methotrexate
EFO-21::PRIMA-1MET
SIMA::Veliparib
CP50-MEL-B::MK-8776
UMC-11::CZC24832
LB2241-RCC::Tretinoin
LB647-SCLC::ML323
SK-OV-3::Sepantronium bromide
RT-112::Afuresertib
LN-18::Ribociclib
CAL-29::IWP-2
LN-18::5-Fluorouracil
CPC-N::PRIMA-1MET
CAL-29::AZD7762
TE-4::AZD5582
SIMA::Sepantronium bromide
SU-DHL-1::GNE-317
EFO-21::AZD8186
U031::Entinostat
ESO51::Lestaurtinib
NCI-H1623::CCT007093
Becker::WZ4003
ChaGo-K-1::GSK591
NCI-H1623::Sapitinib
LC-2-ad::AZD8186
A388::Palbociclib
MEL-HO::MG-132
SK-OV-3::Temozolomide
KP-4::GDC0810
TE-4::Methotrexate
CP50-MEL-B::Osimertinib
KARPAS-620::Dactolisib
CAL-29::Olaparib
LN-18::Obatoclax Mesylate
EFO-21::Docetaxel
U031::LCL161
ESO51::Entospletinib
Becker::LCL161
U031::Wee1 Inhibitor
MEL-HO::LY2109761
SK-OV-3::Dactolisib
AU565::SN-38
NALM-6::Nutlin-3a (-)
LC-2-ad::Vinorelbine
KARPAS-620::Rapamycin
CP50-MEL-B::Foretinib
ESO51::Afatinib
SIMA::Entospletinib
SN12C::Veliparib
SU8686::PCI-34051
MEL-HO::Wee1 Inhibitor
LU-135::Dabrafenib
NCI-H1993::Telomerase Inhibitor IX
NALM-6::SCH772984
Becker::SB216763
EW-22::P22077
SK-OV-3::Osimertinib
KARPAS-620::PD173074
EW-22::Vinorelbine
AU565::Ruxolitinib
EW-22::Wee1 Inhibitor
SIMA::MN-64
JHOS-3::WIKI4
SN12C::Vinblastine
KARPAS-620::AGI-5198
KGN::Trametinib
TE-4::NVP-ADW742
ESO51::MIM1
KP-4::AZD8186
LU-135::P22077
CPC-N::Methotrexate
UMC-11::Sepantronium bromide
CPC-N::LGK974
SK-OV-3::Dinaciclib
KP-4::Vorinostat
NALM-6::Lestaurtinib
OCI-M1::WZ4003
JHOS-3::Ruxolitinib
SIMA::Cediranib
HCC1143::Rucaparib
CAL-29::Vorinostat
ChaGo-K-1::Osimertinib
AU565::EHT-1864
KP-4::Serdemetan
NUGC-4::GSK2606414
NUGC-4::Temsirolimus
SU8686::Fulvestrant
RT-112::WEHI-539
NCI-H1993::Luminespib
CP50-MEL-B::ZM447439
KGN::CCT007093
LN-18::Afatinib
KARPAS-620::Venetoclax
LC-2-ad::GNE-317
DMS-114::AZD3759
OCI-M1::Ruxolitinib
NCI-H1623::Venetoclax
OCI-M1::AGI-5198
SU8686::Vinblastine
LB647-SCLC::5-Fluorouracil
U031::BIBR-1532
SK-OV-3::AZD8186
NOS-1::AGI-5198
LB647-SCLC::Lapatinib
TE-4::Dinaciclib
EFO-21::Obatoclax Mesylate
NCI-H1993::Cisplatin
CP50-MEL-B::SCH772984
TE-4::PFI3
SU8686::Entinostat
Becker::GSK1904529A
CPC-N::Alisertib
OCI-M1::Vinblastine
SU-DHL-1::PRIMA-1MET
RT-112::Afatinib
DMS-114::Lapatinib
LB647-SCLC::SL0101
ESO51::Doramapimod
RT-112::SCH772984
LN-18::AZD8055
LB2241-RCC::AZD4547
NALM-6::Selumetinib
SIMA::PCI-34051
ChaGo-K-1::Epirubicin
TE-4::Talazoparib
LB2241-RCC::GSK591
ChaGo-K-1::Serdemetan
SU-DHL-1::MG-132
UMC-11::Afatinib
MEL-HO::ML323
LB2241-RCC::Elesclomol
KGN::Paclitaxel
DMS-114::AGI-6780
SU8686::Leflunomide
EFO-21::PRT062607
DMS-114::AZD5582
HCC1143::Gemcitabine
ChaGo-K-1::WZ4003
EFO-21::AZD8055
SN12C::JNK Inhibitor VIII
KP-4::MIM1
DMS-114::Pevonedistat
CAL-29::Savolitinib
ChaGo-K-1::Taselisib
SN12C::AGI-6780
SN12C::LCL161
NCI-H1623::Cytarabine
SU-DHL-1::Taselisib
A388::Pevonedistat
OCI-M1::EHT-1864
KP-4::PCI-34051
ESO51::Refametinib
A388::LCL161
NCI-H1623::GSK1904529A
CAL-29::Dabrafenib
HPAF-II::Ruxolitinib
LU-135::GNE-317
LN-18::PRT062607
AU565::Rapamycin
RT-112::Cytarabine
NUGC-4::Rapamycin
KARPAS-620::Talazoparib
CPC-N::GSK1904529A
SN12C::Afuresertib
KP-4::Lenalidomide
LC-2-ad::MK-1775
LC-2-ad::Irinotecan
EFO-21::Olaparib
LU-135::Sepantronium bromide
CAL-29::AGI-6780
EW-22::AZ960
NUGC-4::Taselisib
EFO-21::Tanespimycin
CPC-N::PCI-34051
UMC-11::Ruxolitinib
KGN::Camptothecin
Becker::Nilotinib
NCI-H1993::Daporinad
NB12::Luminespib
ESO51::SB216763
AU565::AGI-6780
Becker::Dactolisib
Becker::WIKI4
NCI-H1993::Afatinib
SK-OV-3::Linsitinib
HCC1143::Foretinib
SU8686::Savolitinib
NCI-H1993::Afuresertib
LU-135::UMI-77
U031::OSI-027
OCI-M1::Cytarabine
HCC1143::MIM1
Becker::I-BRD9
MEL-HO::Savolitinib
KP-4::GW441756
SN12C::KRAS (G12C) Inhibitor-12
LU-135::Axitinib
SIMA::WEHI-539
JHOS-3::I-BET-762
CHP-134::GSK1904529A
ESO51::Cyclophosphamide
HPAF-II::Ipatasertib
SN12C::Vinorelbine
HPAF-II::LY2109761
LB2241-RCC::Irinotecan
LB647-SCLC::JNK Inhibitor VIII
EW-22::AGI-6780
CAL-29::LGK974
UMC-11::Uprosertib
NB12::BMS-536924
SU8686::LGK974
CHP-134::Sorafenib
SU8686::MK-1775
RT-112::5-Fluorouracil
NCI-H1993::I-BRD9
LC-2-ad::WZ4003
LU-135::Navitoclax
SK-OV-3::ML323
SU-DHL-1::AZD8186
EW-22::Cisplatin
A388::Pictilisib
LB2241-RCC::MIRA-1
ChaGo-K-1::SN-38
NOS-1::Oxaliplatin
LN-18::BMS-536924
CAL-29::ZM447439
LN-18::Olaparib
U031::Ipatasertib
RT-112::Irinotecan
MEL-HO::Sapitinib
OCI-M1::Telomerase Inhibitor IX
KARPAS-620::Crizotinib
ChaGo-K-1::SB216763
ESO51::Dasatinib
NB12::P22077
AU565::VX-11e
NUGC-4::Niraparib
EW-22::Erlotinib
SK-OV-3::Lestaurtinib
EW-22::Dinaciclib
CP50-MEL-B::LGK974
NALM-6::Bortezomib
DMS-114::VX-11e
LB647-SCLC::Paclitaxel
SK-OV-3::Venetoclax
NUGC-4::Cytarabine
TE-4::Tamoxifen
Becker::Entinostat
AU565::Talazoparib
HPAF-II::Entinostat
KGN::Crizotinib
RT-112::PFI-1
EFO-21::Alpelisib
NOS-1::AZD8055
SU8686::Wee1 Inhibitor
LB2241-RCC::Trametinib
CAL-29::PRT062607
SU8686::Cisplatin
LC-2-ad::MK-2206
HPAF-II::AMG-319
NCI-H1623::Sorafenib
Becker::Temsirolimus
Becker::AGI-6780
LU-135::Vinorelbine
EFO-21::Uprosertib
SU8686::AZ6102
KGN::I-BRD9
AU565::Sorafenib
SU8686::JQ1
DMS-114::AZD7762
SN12C::SB590885
CHP-134::GSK2578215A
EW-22::ZM447439
MEL-HO::Telomerase Inhibitor IX
LB2241-RCC::Tozasertib
HCC1143::Entospletinib
LC-2-ad::SN-38
RT-112::Pictilisib
CAL-29::NU7441
SU8686::Irinotecan
LC-2-ad::ZM447439
CAL-29::ABT737
MEL-HO::Veliparib
SN12C::CZC24832
NCI-H1993::Dinaciclib
KP-4::Oxaliplatin
AU565::I-BET-762
U031::Linsitinib
TE-4::AZD7762
JHOS-3::AZD7762
NUGC-4::AGI-5198
AU565::WIKI4
TE-4::RO-3306
NOS-1::AZD5582
LU-135::EPZ004777
LB2241-RCC::Lestaurtinib
SU8686::ZM447439
NUGC-4::AMG-319
JHOS-3::I-BRD9
NOS-1::PD0325901
ESO51::Uprosertib
CP50-MEL-B::Epirubicin
NALM-6::Crizotinib
Becker::Rapamycin
RT-112::Rapamycin
Becker::Lestaurtinib
MEL-HO::Ipatasertib
ChaGo-K-1::Elesclomol
Becker::LJI308
CAL-29::Sepantronium bromide
LB2241-RCC::CHIR-99021
KP-4::Temsirolimus
EFO-21::MN-64
LB2241-RCC::Bosutinib
U031::PF-4708671
NCI-H1623::Vinblastine
KGN::Epirubicin
SU8686::5-Fluorouracil
SU8686::Linsitinib
LN-18::Temsirolimus
KP-4::AZ960
SK-OV-3::AZ6102
HCC1143::Taselisib
CP50-MEL-B::Erlotinib
RT-112::Talazoparib
MEL-HO::Entospletinib
CHP-134::AZ6102
LC-2-ad::Avagacestat
MEL-HO::AZ960
LU-135::SGC0946
ChaGo-K-1::Avagacestat
CHP-134::XAV939
EFO-21::EPZ5676
UMC-11::Linsitinib
CAL-29::WEHI-539
LU-135::Venetoclax
EW-22::ML323
U031::GSK1904529A
LC-2-ad::Alisertib
EFO-21::Pictilisib
LB2241-RCC::PF-4708671
A388::RVX-208
NB12::Olaparib
NCI-H1993::Tanespimycin
NUGC-4::Epirubicin
JHOS-3::PRT062607
ESO51::YK-4-279
A388::Dabrafenib
EFO-21::PCI-34051
LB2241-RCC::Vismodegib
SN12C::MK-8776
SU8686::NVP-ADW742
DMS-114::AZ960
CPC-N::Avagacestat
NALM-6::Obatoclax Mesylate
KARPAS-620::Uprosertib
CPC-N::KRAS (G12C) Inhibitor-12
A388::KRAS (G12C) Inhibitor-12
A388::Talazoparib
HCC1143::AGI-5198
A388::Pyridostatin
SK-OV-3::Tanespimycin
MEL-HO::Niraparib
LB2241-RCC::AZD3759
NB12::Crizotinib
Becker::NVP-ADW742
NCI-H1993::Axitinib
EW-22::NVP-ADW742
NOS-1::Tamoxifen
KP-4::P22077
MEL-HO::Rucaparib
HCC1143::CCT007093
KARPAS-620::Vorinostat
Becker::Rucaparib
NB12::Telomerase Inhibitor IX
MEL-HO::AMG-319
HCC1143::Tanespimycin
TE-4::CZC24832
U031::VE821
CHP-134::AGI-5198
EFO-21::PFI-1
CPC-N::ZM447439
OCI-M1::AZD4547
NOS-1::Niraparib
EFO-21::SN-38
CPC-N::Vismodegib
LN-18::MK-1775
U031::Avagacestat
EW-22::PFI-1
MEL-HO::Pyridostatin
NB12::MK-1775
SU8686::I-BET-762
DMS-114::Sabutoclax
U031::MG-132
NCI-H1993::Dactolisib
HCC1143::MK-2206
SN12C::AZD3759
DMS-114::Trametinib
SU-DHL-1::OSI-027
A388::I-BET-762
CAL-29::AMG-319
SK-OV-3::Wnt-C59
U031::Alisertib
LB647-SCLC::Vinorelbine
NCI-H1993::PFI3
CAL-29::Axitinib
NB12::ABT737
ESO51::MK-2206
HCC1143::AZD6482
ChaGo-K-1::Palbociclib
HCC1143::Fulvestrant
TE-4::VX-11e
LC-2-ad::JNK Inhibitor VIII
MEL-HO::WIKI4
SN12C::Afatinib
HCC1143::I-BRD9
EW-22::WEHI-539
LB647-SCLC::LY2109761
LC-2-ad::PFI-1
CP50-MEL-B::ML323
U031::GDC0810
NB12::Axitinib
SN12C::BMS-536924
LN-18::LJI308
KGN::Vismodegib
LN-18::RVX-208
LN-18::Ipatasertib
JHOS-3::Oxaliplatin
AU565::Selumetinib
CPC-N::Cyclophosphamide
LC-2-ad::LJI308
NUGC-4::Veliparib
LN-18::GSK2830371
JHOS-3::Alisertib
DMS-114::Olaparib
CP50-MEL-B::5-Fluorouracil
KGN::Taselisib
AU565::Vismodegib
HPAF-II::Pictilisib
CP50-MEL-B::GSK269962A
CP50-MEL-B::BMS-345541
CP50-MEL-B::GSK2606414
NCI-H1623::Cyclophosphamide
AU565::AZD3759
KGN::AZD6738
ChaGo-K-1::AGI-6780
HPAF-II::PLX-4720
LN-18::Lestaurtinib
NUGC-4::MK-1775
DMS-114::MK-1775
RT-112::MK-2206
EFO-21::AMG-319
SIMA::MIM1
EW-22::Dactolisib
SK-OV-3::Uprosertib
MEL-HO::KRAS (G12C) Inhibitor-12
ChaGo-K-1::BMS-536924
LB647-SCLC::Dasatinib
NOS-1::XAV939
ChaGo-K-1::GSK343
ESO51::Pyridostatin
CPC-N::WIKI4
U031::CZC24832
OCI-M1::Ibrutinib
RT-112::ABT737
CPC-N::Uprosertib
LB647-SCLC::Bortezomib
EFO-21::PFI3
HCC1143::Crizotinib
KARPAS-620::CZC24832
SN12C::GW441756
CAL-29::Afatinib
TE-4::YK-4-279
CPC-N::OTX015
SK-OV-3::Ruxolitinib
HCC1143::Cyclophosphamide
NCI-H1623::Lenalidomide
KARPAS-620::Gefitinib
ESO51::Vinorelbine
CPC-N::CZC24832
NALM-6::AZ960
MEL-HO::Tozasertib
LB2241-RCC::Dactolisib
SU-DHL-1::YK-4-279
EW-22::MK-2206
LB2241-RCC::GW441756
NCI-H1993::GW441756
LB2241-RCC::OSI-027
Becker::Bosutinib
LB647-SCLC::Nutlin-3a (-)
A388::MK-2206
Becker::Pevonedistat
SIMA::ML323
JHOS-3::Alpelisib
NB12::Savolitinib
CHP-134::Gefitinib
MEL-HO::Luminespib
NB12::Cyclophosphamide
AU565::Navitoclax
NCI-H1623::PD0325901
NALM-6::GSK1904529A
CAL-29::PCI-34051
SN12C::Ruxolitinib
UMC-11::Cyclophosphamide
Becker::Tanespimycin
RT-112::MIRA-1
LN-18::Irinotecan
UMC-11::Vorinostat
SU8686::AZD8055
RT-112::Epirubicin
NUGC-4::AZD4547
JHOS-3::Gemcitabine
UMC-11::Pyridostatin
TE-4::RVX-208
Becker::Pictilisib
LB2241-RCC::Entospletinib
AU565::Lenalidomide
ChaGo-K-1::CZC24832
HCC1143::AZD6738
OCI-M1::5-Fluorouracil
ChaGo-K-1::Bortezomib
LB2241-RCC::SB590885
LN-18::KRAS (G12C) Inhibitor-12
CPC-N::Sorafenib
EFO-21::EPZ004777
NB12::OSI-027
KARPAS-620::GSK2578215A
OCI-M1::PD173074
DMS-114::Avagacestat
NALM-6::Entinostat
KP-4::SB590885
DMS-114::Ribociclib
JHOS-3::Bortezomib
NCI-H1993::JNK Inhibitor VIII
RT-112::UMI-77
CHP-134::AZ960
A388::ABT737
EFO-21::BI-2536
NUGC-4::Bosutinib
MEL-HO::Vorinostat
HCC1143::Temsirolimus
NUGC-4::Vinblastine
LB2241-RCC::Vorinostat
EFO-21::SCH772984
LB2241-RCC::Talazoparib
UMC-11::YK-4-279
EFO-21::Pyridostatin
U031::AMG-319
UMC-11::5-Fluorouracil
A388::VX-11e
ESO51::Crizotinib
CHP-134::Nutlin-3a (-)
U031::Pevonedistat
KARPAS-620::WIKI4
U031::IWP-2
NUGC-4::Nilotinib
LB2241-RCC::Gemcitabine
A388::WEHI-539
NALM-6::AZD3759
OCI-M1::AZD5582
TE-4::VE821
KGN::PFI-1
EW-22::ABT737
HPAF-II::Alpelisib
LB647-SCLC::Dactolisib
NCI-H1993::Bosutinib
MEL-HO::Wnt-C59
SU8686::AGI-6780
EW-22::Veliparib
KARPAS-620::Bleomycin (50 uM)
ChaGo-K-1::Daporinad
KP-4::WIKI4
A388::OF-1
U031::AGI-5198
A388::Bicalutamide
NOS-1::Veliparib
MEL-HO::MK-2206
NCI-H1623::ZM447439
JHOS-3::Camptothecin
SU8686::KU-55933
AU565::Epirubicin
CAL-29::PFI-1
KGN::Cyclophosphamide
NCI-H1993::Vinblastine
RT-112::PLX-4720
DMS-114::KRAS (G12C) Inhibitor-12
EFO-21::KU-55933
SK-OV-3::ABT737
NUGC-4::GW441756
AU565::Tanespimycin
MEL-HO::MK-1775
MEL-HO::PFI3
LU-135::PFI3
MEL-HO::Venetoclax
OCI-M1::BIBR-1532
U031::I-BET-762
EW-22::Gemcitabine
SIMA::JQ1
CHP-134::Ruxolitinib
LB647-SCLC::Doramapimod
HCC1143::JQ1
CP50-MEL-B::OSI-027
NB12::AZD7762
HPAF-II::SB216763
SU-DHL-1::Lenalidomide
A388::KU-55933
NCI-H1993::CZC24832
AU565::SB590885
HCC1143::ZM447439
LU-135::RVX-208
SU-DHL-1::CZC24832
KARPAS-620::Motesanib
LU-135::Obatoclax Mesylate
LC-2-ad::Entinostat
ESO51::Cytarabine
CAL-29::MK-1775
ESO51::Tanespimycin
CHP-134::Dabrafenib
CHP-134::Linsitinib
NCI-H1993::OTX015
EW-22::Rapamycin
SU8686::EHT-1864
ChaGo-K-1::Olaparib
LN-18::Fulvestrant
LU-135::WZ4003
KARPAS-620::Gemcitabine
NCI-H1623::Nutlin-3a (-)
KARPAS-620::Paclitaxel
NOS-1::AZD8186
HPAF-II::Pevonedistat
NOS-1::Alpelisib
JHOS-3::Sapitinib
ChaGo-K-1::Picolinici-acid
NB12::LJI308
Becker::Venetoclax
MEL-HO::BX795
EFO-21::MK-8776
JHOS-3::JNK Inhibitor VIII
SK-OV-3::5-Fluorouracil
NCI-H1993::Pyridostatin
SU-DHL-1::Bicalutamide
LN-18::Alisertib
NB12::Ribociclib
HCC1143::Uprosertib
NALM-6::AZD6738
EFO-21::AGI-6780
CP50-MEL-B::LJI308
CHP-134::MG-132
LB647-SCLC::Picolinici-acid
NCI-H1623::Osimertinib
SIMA::Dinaciclib
Becker::MIM1
LC-2-ad::Telomerase Inhibitor IX
NALM-6::Dinaciclib
NUGC-4::Pevonedistat
MEL-HO::AZD6738
OCI-M1::Taselisib
SK-OV-3::PCI-34051
SU8686::Doramapimod
UMC-11::GSK2606414
EW-22::GSK2578215A
NCI-H1623::Axitinib
CHP-134::Crizotinib
NB12::TW 37
LC-2-ad::Sapitinib
CHP-134::Entinostat
SU-DHL-1::Camptothecin
U031::RVX-208
ChaGo-K-1::VE821
LB647-SCLC::GSK591
SK-OV-3::EHT-1864
NB12::AZD8055
OCI-M1::OF-1
SK-OV-3::Foretinib
RT-112::Nutlin-3a (-)
OCI-M1::MN-64
EFO-21::GSK591
SU-DHL-1::BMS-345541
MEL-HO::SB505124
SN12C::Bortezomib
SIMA::UMI-77
LB647-SCLC::Navitoclax
NB12::MG-132
EW-22::Oxaliplatin
SIMA::Telomerase Inhibitor IX
CPC-N::Doramapimod
A388::Lenalidomide
SN12C::GNE-317
CP50-MEL-B::Telomerase Inhibitor IX
ESO51::Bosutinib
HCC1143::Cytarabine
NCI-H1993::MK-8776
LU-135::Cyclophosphamide
MEL-HO::Trametinib
LC-2-ad::Uprosertib
EW-22::5-Fluorouracil
KARPAS-620::TW 37
LN-18::Rapamycin
OCI-M1::RO-3306
TE-4::Sorafenib
CP50-MEL-B::VE821
CHP-134::NVP-ADW742
KP-4::Avagacestat
RT-112::Wnt-C59
HPAF-II::I-BET-762
LU-135::Serdemetan
SIMA::VX-11e
LN-18::SB590885
SN12C::VE-822
SK-OV-3::Ibrutinib
HPAF-II::MK-2206
UMC-11::Bortezomib
ESO51::Paclitaxel
JHOS-3::BIBR-1532
LB647-SCLC::AZD3759
KGN::Irinotecan
NOS-1::MG-132
DMS-114::Picolinici-acid
NUGC-4::Alisertib
HPAF-II::Cisplatin
LC-2-ad::P22077
LC-2-ad::PCI-34051
LB2241-RCC::MK-1775
AU565::Osimertinib
SU8686::Avagacestat
UMC-11::Dactolisib
RT-112::Leflunomide
CHP-134::MIRA-1
HCC1143::Cisplatin
ChaGo-K-1::Wnt-C59
CHP-134::Erlotinib
LC-2-ad::BI-2536
LN-18::BIBR-1532
RT-112::MN-64
NOS-1::Axitinib
CAL-29::MN-64
SU8686::Foretinib
NOS-1::Motesanib
LB647-SCLC::AZ6102
LU-135::Vismodegib
U031::Alpelisib
UMC-11::Crizotinib
U031::Piperlongumine
TE-4::OSI-027
LB2241-RCC::SGC0946
SK-OV-3::Veliparib
Becker::I-BET-762
SN12C::Crizotinib
NB12::BIBR-1532
TE-4::Taselisib
A388::BX795
NALM-6::GSK2830371
KP-4::Dasatinib
SU-DHL-1::BI-2536
LC-2-ad::AZD4547
NUGC-4::WEHI-539
NALM-6::CZC24832
KARPAS-620::GNE-317
CP50-MEL-B::Linsitinib
SK-OV-3::MG-132
CPC-N::Nutlin-3a (-)
AU565::Tozasertib
CAL-29::GSK2606414
KARPAS-620::AZD6738
LU-135::Fulvestrant
JHOS-3::KU-55933
HCC1143::Camptothecin
SU8686::SGC0946
OCI-M1::EPZ004777
RT-112::Refametinib
NCI-H1993::LCL161
CAL-29::KRAS (G12C) Inhibitor-12
LB647-SCLC::MIRA-1
ChaGo-K-1::GDC0810
CHP-134::KRAS (G12C) Inhibitor-12
U031::Afatinib
KARPAS-620::SCH772984
KARPAS-620::Temozolomide
NUGC-4::Vismodegib
LN-18::GDC0810
JHOS-3::SCH772984
LU-135::Dinaciclib
NALM-6::NU7441
KARPAS-620::PD0325901
SU-DHL-1::AZ6102
SIMA::AZD8055
UMC-11::LCL161
LB647-SCLC::SN-38
LC-2-ad::MG-132
HPAF-II::Pyridostatin
RT-112::AZD3759
LN-18::Docetaxel
EW-22::RO-3306
EFO-21::Sabutoclax
SK-OV-3::OSI-027
CHP-134::Cisplatin
UMC-11::SCH772984
CHP-134::Pictilisib
SN12C::Dinaciclib
LU-135::Uprosertib
MEL-HO::Selumetinib
SIMA::Serdemetan
RT-112::Rucaparib
ESO51::ZM447439
OCI-M1::BI-2536
CPC-N::Pevonedistat
HCC1143::Palbociclib
HCC1143::Dinaciclib
EFO-21::Paclitaxel
ChaGo-K-1::Motesanib
CP50-MEL-B::Methotrexate
NCI-H1993::Bortezomib
SU8686::Trametinib
CHP-134::LY2109761
SK-OV-3::Crizotinib
CAL-29::Lenalidomide
LC-2-ad::AZD6482
NOS-1::AZD4547
SK-OV-3::SCH772984
NALM-6::TW 37
CPC-N::Sapitinib
DMS-114::Sapitinib
A388::GDC0810
CP50-MEL-B::Docetaxel
NCI-H1623::Gemcitabine
OCI-M1::Serdemetan
SK-OV-3::YK-4-279
LU-135::Tamoxifen
NCI-H1623::LY2109761
RT-112::YK-4-279
UMC-11::Temozolomide
SU-DHL-1::LGK974
EFO-21::Palbociclib
HPAF-II::Osimertinib
SIMA::AZ960
SN12C::Fulvestrant
KARPAS-620::SGC0946
DMS-114::IWP-2
NOS-1::LY2109761
NCI-H1993::LY2109761
JHOS-3::GSK591
LC-2-ad::SB590885
SU-DHL-1::Pyridostatin
UMC-11::PLX-4720
LC-2-ad::GSK1904529A
LC-2-ad::Osimertinib
CP50-MEL-B::AGI-6780
HCC1143::Vismodegib
CAL-29::MG-132
DMS-114::WIKI4
U031::Taselisib
CPC-N::Gefitinib
OCI-M1::Bosutinib
CAL-29::AZD6738
SK-OV-3::NVP-ADW742
NOS-1::LGK974
JHOS-3::Vinorelbine
HPAF-II::PRIMA-1MET
CAL-29::Taselisib
CHP-134::Pevonedistat
NOS-1::CCT007093
LN-18::GSK2606414
DMS-114::RO-3306
UMC-11::CCT007093
NALM-6::YK-4-279
KGN::AZD8186
KP-4::Navitoclax
EFO-21::AZ960
AU565::UMI-77
EW-22::BMS-536924
MEL-HO::Temozolomide
U031::XAV939
LB2241-RCC::Avagacestat
KARPAS-620::MG-132
HPAF-II::GDC0810
U031::GSK591
A388::MIRA-1
U031::Afuresertib
SU8686::GSK591
SK-OV-3::ZM447439
ChaGo-K-1::PCI-34051
EW-22::Cyclophosphamide
LN-18::NVP-ADW742
SN12C::Camptothecin
LN-18::LCL161
ChaGo-K-1::AZD4547
EFO-21::Entospletinib
ESO51::PLX-4720
U031::SGC0946
ChaGo-K-1::Afuresertib
SU8686::IWP-2
SU-DHL-1::NU7441
AU565::Bleomycin (50 uM)
SN12C::BMS-345541
HPAF-II::Afatinib
AU565::Picolinici-acid
CPC-N::BMS-536924
U031::LY2109761
LB647-SCLC::AZ960
NB12::Obatoclax Mesylate
HCC1143::Rapamycin
ESO51::Ipatasertib
NCI-H1623::Paclitaxel
JHOS-3::AGI-6780
LB647-SCLC::SGC0946
SN12C::UMI-77
LN-18::Vinblastine
Becker::CZC24832
EW-22::Temsirolimus
NALM-6::EHT-1864
AU565::Wee1 Inhibitor
LU-135::LGK974
NCI-H1993::SGC0946
Becker::Methotrexate
LB2241-RCC::EHT-1864
Becker::Vorinostat
HCC1143::GSK2830371
HPAF-II::LCL161
KGN::GSK2578215A
EW-22::IWP-2
MEL-HO::BMS-536924
UMC-11::Vinorelbine
LB647-SCLC::Epirubicin
CAL-29::Pictilisib
KGN::VX-11e
EFO-21::Sapitinib
SK-OV-3::Selumetinib
Becker::GNE-317
CP50-MEL-B::PCI-34051
KP-4::Erlotinib
U031::Selumetinib
AU565::Entospletinib
KP-4::Ribociclib
NALM-6::ABT737
ChaGo-K-1::AZD3759
LC-2-ad::Paclitaxel
KP-4::AZD4547
LB647-SCLC::AZD7762
LB2241-RCC::GSK2578215A
LC-2-ad::CZC24832
SN12C::Venetoclax
HCC1143::Niraparib
ESO51::Pevonedistat
ESO51::Afuresertib
KGN::Temozolomide
NUGC-4::SGC0946
LC-2-ad::Lestaurtinib
LU-135::Nilotinib
LB647-SCLC::Ibrutinib
SU8686::MN-64
KP-4::NU7441
NALM-6::XAV939
LU-135::MK-1775
KGN::Pictilisib
LU-135::PLX-4720
KARPAS-620::GSK1904529A
Becker::TW 37
KP-4::Rapamycin
ESO51::BMS-536924
ChaGo-K-1::ABT737
KP-4::CCT007093
CP50-MEL-B::Crizotinib
A388::Dinaciclib
LB2241-RCC::IOX2
KGN::PD173074
KARPAS-620::WEHI-539
EW-22::XAV939
SU-DHL-1::OTX015
RT-112::MG-132
SN12C::Paclitaxel
LU-135::Erlotinib
KARPAS-620::Entinostat
CAL-29::Fulvestrant
CP50-MEL-B::RO-3306
A388::Oxaliplatin
KARPAS-620::Oxaliplatin
LU-135::Ribociclib
SIMA::VE-822
SU-DHL-1::PRT062607
MEL-HO::Ribociclib
CPC-N::P22077
EW-22::AZD5582
RT-112::BI-2536
KGN::Tamoxifen
U031::MK-2206
SK-OV-3::Tamoxifen
LB2241-RCC::Paclitaxel
AU565::AZD8186
SU8686::Talazoparib
LB2241-RCC::Dabrafenib
U031::Daporinad
LC-2-ad::Gemcitabine
OCI-M1::SGC0946
NALM-6::Daporinad
LB2241-RCC::GSK2606414
SIMA::SN-38
SU-DHL-1::MIRA-1
EFO-21::GSK1904529A
MEL-HO::CZC24832
SIMA::AMG-319
NOS-1::Irinotecan
ESO51::VE-822
CPC-N::AMG-319
LB647-SCLC::Temozolomide
NUGC-4::5-Fluorouracil
NOS-1::SCH772984
CHP-134::LGK974
NOS-1::AGI-6780
LC-2-ad::Doramapimod
LB647-SCLC::Olaparib
LN-18::PFI3
KARPAS-620::Ibrutinib
CP50-MEL-B::Paclitaxel
ESO51::Pictilisib
TE-4::Dabrafenib
EW-22::Docetaxel
RT-112::LY2109761
CHP-134::PD173074
SU-DHL-1::Cyclophosphamide
U031::Doramapimod
A388::EPZ004777
CPC-N::UMI-77
OCI-M1::Pevonedistat
NUGC-4::Osimertinib
LC-2-ad::Taselisib
SIMA::BIBR-1532
A388::Selumetinib
LB2241-RCC::Luminespib
SU-DHL-1::Sepantronium bromide
CP50-MEL-B::Veliparib
NOS-1::BMS-345541
TE-4::Tanespimycin
CAL-29::VE-822
TE-4::5-Fluorouracil
SK-OV-3::Vinorelbine
AU565::Camptothecin
SIMA::OF-1
LC-2-ad::GSK2578215A
DMS-114::Lenalidomide
LU-135::GSK591
DMS-114::Lestaurtinib
LN-18::JNK Inhibitor VIII
EW-22::AMG-319
LB2241-RCC::PFI-1
KP-4::Rucaparib
KGN::MIM1
KARPAS-620::MK-1775
KP-4::Wnt-C59
LB647-SCLC::Selumetinib
ESO51::OTX015
SK-OV-3::LCL161
UMC-11::GSK2830371
HCC1143::Veliparib
A388::Telomerase Inhibitor IX
KARPAS-620::ZM447439
ESO51::PD173074
KP-4::TW 37
SK-OV-3::Gefitinib
NOS-1::Avagacestat
SK-OV-3::MIM1
DMS-114::PCI-34051
CAL-29::OSI-027
JHOS-3::CCT007093
RT-112::Luminespib
OCI-M1::UMI-77
LB2241-RCC::NU7441
HCC1143::AZD8186
LN-18::AZ960
LB647-SCLC::RVX-208
U031::Trametinib
NOS-1::5-Fluorouracil
NB12::Nilotinib
SIMA::EPZ004777
MEL-HO::Uprosertib
RT-112::Dactolisib
LC-2-ad::Daporinad
NOS-1::Gemcitabine
RT-112::Savolitinib
Becker::Ribociclib
SU8686::Temozolomide
NUGC-4::MG-132
SIMA::5-Fluorouracil
SIMA::GSK343
LB647-SCLC::MK-1775
U031::Dasatinib
SN12C::GSK2830371
EFO-21::PD173074
KARPAS-620::Navitoclax
SN12C::Luminespib
CPC-N::Vinblastine
U031::Leflunomide
LU-135::AZD4547
NALM-6::Alisertib
KGN::Linsitinib
NCI-H1623::Afatinib
ESO51::Savolitinib
A388::Osimertinib
NOS-1::Serdemetan
NALM-6::Rapamycin
NUGC-4::Selumetinib
TE-4::Oxaliplatin
EFO-21::IWP-2
SN12C::Bleomycin (50 uM)
NCI-H1993::Temsirolimus
NOS-1::P22077
AU565::Irinotecan
KARPAS-620::RO-3306
LC-2-ad::SGC0946
EW-22::LY2109761
NOS-1::GSK2606414
A388::AGI-6780
RT-112::PRT062607
MEL-HO::Dasatinib
NCI-H1993::Ribociclib
SN12C::PRIMA-1MET
RT-112::Lenalidomide
HCC1143::Entinostat
RT-112::VX-11e
LU-135::AMG-319
RT-112::MK-1775
MEL-HO::PD0325901
CHP-134::AGI-6780
DMS-114::EPZ004777
LC-2-ad::5-Fluorouracil
NALM-6::KU-55933
SU-DHL-1::Axitinib
Becker::Dabrafenib
ChaGo-K-1::Vismodegib
Becker::OSI-027
NALM-6::I-BRD9
CHP-134::OSI-027
LB2241-RCC::PD173074
LB647-SCLC::SB216763
LU-135::VE821
SU-DHL-1::GSK1904529A
DMS-114::Pyridostatin
NALM-6::Osimertinib
ESO51::AZD4547
LC-2-ad::MK-8776
KP-4::Dinaciclib
NCI-H1623::PRT062607
CP50-MEL-B::Bortezomib
SN12C::CCT007093
ESO51::SN-38
UMC-11::UMI-77
U031::Tanespimycin
Becker::RVX-208
SU8686::Oxaliplatin
LB2241-RCC::Pyridostatin
ChaGo-K-1::EPZ5676
CHP-134::BMS-345541
NB12::BI-2536
NCI-H1623::Telomerase Inhibitor IX
SU8686::Pictilisib
SU8686::Ibrutinib
CHP-134::I-BET-762
CP50-MEL-B::Selumetinib
NOS-1::EPZ5676
CPC-N::Leflunomide
SU-DHL-1::IWP-2
MEL-HO::CCT-018159
JHOS-3::PFI-1
CHP-134::Ipatasertib
NCI-H1993::VE821
KP-4::IWP-2
DMS-114::Luminespib
HPAF-II::Nutlin-3a (-)
MEL-HO::CCT007093
CP50-MEL-B::GSK2578215A
KP-4::Taselisib
LB647-SCLC::Avagacestat
ESO51::GSK1904529A
LN-18::Temozolomide
SU8686::Vinorelbine
NB12::MK-8776
RT-112::Daporinad
LB2241-RCC::Entinostat
Becker::JQ1
MEL-HO::GW441756
CAL-29::GDC0810
LN-18::Vinorelbine
SU-DHL-1::Lestaurtinib
JHOS-3::Uprosertib
ESO51::Sepantronium bromide
SU8686::GDC0810
CAL-29::JQ1
LN-18::Crizotinib
HPAF-II::Irinotecan
NCI-H1993::Ruxolitinib
NOS-1::Ribociclib
KGN::GSK2830371
LC-2-ad::OF-1
RT-112::Selumetinib
NALM-6::KRAS (G12C) Inhibitor-12
LB2241-RCC::Bicalutamide
A388::PCI-34051
AU565::Linsitinib
U031::Luminespib
U031::PCI-34051
SN12C::Ribociclib
NCI-H1623::NU7441
SIMA::WIKI4
CHP-134::Dactolisib
LN-18::Cisplatin
EW-22::Sorafenib
NUGC-4::P22077
RT-112::GSK2606414
EW-22::SB216763
MEL-HO::PLX-4720
NCI-H1623::Leflunomide
OCI-M1::Ribociclib
LC-2-ad::Refametinib
SU-DHL-1::Paclitaxel
HPAF-II::GSK2606414
CP50-MEL-B::ABT737
CHP-134::Axitinib
KARPAS-620::Sabutoclax
OCI-M1::LJI308
ChaGo-K-1::Bosutinib
SU8686::Osimertinib
NUGC-4::AZD8055
SU8686::UMI-77
EW-22::Pyridostatin
SN12C::AZD5582
JHOS-3::PD0325901
RT-112::Sabutoclax
NALM-6::Talazoparib
AU565::IWP-2
CAL-29::PFI3
UMC-11::GDC0810
UMC-11::GNE-317
HPAF-II::Daporinad
NALM-6::MIM1
SU8686::Epirubicin
A388::Sepantronium bromide
ChaGo-K-1::Lestaurtinib
A388::Leflunomide
CP50-MEL-B::SB505124
SN12C::PFI3
NALM-6::UMI-77
CP50-MEL-B::CHIR-99021
HCC1143::Telomerase Inhibitor IX
SU-DHL-1::Epirubicin
LU-135::Ibrutinib
CPC-N::NU7441
NOS-1::Pyridostatin
CAL-29::Cyclophosphamide
NCI-H1623::Camptothecin
KGN::ZM447439
Becker::OF-1
LU-135::Entinostat
LB647-SCLC::MK-2206
HPAF-II::GNE-317
NOS-1::WZ4003
DMS-114::Venetoclax
KP-4::XAV939
LU-135::Osimertinib
UMC-11::I-BRD9
JHOS-3::Pictilisib
ChaGo-K-1::Axitinib
UMC-11::Oxaliplatin
HCC1143::KRAS (G12C) Inhibitor-12
LB2241-RCC::EPZ004777
LC-2-ad::Serdemetan
CAL-29::Rapamycin
Becker::Epirubicin
CAL-29::XAV939
LB2241-RCC::AZ960
LU-135::YK-4-279
NALM-6::Ibrutinib
ChaGo-K-1::P22077
EW-22::Dabrafenib
NCI-H1623::JNK Inhibitor VIII
LU-135::AZD3759
SN12C::Cisplatin
NUGC-4::LCL161
LU-135::EHT-1864
LN-18::JQ1
ChaGo-K-1::I-BRD9
Becker::Sapitinib
LU-135::Irinotecan
SK-OV-3::Vorinostat
UMC-11::Picolinici-acid
Becker::Refametinib
SU8686::Lapatinib
NALM-6::AGI-6780
UMC-11::LGK974
CP50-MEL-B::NU7441
Becker::Linsitinib
LN-18::KU-55933
CP50-MEL-B::Refametinib
ESO51::Navitoclax
MEL-HO::Talazoparib
EFO-21::Serdemetan
U031::CHIR-99021
RT-112::GSK2578215A
NCI-H1993::Nilotinib
JHOS-3::Avagacestat
HPAF-II::5-Fluorouracil
SK-OV-3::Bleomycin (50 uM)
NALM-6::Wnt-C59
DMS-114::Rapamycin
LN-18::Entospletinib
A388::GSK591
NCI-H1993::VX-11e
Becker::Temozolomide
KARPAS-620::VE821
NCI-H1993::Lenalidomide
NUGC-4::Telomerase Inhibitor IX
NALM-6::Linsitinib
SU-DHL-1::Nutlin-3a (-)
CHP-134::ABT737
NUGC-4::Dinaciclib
CP50-MEL-B::Tretinoin
ChaGo-K-1::Dinaciclib
OCI-M1::Avagacestat
NCI-H1993::Bleomycin (50 uM)
LN-18::PRIMA-1MET
EW-22::SN-38
RT-112::GNE-317
Becker::Docetaxel
LN-18::Ruxolitinib
HPAF-II::JNK Inhibitor VIII
LC-2-ad::GW441756
CPC-N::AGI-5198
TE-4::AGI-6780
CHP-134::AZD7762
CAL-29::Bleomycin (50 uM)
SU-DHL-1::Selumetinib
RT-112::Veliparib
LB647-SCLC::Ipatasertib
CAL-29::Avagacestat
RT-112::AZ960
UMC-11::Motesanib
LC-2-ad::Epirubicin
KARPAS-620::Telomerase Inhibitor IX
CPC-N::Bosutinib
SU8686::PD173074
NOS-1::Docetaxel
SU-DHL-1::Bosutinib
SU-DHL-1::Dabrafenib
LC-2-ad::BIBR-1532
JHOS-3::YK-4-279
TE-4::Linsitinib
UMC-11::ML323
SN12C::ZM447439
LC-2-ad::GSK2606414
SIMA::Docetaxel
CPC-N::Rapamycin
UMC-11::Axitinib
ChaGo-K-1::Entospletinib
CHP-134::Fulvestrant
NALM-6::Tamoxifen
Becker::MIRA-1
ChaGo-K-1::AZ6102
DMS-114::GSK343
MEL-HO::Motesanib
HCC1143::NU7441
NCI-H1623::Picolinici-acid
LB2241-RCC::AZD5582
U031::Osimertinib
CHP-134::WZ4003
DMS-114::GSK1904529A
EFO-21::AZD4547
LN-18::Cytarabine
KARPAS-620::Cisplatin
NCI-H1623::Oxaliplatin
SIMA::Vinblastine
SK-OV-3::Lapatinib
LC-2-ad::SCH772984
LN-18::Dasatinib
KP-4::MK-2206
HPAF-II::AZD8186
NCI-H1993::Uprosertib
CPC-N::Irinotecan
LN-18::Entinostat
LB647-SCLC::XAV939
Becker::VX-11e
U031::BMS-345541
SU8686::ML323
CPC-N::Temozolomide
LB647-SCLC::Dinaciclib
Becker::PRIMA-1MET
Becker::Bortezomib
A388::I-BRD9
CAL-29::AZD5582
EFO-21::Daporinad
TE-4::EPZ004777
LC-2-ad::Erlotinib
LB647-SCLC::AZD5582
NOS-1::Ibrutinib
HCC1143::WZ4003
SU-DHL-1::KU-55933
HPAF-II::Vinblastine
CAL-29::Motesanib
LU-135::Lestaurtinib
SK-OV-3::Gemcitabine
NB12::Erlotinib
HPAF-II::AGI-6780
LN-18::GSK591
LB647-SCLC::I-BET-762
KGN::EPZ004777
SK-OV-3::Erlotinib
Becker::EPZ5676
NOS-1::AZD7762
KARPAS-620::PFI-1
AU565::GSK343
NCI-H1623::Uprosertib
NUGC-4::Ribociclib
RT-112::Obatoclax Mesylate
JHOS-3::ML323
ChaGo-K-1::I-BET-762
KP-4::SN-38
NCI-H1993::Methotrexate
SN12C::Selumetinib
DMS-114::PRIMA-1MET
LU-135::GSK2830371
KGN::Alpelisib
LN-18::EPZ5676
SIMA::OTX015
NALM-6::LJI308
NCI-H1993::RVX-208
SU-DHL-1::ZM447439
A388::LGK974
SU8686::Wnt-C59
SN12C::Osimertinib
KGN::Daporinad
NUGC-4::Motesanib
UMC-11::RVX-208
LB2241-RCC::CCT-018159
CHP-134::AZD3759
HCC1143::Afuresertib
TE-4::Leflunomide
A388::Picolinici-acid
SN12C::Cediranib
SK-OV-3::OTX015
MEL-HO::I-BRD9
SU-DHL-1::SB590885
JHOS-3::VE821
JHOS-3::Docetaxel
LU-135::LCL161
SK-OV-3::Pictilisib
TE-4::Ipatasertib
NALM-6::MK-2206
EW-22::MK-1775
ChaGo-K-1::NU7441
KP-4::ML323
LB647-SCLC::Niraparib
JHOS-3::Linsitinib
NOS-1::Uprosertib
KP-4::MN-64
EW-22::Alpelisib
HPAF-II::AZD6738
NUGC-4::Methotrexate
CHP-134::VE821
CAL-29::Methotrexate
LB647-SCLC::GW441756
ChaGo-K-1::KRAS (G12C) Inhibitor-12
Becker::AZD8186
ESO51::LJI308
NUGC-4::VE-822
LC-2-ad::PD0325901
KP-4::Ruxolitinib
NOS-1::Ruxolitinib
LB2241-RCC::BX795
SU8686::Lenalidomide
SIMA::LJI308
Becker::BIBR-1532
NUGC-4::PD173074
CP50-MEL-B::SL0101
CHP-134::MN-64
KP-4::I-BRD9
KGN::Palbociclib
LC-2-ad::JQ1
JHOS-3::Elesclomol
SU8686::Tanespimycin
LC-2-ad::RVX-208
TE-4::Serdemetan
NCI-H1623::GSK2830371
ESO51::MIRA-1
MEL-HO::Picolinici-acid
HPAF-II::Erlotinib
NCI-H1993::SB590885
LU-135::Afuresertib
CPC-N::IWP-2
NCI-H1623::EPZ004777
JHOS-3::PCI-34051
KP-4::Cisplatin
NCI-H1623::MN-64
NCI-H1993::PFI-1
HCC1143::LGK974
EFO-21::MG-132
LC-2-ad::Alpelisib
HPAF-II::NVP-ADW742
SU-DHL-1::WZ4003
LC-2-ad::NU7441
RT-112::Palbociclib
TE-4::Motesanib
JHOS-3::AGI-5198
LB2241-RCC::GDC0810
MEL-HO::Tamoxifen
OCI-M1::Nilotinib
MEL-HO::Pictilisib
MEL-HO::Refametinib
SN12C::Erlotinib
CHP-134::Talazoparib
LN-18::Erlotinib
HCC1143::Sorafenib
CPC-N::Vorinostat
SU-DHL-1::GSK269962A
ESO51::Docetaxel
SU-DHL-1::SB505124
CAL-29::Tanespimycin
LB647-SCLC::Rucaparib
ChaGo-K-1::Tozasertib
CP50-MEL-B::Alisertib
Becker::NU7441
TE-4::PD0325901
LN-18::LGK974
KARPAS-620::I-BET-762
LC-2-ad::Pictilisib
CP50-MEL-B::Savolitinib
NCI-H1623::Obatoclax Mesylate
JHOS-3::SL0101
KP-4::Niraparib
HPAF-II::RO-3306
NALM-6::Bleomycin (50 uM)
Becker::Sepantronium bromide
JHOS-3::AZD5582
MEL-HO::RO-3306
EFO-21::Venetoclax
SU8686::Selumetinib
AU565::WZ4003
LB647-SCLC::PRT062607
HCC1143::LY2109761
RT-112::P22077
SN12C::YK-4-279
OCI-M1::Pyridostatin
LN-18::Venetoclax
JHOS-3::Gefitinib
Becker::Veliparib
LB2241-RCC::IWP-2
SN12C::Temsirolimus
AU565::Dasatinib
NCI-H1623::MIM1
JHOS-3::MK-1775
NCI-H1623::VE-822
SU-DHL-1::ABT737
CHP-134::Cediranib
SN12C::Docetaxel
JHOS-3::Entospletinib
LB2241-RCC::VE821
CP50-MEL-B::Ribociclib
NB12::Linsitinib
SU8686::Sabutoclax
TE-4::Irinotecan
CPC-N::Obatoclax Mesylate
MEL-HO::Epirubicin
UMC-11::IWP-2
ChaGo-K-1::Venetoclax
MEL-HO::Avagacestat
DMS-114::Refametinib
DMS-114::Ibrutinib
LB2241-RCC::SCH772984
CAL-29::AZD8186
JHOS-3::VE-822
MEL-HO::GSK269962A
HPAF-II::PD173074
SU8686::Olaparib
AU565::Uprosertib
LB2241-RCC::LCL161
LU-135::IWP-2
KGN::Fulvestrant
Becker::Dinaciclib
EW-22::SCH772984
OCI-M1::Wnt-C59
LN-18::PD0325901
KP-4::Ibrutinib
Becker::Tamoxifen
LN-18::AZD7762
HPAF-II::BMS-536924
NCI-H1623::Lapatinib
NB12::Venetoclax
NCI-H1623::PD173074
LU-135::MK-2206
NB12::Gemcitabine
EFO-21::Gemcitabine
NALM-6::Sepantronium bromide
LU-135::SN-38
RT-112::I-BET-762
LN-18::Lenalidomide
SU-DHL-1::MK-2206
NALM-6::Picolinici-acid
UMC-11::NU7441
NOS-1::Vorinostat
SK-OV-3::Obatoclax Mesylate
RT-112::EPZ5676
UMC-11::BI-2536
KP-4::VE821
A388::Foretinib
SIMA::AGI-6780
KP-4::Cytarabine
KGN::MIRA-1
RT-112::AMG-319
SIMA::Uprosertib
KARPAS-620::Taselisib
SIMA::GSK2606414
EW-22::JNK Inhibitor VIII
TE-4::MIM1
LC-2-ad::ML323
NUGC-4::PRT062607
HPAF-II::P22077
ChaGo-K-1::Dasatinib
SU8686::Serdemetan
LN-18::OTX015
HCC1143::NVP-ADW742
U031::Ribociclib
KARPAS-620::PRIMA-1MET
OCI-M1::Tanespimycin
ESO51::WZ4003
LB647-SCLC::Camptothecin
CP50-MEL-B::Talazoparib
KP-4::LGK974
ChaGo-K-1::WIKI4
CPC-N::Osimertinib
NCI-H1993::GSK591
CPC-N::ML323
SU8686::Sepantronium bromide
CPC-N::Navitoclax
U031::Tamoxifen
LU-135::Rapamycin
SN12C::IWP-2
LC-2-ad::LCL161
EFO-21::Bleomycin (50 uM)
NALM-6::GSK591
KGN::Savolitinib
U031::BX795
A388::Ruxolitinib
CAL-29::BIBR-1532
NOS-1::JQ1
NCI-H1623::Motesanib
TE-4::P22077
NALM-6::Cyclophosphamide
NCI-H1993::PD0325901
RT-112::Vorinostat
OCI-M1::ABT737
LB647-SCLC::KU-55933
KGN::Docetaxel
A388::Gefitinib
DMS-114::Niraparib
TE-4::GSK2606414
TE-4::SN-38
U031::KU-55933
SU-DHL-1::SB216763
KARPAS-620::Cediranib
LU-135::Sorafenib
SU8686::AMG-319
KP-4::PRIMA-1MET
ChaGo-K-1::Methotrexate
EW-22::I-BET-762
CHP-134::Palbociclib
LU-135::GSK1904529A
U031::Navitoclax
NB12::Tanespimycin
CHP-134::Wnt-C59
EW-22::UMI-77
Becker::Alisertib
HCC1143::MIRA-1
OCI-M1::Picolinici-acid
LU-135::Cediranib
HPAF-II::BIBR-1532
ESO51::RVX-208
TE-4::Lenalidomide
NOS-1::Osimertinib
NB12::Tamoxifen
CPC-N::MK-8776
CAL-29::Tamoxifen
Becker::Lapatinib
LB2241-RCC::RO-3306
LU-135::PRIMA-1MET
EFO-21::GSK343
NCI-H1993::PRT062607
NALM-6::Lapatinib
LU-135::Niraparib
CAL-29::Epirubicin
NB12::JNK Inhibitor VIII
OCI-M1::PRT062607
SU8686::Picolinici-acid
LB2241-RCC::Ibrutinib
NCI-H1993::AZD8186
HCC1143::Lenalidomide
NUGC-4::AZD7762
TE-4::Veliparib
KP-4::Gemcitabine
KARPAS-620::VE-822
CAL-29::Nutlin-3a (-)
MEL-HO::SCH772984
KP-4::Palbociclib
UMC-11::MG-132
ChaGo-K-1::GSK2578215A
KP-4::GSK2830371
MEL-HO::Dinaciclib
EW-22::Selumetinib
EW-22::PRT062607
OCI-M1::Sapitinib
LB2241-RCC::Sapitinib
ESO51::GDC0810
OCI-M1::Sepantronium bromide
NB12::Dabrafenib
CAL-29::Ribociclib
CP50-MEL-B::Sepantronium bromide
SU-DHL-1::Dinaciclib
LU-135::JNK Inhibitor VIII
SK-OV-3::JNK Inhibitor VIII
NUGC-4::Entinostat
LU-135::LJI308
NALM-6::MIRA-1
LU-135::MN-64
NOS-1::Pevonedistat
KARPAS-620::I-BRD9
NCI-H1993::SCH772984
ESO51::PRIMA-1MET
NCI-H1623::Foretinib
EFO-21::GSK2606414
SK-OV-3::Irinotecan
LB647-SCLC::Sapitinib
LC-2-ad::Motesanib
ESO51::I-BET-762
KP-4::PFI3
EFO-21::Rapamycin
TE-4::AZ6102
SIMA::MIRA-1
DMS-114::Vinblastine
MEL-HO::Docetaxel
EFO-21::Taselisib
HCC1143::Axitinib
HPAF-II::Navitoclax
HCC1143::PLX-4720
CPC-N::JQ1
CAL-29::SB216763
EFO-21::BIBR-1532
RT-112::Motesanib
NALM-6::GDC0810
LC-2-ad::Veliparib
NB12::Lestaurtinib
U031::Epirubicin
UMC-11::AMG-319
SIMA::GSK2578215A
OCI-M1::Temsirolimus
CP50-MEL-B::MK-2206
DMS-114::VE821
JHOS-3::LGK974
LB647-SCLC::Wee1 Inhibitor
EFO-21::5-Fluorouracil
LU-135::ZM447439
NCI-H1623::Serdemetan
SK-OV-3::Paclitaxel
LB647-SCLC::GDC0810
RT-112::TW 37
NUGC-4::OF-1
LC-2-ad::NVP-ADW742
DMS-114::AZD6738
HCC1143::WIKI4
NCI-H1623::Taselisib
MEL-HO::Bicalutamide
RT-112::WIKI4
NALM-6::Veliparib
ChaGo-K-1::Telomerase Inhibitor IX
OCI-M1::GSK2606414
KP-4::AMG-319
LN-18::EPZ004777
EFO-21::CZC24832
SN12C::OF-1
NCI-H1993::Motesanib
AU565::GNE-317
TE-4::AGI-5198
EFO-21::Rucaparib
CP50-MEL-B::KU-55933
KGN::Lestaurtinib
KP-4::Entospletinib
Becker::AMG-319
LC-2-ad::GSK591
OCI-M1::VX-11e
DMS-114::Taselisib
NB12::Vismodegib
DMS-114::UMI-77
NCI-H1623::Temozolomide
NALM-6::Rucaparib
NCI-H1623::MK-2206
EW-22::Lestaurtinib
MEL-HO::JQ1
NCI-H1993::LJI308
CAL-29::Sapitinib
HCC1143::Savolitinib
SIMA::EHT-1864
LB2241-RCC::Fulvestrant
LN-18::PCI-34051
KARPAS-620::SB590885
LN-18::Foretinib
LB647-SCLC::Venetoclax
CPC-N::TW 37
SN12C::OSI-027
CPC-N::Telomerase Inhibitor IX
UMC-11::Ribociclib
NUGC-4::Serdemetan
MEL-HO::Afuresertib
MEL-HO::ABT737
EFO-21::Temsirolimus
SK-OV-3::Telomerase Inhibitor IX
LN-18::BI-2536
LC-2-ad::EHT-1864
HCC1143::BIBR-1532
TE-4::Nilotinib
CHP-134::AZD4547
ESO51::Bleomycin (50 uM)
CHP-134::VE-822
NUGC-4::SB590885
KP-4::Osimertinib
CAL-29::Paclitaxel
ESO51::SB590885
SN12C::Entospletinib
CHP-134::Paclitaxel
JHOS-3::Piperlongumine
RT-112::LJI308
OCI-M1::ML323
A388::Avagacestat
NALM-6::BIBR-1532
CP50-MEL-B::WIKI4
EW-22::Sepantronium bromide
KGN::P22077
HCC1143::OF-1
HPAF-II::AZ6102
SU8686::Venetoclax
ChaGo-K-1::GSK269962A
AU565::RO-3306
RT-112::Pevonedistat
SIMA::Refametinib
TE-4::Ribociclib
U031::GSK2606414
LC-2-ad::SB505124
SK-OV-3::BI-2536
KP-4::OSI-027
TE-4::MK-8776
NUGC-4::AZD5582
U031::Venetoclax
NUGC-4::XAV939
SN12C::PFI-1
NUGC-4::LGK974
OCI-M1::JQ1
NB12::AZD3759
SK-OV-3::Alpelisib
EFO-21::Afatinib
NOS-1::Dabrafenib
CPC-N::RO-3306
AU565::WEHI-539
CPC-N::GSK2830371
EFO-21::AZ6102
LN-18::Motesanib
AU565::CCT007093
DMS-114::Entospletinib
AU565::Pyridostatin
EFO-21::Lenalidomide
RT-112::Ribociclib
MEL-HO::BI-2536
LB647-SCLC::AZD6738
HPAF-II::PRT062607
SIMA::NVP-ADW742
SU8686::Methotrexate
LB2241-RCC::RVX-208
CP50-MEL-B::AZD8186
TE-4::PRT062607
HCC1143::Bleomycin (50 uM)
NALM-6::SB590885
U031::Vinorelbine
LN-18::CZC24832
LN-18::Epirubicin
LB647-SCLC::VE821
NCI-H1993::MIRA-1
CPC-N::GSK2606414
RT-112::Pyridostatin
AU565::Pevonedistat
NALM-6::Uprosertib
KARPAS-620::Camptothecin
UMC-11::P22077
KARPAS-620::BIBR-1532
EW-22::BIBR-1532
LU-135::OTX015
Becker::Lenalidomide
AU565::Alpelisib
NUGC-4::Vorinostat
JHOS-3::NU7441
U031::WIKI4
DMS-114::Veliparib
LB647-SCLC::Elesclomol
KP-4::5-Fluorouracil
DMS-114::CCT007093
OCI-M1::AZD6738
DMS-114::Doramapimod
LU-135::AGI-5198
KARPAS-620::Niraparib
HCC1143::AMG-319
ChaGo-K-1::Tamoxifen
A388::Wnt-C59
LN-18::IWP-2
NALM-6::Afuresertib
NUGC-4::Lenalidomide
LB2241-RCC::JNK Inhibitor VIII
TE-4::Cisplatin
CAL-29::AZ6102
LN-18::AGI-6780
NALM-6::GNE-317
SU8686::Afatinib
OCI-M1::Vorinostat
ChaGo-K-1::PRIMA-1MET
RT-112::Entinostat
SN12C::LY2109761
KARPAS-620::YK-4-279
SIMA::Talazoparib
OCI-M1::I-BRD9
CPC-N::Taselisib
DMS-114::PFI3
EFO-21::Epirubicin
NALM-6::WIKI4
CHP-134::LJI308
LB2241-RCC::XAV939
MEL-HO::Gemcitabine
ESO51::Serdemetan
LN-18::Nilotinib
CAL-29::Uprosertib
KARPAS-620::Afuresertib
KARPAS-620::Erlotinib
CAL-29::OF-1
NB12::Dasatinib
LB2241-RCC::Telomerase Inhibitor IX
NB12::Foretinib
AU565::Luminespib
A388::MK-1775
AU565::MIRA-1
Becker::Paclitaxel
NUGC-4::Entospletinib
NOS-1::YK-4-279
NB12::Afatinib
NOS-1::Savolitinib
EW-22::OTX015
LB2241-RCC::Epirubicin
NB12::Methotrexate
HCC1143::Sapitinib
NALM-6::Temsirolimus
ESO51::Cisplatin
LN-18::Pyridostatin
AU565::Dinaciclib
EFO-21::GSK2578215A
LC-2-ad::Wnt-C59
NCI-H1993::PLX-4720
HPAF-II::Dactolisib
CP50-MEL-B::Vismodegib
SN12C::SGC0946
A388::SN-38
SU-DHL-1::Venetoclax
DMS-114::Erlotinib
RT-112::Bortezomib
SIMA::Avagacestat
RT-112::XAV939
ESO51::I-BRD9
SU8686::CCT007093
CHP-134::Telomerase Inhibitor IX
OCI-M1::Cyclophosphamide
KP-4::Selumetinib
UMC-11::Avagacestat
HPAF-II::Gemcitabine
NCI-H1993::EPZ5676
KARPAS-620::Luminespib
TE-4::Picolinici-acid
CAL-29::GNE-317
SU8686::WIKI4
CAL-29::GW441756
LN-18::MG-132
UMC-11::Wee1 Inhibitor
Becker::ABT737
NB12::GSK2578215A
NOS-1::Cisplatin
NUGC-4::WZ4003
LN-18::Refametinib
LB647-SCLC::OF-1
ESO51::AGI-6780
DMS-114::Fulvestrant
HPAF-II::Talazoparib
OCI-M1::Docetaxel
Becker::JNK Inhibitor VIII
EFO-21::Vinblastine
KGN::Obatoclax Mesylate
DMS-114::5-Fluorouracil
LB2241-RCC::SL0101
ChaGo-K-1::Nutlin-3a (-)
LN-18::Methotrexate
TE-4::Ibrutinib
HCC1143::EPZ5676
LB647-SCLC::PD173074
HCC1143::PRT062607
NB12::Bosutinib
CAL-29::NVP-ADW742
NOS-1::Pictilisib
NALM-6::PD0325901
TE-4::SB590885
ChaGo-K-1::BIBR-1532
EW-22::OSI-027
CP50-MEL-B::Gemcitabine
AU565::Obatoclax Mesylate
NALM-6::Pictilisib
ChaGo-K-1::IOX2
NB12::MK-2206
Becker::EHT-1864
SN12C::AMG-319
U031::Docetaxel
NOS-1::ABT737
NOS-1::PFI3
MEL-HO::EPZ004777
LU-135::Cytarabine
TE-4::Afatinib
KARPAS-620::AZ960
SU-DHL-1::AZ960
CP50-MEL-B::AZD6482
KP-4::Epirubicin
SIMA::Oxaliplatin
ChaGo-K-1::EPZ004777
HCC1143::Motesanib
Becker::Navitoclax
AU565::Sabutoclax
AU565::MK-8776
KARPAS-620::Ipatasertib
CAL-29::Camptothecin
NOS-1::KU-55933
HPAF-II::Nilotinib
LB2241-RCC::Taselisib
NOS-1::RVX-208
AU565::Foretinib
NALM-6::PFI3
SN12C::TW 37
NCI-H1993::Temozolomide
U031::KRAS (G12C) Inhibitor-12
LB647-SCLC::SB505124
JHOS-3::Ribociclib
KARPAS-620::Doramapimod
EW-22::Cytarabine
A388::Vinorelbine
JHOS-3::MK-8776
AU565::Afatinib
NUGC-4::GSK591
KGN::SB590885
A388::Nilotinib
JHOS-3::Sepantronium bromide
TE-4::OTX015
LC-2-ad::BMS-345541
CHP-134::Irinotecan
SU-DHL-1::RVX-208
NB12::Doramapimod
LU-135::CZC24832
NCI-H1993::PCI-34051
CP50-MEL-B::Piperlongumine
NCI-H1623::LGK974
HCC1143::PCI-34051
CPC-N::Rucaparib
ESO51::BI-2536
EFO-21::BMS-536924
TE-4::BMS-345541
KP-4::Refametinib
Becker::Telomerase Inhibitor IX
KARPAS-620::Fulvestrant
AU565::PF-4708671
SU8686::PRT062607
DMS-114::Leflunomide
DMS-114::AZD8186
CAL-29::Telomerase Inhibitor IX
NCI-H1623::Nilotinib
MEL-HO::Sorafenib
CP50-MEL-B::BX795
AU565::NU7441
CPC-N::Palbociclib
LC-2-ad::Luminespib
AU565::Docetaxel
HCC1143::Serdemetan
LB2241-RCC::ML323
A388::Vismodegib
KP-4::PLX-4720
SIMA::NU7441
KARPAS-620::AZD8055
SU-DHL-1::SL0101
SU-DHL-1::Afatinib
CPC-N::Picolinici-acid
CPC-N::AZD3759
U031::AZD8186
NCI-H1993::ABT737
SK-OV-3::PFI-1
RT-112::Ruxolitinib
Becker::Gefitinib
U031::Savolitinib
CP50-MEL-B::IWP-2
KARPAS-620::Lapatinib
UMC-11::SN-38
CPC-N::Ruxolitinib
NCI-H1993::Entospletinib
SK-OV-3::SB590885
NCI-H1623::WIKI4
LB2241-RCC::OF-1
HPAF-II::Cediranib
RT-112::PD0325901
LU-135::Gemcitabine
HPAF-II::VE-822
JHOS-3::Ipatasertib
ESO51::EHT-1864
A388::JQ1
LU-135::ML323
NUGC-4::Trametinib
ESO51::Rucaparib
TE-4::AZD8186
DMS-114::Bortezomib
NB12::Nutlin-3a (-)
HCC1143::MK-8776
UMC-11::Venetoclax
AU565::Alisertib
AU565::YK-4-279
JHOS-3::Tanespimycin
NUGC-4::RO-3306
NALM-6::ZM447439
LC-2-ad::AZD7762
OCI-M1::Pictilisib
NUGC-4::Vinorelbine
ESO51::Sorafenib
HPAF-II::KRAS (G12C) Inhibitor-12
ESO51::PFI-1
TE-4::BIBR-1532
KGN::Alisertib
AU565::NVP-ADW742
LC-2-ad::Sabutoclax
LC-2-ad::Bortezomib
CPC-N::SB590885
RT-112::Lapatinib
NB12::I-BRD9
SK-OV-3::Luminespib
SU8686::WEHI-539
NB12::Oxaliplatin
SK-OV-3::P22077
SIMA::Lapatinib
A388::CCT-018159
CAL-29::I-BRD9
KP-4::EHT-1864
CPC-N::Niraparib
A388::Epirubicin
CHP-134::Alpelisib
SU-DHL-1::AZD6738
NCI-H1993::BIBR-1532
NCI-H1623::WZ4003
CP50-MEL-B::MK-1775
SK-OV-3::Pyridostatin
A388::Crizotinib
LB647-SCLC::YK-4-279
CP50-MEL-B::GSK591
MEL-HO::EHT-1864
TE-4::OF-1
CAL-29::Alpelisib
NB12::Avagacestat
JHOS-3::Bosutinib
JHOS-3::RO-3306
SU-DHL-1::WIKI4
ChaGo-K-1::Vinorelbine
ChaGo-K-1::Ipatasertib
SU8686::Bleomycin (50 uM)
DMS-114::GSK2578215A
SU-DHL-1::Dactolisib
NCI-H1993::Gefitinib
LU-135::MIM1
ESO51::Tamoxifen
KGN::Pyridostatin
A388::GSK1904529A
JHOS-3::Vismodegib
RT-112::Tanespimycin
U031::GW441756
HPAF-II::Wnt-C59
TE-4::Bleomycin (50 uM)
U031::Dinaciclib
ChaGo-K-1::Tanespimycin
LC-2-ad::Tozasertib
U031::MK-8776
LU-135::AZD8055
CPC-N::ABT737
CP50-MEL-B::Pyridostatin
NB12::AZD4547
LC-2-ad::AGI-5198
ChaGo-K-1::Entinostat
LU-135::AZD8186
EFO-21::ML323
U031::SCH772984
Becker::MK-2206
ChaGo-K-1::Cyclophosphamide
JHOS-3::GSK1904529A
LB647-SCLC::Luminespib
UMC-11::Rapamycin
CAL-29::Trametinib
SK-OV-3::LJI308
ESO51::CCT007093
UMC-11::Savolitinib
A388::Dactolisib
CP50-MEL-B::Motesanib
OCI-M1::OTX015
SU-DHL-1::PFI-1
HCC1143::Pevonedistat
CHP-134::YK-4-279
HPAF-II::VE821
SIMA::SB590885
EFO-21::Osimertinib
CAL-29::VX-11e
OCI-M1::OSI-027
A388::Temsirolimus
EFO-21::EHT-1864
ESO51::Luminespib
KP-4::GSK2578215A
KARPAS-620::Refametinib
OCI-M1::WEHI-539
NB12::Dactolisib
JHOS-3::LY2109761
ChaGo-K-1::Gemcitabine
JHOS-3::AMG-319
CP50-MEL-B::CCT-018159
KP-4::Trametinib
SN12C::EPZ004777
ChaGo-K-1::OSI-027
UMC-11::XAV939
HCC1143::LCL161
SU8686::GSK2830371
LC-2-ad::RO-3306
UMC-11::Nilotinib
EW-22::JQ1
KP-4::VX-11e
LB2241-RCC::Lenalidomide
ESO51::GSK343
NALM-6::Methotrexate
CPC-N::YK-4-279
DMS-114::Docetaxel
MEL-HO::Palbociclib
Becker::GSK591
ChaGo-K-1::ZM447439
SK-OV-3::Dasatinib
LN-18::Luminespib
LB647-SCLC::GSK269962A
NCI-H1623::PFI3
OCI-M1::YK-4-279
UMC-11::MK-1775
CPC-N::AZD8055
CAL-29::Rucaparib
CAL-29::Dinaciclib
KGN::GW441756
NCI-H1993::Olaparib
DMS-114::OF-1
ChaGo-K-1::Oxaliplatin
ESO51::WEHI-539
SU8686::EPZ004777
KARPAS-620::LGK974
DMS-114::Daporinad
RT-112::OTX015
SIMA::Osimertinib
JHOS-3::Lestaurtinib
ESO51::Foretinib
NCI-H1623::Alpelisib
KARPAS-620::ABT737
Becker::Taselisib
KARPAS-620::Dabrafenib
LN-18::VE-822
UMC-11::Serdemetan
DMS-114::GW441756
CHP-134::Navitoclax
AU565::Ipatasertib
OCI-M1::Savolitinib
NCI-H1993::Trametinib
OCI-M1::Fulvestrant
LB647-SCLC::Ruxolitinib
DMS-114::XAV939
DMS-114::Oxaliplatin
SIMA::Alisertib
SK-OV-3::AZD8055
KP-4::Paclitaxel
SU-DHL-1::OF-1
LB647-SCLC::CCT-018159
CP50-MEL-B::Cediranib
HPAF-II::Dabrafenib
HCC1143::Lestaurtinib
SIMA::Dactolisib
KP-4::LCL161
SIMA::Cisplatin
CP50-MEL-B::Entinostat
SK-OV-3::Navitoclax
EW-22::GSK343
SIMA::AZD6738
EW-22::Nilotinib
OCI-M1::PCI-34051
MEL-HO::BIBR-1532
LU-135::Cisplatin
CAL-29::RO-3306
CHP-134::BMS-536924
TE-4::Gemcitabine
NUGC-4::CZC24832
HCC1143::Sabutoclax
SK-OV-3::AZ960
UMC-11::GSK2578215A
SIMA::Nilotinib
RT-112::GW441756
OCI-M1::Obatoclax Mesylate
HPAF-II::XAV939
KARPAS-620::Temsirolimus
UMC-11::Navitoclax
SN12C::GSK1904529A
NB12::Paclitaxel
CPC-N::EHT-1864
NOS-1::Cyclophosphamide
SU-DHL-1::Fulvestrant
EW-22::BMS-345541
NB12::Bleomycin (50 uM)
RT-112::MIM1
NUGC-4::Venetoclax
OCI-M1::GSK2578215A
KP-4::MG-132
NCI-H1993::TW 37
DMS-114::JQ1
NCI-H1623::Tamoxifen
KP-4::YK-4-279
LB2241-RCC::P22077
KP-4::Nilotinib
JHOS-3::GW441756
CPC-N::I-BRD9
LC-2-ad::Afatinib
NOS-1::PLX-4720
NUGC-4::AZ960
NCI-H1623::OF-1
NUGC-4::Pictilisib
NUGC-4::Uprosertib
LC-2-ad::Vorinostat
KP-4::WEHI-539
SU-DHL-1::LJI308
SU-DHL-1::Pictilisib
NCI-H1623::ABT737
NCI-H1623::Methotrexate
MEL-HO::Doramapimod
HCC1143::Alisertib
NCI-H1623::AZD8186
AU565::GSK591
SU-DHL-1::Uprosertib
MEL-HO::GSK343
SIMA::Pevonedistat
U031::Veliparib
SIMA::Rucaparib
KGN::Veliparib
KGN::Afatinib
JHOS-3::PFI3
CPC-N::VX-11e
LN-18::Gemcitabine
U031::Motesanib
NOS-1::AMG-319
AU565::Erlotinib
SK-OV-3::AGI-5198
SK-OV-3::Epirubicin
LB647-SCLC::Pyridostatin
AU565::Niraparib
NALM-6::PLX-4720
Becker::Dasatinib
SU-DHL-1::LCL161
JHOS-3::BMS-345541
HCC1143::MG-132
KARPAS-620::Cytarabine
CAL-29::Ruxolitinib
NOS-1::WIKI4
CHP-134::Venetoclax
DMS-114::Foretinib
NUGC-4::Cyclophosphamide
NUGC-4::BIBR-1532
JHOS-3::Temozolomide
RT-112::Temsirolimus
SU-DHL-1::GSK2578215A
HPAF-II::AZD5582
EW-22::Ribociclib
LC-2-ad::Lenalidomide
LU-135::Pevonedistat
TE-4::Alpelisib
CAL-29::Talazoparib
CPC-N::GSK2578215A
SK-OV-3::CCT007093
NCI-H1623::Irinotecan
UMC-11::Ipatasertib
CPC-N::AZD8186
SIMA::PLX-4720
NCI-H1623::RO-3306
NOS-1::Rapamycin
SK-OV-3::Vinblastine
TE-4::Dasatinib
NCI-H1993::Docetaxel
KARPAS-620::Foretinib
SIMA::Obatoclax Mesylate
LU-135::AZ6102
SU8686::Nutlin-3a (-)
CP50-MEL-B::Avagacestat
NOS-1::SN-38
ChaGo-K-1::Leflunomide
TE-4::KU-55933
NCI-H1993::MN-64
SU8686::PFI-1
EFO-21::VE-822
A388::Linsitinib
MEL-HO::Tanespimycin
LU-135::Temsirolimus
NB12::EPZ004777
MEL-HO::Nilotinib
SIMA::Pyridostatin
HPAF-II::Palbociclib
LC-2-ad::WIKI4
NCI-H1993::Navitoclax
LB2241-RCC::Olaparib
NOS-1::MN-64
RT-112::KRAS (G12C) Inhibitor-12
SIMA::Tanespimycin
NCI-H1623::GNE-317
LB647-SCLC::PRIMA-1MET
NALM-6::Nilotinib
MEL-HO::Irinotecan
SU8686::AZD5582
NCI-H1993::SN-38
LB2241-RCC::Axitinib
RT-112::SN-38
SU-DHL-1::SGC0946
DMS-114::Talazoparib
SN12C::PCI-34051
CAL-29::LCL161
NALM-6::OSI-027
SK-OV-3::GSK2606414
LN-18::Ibrutinib
U031::Lapatinib
NOS-1::Talazoparib
NB12::Afuresertib
NUGC-4::Docetaxel
LC-2-ad::PRT062607
LC-2-ad::Dabrafenib
NUGC-4::Afatinib
CPC-N::Luminespib
KGN::Vinblastine
NB12::GDC0810
CPC-N::Sepantronium bromide
SU8686::Refametinib
LC-2-ad::IOX2
LB647-SCLC::GNE-317
Becker::EPZ004777
NCI-H1993::BMS-345541
JHOS-3::Selumetinib
CHP-134::Vinblastine
A388::Axitinib
MEL-HO::GDC0810
NOS-1::AZ960
DMS-114::SN-38
SU-DHL-1::RO-3306
MEL-HO::VX-11e
NCI-H1623::Sabutoclax
U031::Camptothecin
CP50-MEL-B::AZD4547
UMC-11::Afuresertib
KGN::NVP-ADW742
ChaGo-K-1::Niraparib
EFO-21::GDC0810
UMC-11::Tamoxifen
SU-DHL-1::Bortezomib
JHOS-3::SGC0946
A388::Wee1 Inhibitor
NOS-1::MK-1775
CAL-29::Palbociclib
ESO51::MK-1775
NOS-1::I-BET-762
OCI-M1::Foretinib
LB2241-RCC::Niraparib
SK-OV-3::Camptothecin
CPC-N::AZ960
LN-18::Telomerase Inhibitor IX
A388::Bortezomib
SU-DHL-1::Veliparib
NUGC-4::EPZ5676
NALM-6::WZ4003
AU565::LY2109761
NCI-H1993::Ibrutinib
CP50-MEL-B::OTX015
SU8686::Sapitinib
SIMA::MK-8776
AU565::Vinblastine
RT-112::Dabrafenib
CPC-N::Lapatinib
NCI-H1623::Savolitinib
SU-DHL-1::Ipatasertib
U031::PRT062607
HPAF-II::Entospletinib
NB12::VX-11e
RT-112::Sapitinib
KGN::Bosutinib
Becker::PD173074
CP50-MEL-B::YK-4-279
NCI-H1993::Pevonedistat
OCI-M1::Entinostat
DMS-114::MIRA-1
SIMA::Paclitaxel
SN12C::Pyridostatin
EW-22::GSK1904529A
ESO51::Bortezomib
CHP-134::AMG-319
SIMA::KRAS (G12C) Inhibitor-12
SN12C::Leflunomide
Becker::PCI-34051
HCC1143::AZ6102
SU8686::Niraparib
NUGC-4::KRAS (G12C) Inhibitor-12
JHOS-3::PLX-4720
NCI-H1623::XAV939
AU565::P22077
CPC-N::Dasatinib
HCC1143::Vinorelbine
EFO-21::Veliparib
SN12C::Sabutoclax
ChaGo-K-1::GSK2606414
CHP-134::PLX-4720
AU565::PCI-34051
CP50-MEL-B::AZD5582
OCI-M1::AZ960
LB2241-RCC::AZD7762
UMC-11::Camptothecin
A388::Veliparib
EFO-21::VE821
CHP-134::Taselisib
A388::Irinotecan
CHP-134::Alisertib
AU565::Refametinib
TE-4::Docetaxel
NCI-H1993::Ipatasertib
HCC1143::Methotrexate
NCI-H1993::GDC0810
LB647-SCLC::Taselisib
LU-135::GSK343
SN12C::Taselisib
CHP-134::Sabutoclax
CHP-134::Savolitinib
LN-18::Tanespimycin
NCI-H1623::Refametinib
NOS-1::Lenalidomide
DMS-114::Cyclophosphamide
LB2241-RCC::Tamoxifen
SU8686::Ribociclib
HCC1143::GDC0810
UMC-11::WEHI-539
NCI-H1993::I-BET-762
AU565::OF-1
SIMA::MK-2206
SU-DHL-1::Oxaliplatin
LN-18::Axitinib
OCI-M1::BMS-345541
KP-4::Tanespimycin
EFO-21::Lestaurtinib
A388::CZC24832
TE-4::XAV939
A388::Luminespib
U031::Entospletinib
NB12::Alisertib
NUGC-4::Dasatinib
LB2241-RCC::BMS-345541
Becker::LGK974
RT-112::Telomerase Inhibitor IX
LN-18::Camptothecin
KP-4::BIBR-1532
NCI-H1623::KRAS (G12C) Inhibitor-12
CP50-MEL-B::GSK343
ESO51::AZD7762
KARPAS-620::UMI-77
SN12C::Niraparib
CAL-29::GSK1904529A
KP-4::GSK1904529A
LN-18::Bosutinib
A388::Rapamycin
SIMA::Olaparib
SIMA::Cytarabine
RT-112::KU-55933
U031::AZD3759
ESO51::Rapamycin
EW-22::MG-132
HCC1143::Venetoclax
NALM-6::Tanespimycin
LB2241-RCC::Doramapimod
EW-22::AZD6738
EW-22::VE-822
NALM-6::SN-38
CPC-N::Oxaliplatin
TE-4::ABT737
ChaGo-K-1::Docetaxel
ESO51::Vinblastine
LN-18::ABT737
U031::ABT737
LB647-SCLC::Bicalutamide
CHP-134::Osimertinib
CPC-N::Foretinib
UMC-11::ZM447439
NUGC-4::LJI308
CPC-N::BIBR-1532
RT-112::Wee1 Inhibitor
KARPAS-620::Picolinici-acid
TE-4::IWP-2
A388::BI-2536
EFO-21::Vismodegib
SU-DHL-1::Cediranib
UMC-11::EPZ5676
NALM-6::Gemcitabine
OCI-M1::NVP-ADW742
SU8686::GNE-317
SK-OV-3::SN-38
A388::AZ6102
AU565::Paclitaxel
U031::CCT007093
UMC-11::PFI-1
NALM-6::Axitinib
ChaGo-K-1::PLX-4720
CHP-134::GNE-317
SU-DHL-1::Refametinib
TE-4::Pictilisib
SK-OV-3::MK-1775
NB12::SB216763
SU-DHL-1::Picolinici-acid
KARPAS-620::Nilotinib
SU-DHL-1::Wnt-C59
KARPAS-620::Trametinib
RT-112::BIBR-1532
EW-22::CCT007093
CAL-29::AZD4547
JHOS-3::Tozasertib
SIMA::Ruxolitinib
SIMA::ABT737
LN-18::Sabutoclax
KP-4::GSK591
SN12C::SB216763
Becker::Vismodegib
ESO51::RO-3306
NCI-H1623::NVP-ADW742
LB647-SCLC::Vorinostat
U031::VE-822
UMC-11::Cytarabine
EFO-21::Ipatasertib
KGN::Nilotinib
KARPAS-620::CCT007093
KGN::Sapitinib
SN12C::EPZ5676
SK-OV-3::Bortezomib
A388::Ipatasertib
LB2241-RCC::Alpelisib
LU-135::Lapatinib
NOS-1::Linsitinib
NUGC-4::Savolitinib
DMS-114::Afatinib
KP-4::GNE-317
RT-112::Serdemetan
TE-4::Gefitinib
HCC1143::GW441756
LN-18::Picolinici-acid
ChaGo-K-1::XAV939
NB12::5-Fluorouracil
SN12C::Refametinib
HPAF-II::RVX-208
DMS-114::Wee1 Inhibitor
LU-135::PFI-1
CP50-MEL-B::MG-132
LN-18::Avagacestat
CPC-N::OF-1
NCI-H1623::PFI-1
SN12C::GSK2606414
LN-18::MK-2206
NB12::Lenalidomide
CP50-MEL-B::Vinorelbine
LU-135::BI-2536
SU-DHL-1::AZD6482
OCI-M1::Refametinib
UMC-11::Paclitaxel
CAL-29::Crizotinib
KGN::Dabrafenib
KARPAS-620::AZD5582
JHOS-3::Fulvestrant
LU-135::Pictilisib
Becker::MN-64
EFO-21::Telomerase Inhibitor IX
LN-18::VE821
KP-4::GSK343
MEL-HO::SN-38
OCI-M1::PRIMA-1MET
NALM-6::Vorinostat
CPC-N::MIRA-1
LB647-SCLC::BMS-536924
LB2241-RCC::KRAS (G12C) Inhibitor-12
HCC1143::Ipatasertib
EFO-21::Lapatinib
CPC-N::GSK343
NALM-6::Paclitaxel
EFO-21::Wnt-C59
CHP-134::IWP-2
JHOS-3::Telomerase Inhibitor IX
KGN::Temsirolimus
NOS-1::ML323
SN12C::P22077
DMS-114::EPZ5676
EW-22::LGK974
HPAF-II::PFI3
NUGC-4::GSK2830371
NALM-6::Venetoclax
SU8686::BI-2536
KARPAS-620::Osimertinib
CPC-N::PD173074
LN-18::Trametinib
JHOS-3::Palbociclib
RT-112::Oxaliplatin
CAL-29::VE821
OCI-M1::Rapamycin
NB12::AZ6102
LU-135::Trametinib
SIMA::Navitoclax
KARPAS-620::Daporinad
EW-22::EHT-1864
U031::EHT-1864
KP-4::Entinostat
RT-112::Alisertib
LB647-SCLC::Sorafenib
SIMA::Niraparib
UMC-11::Gemcitabine
KP-4::Luminespib
LB2241-RCC::Linsitinib
TE-4::Lestaurtinib
SIMA::AZD4547
HCC1143::PRIMA-1MET
NUGC-4::GNE-317
LN-18::AZD5582
NCI-H1993::GSK343
SK-OV-3::WZ4003
LC-2-ad::WEHI-539
LU-135::Dasatinib
SU-DHL-1::MN-64
U031::VX-11e
Becker::BMS-345541
SN12C::Epirubicin
LN-18::WIKI4
NCI-H1623::Crizotinib
ChaGo-K-1::Piperlongumine
NCI-H1993::Foretinib
SU-DHL-1::AGI-6780
KARPAS-620::NU7441
NUGC-4::Ipatasertib
LN-18::Doramapimod
SK-OV-3::I-BRD9
SU-DHL-1::VE821
MEL-HO::Daporinad
TE-4::JNK Inhibitor VIII
HPAF-II::IWP-2
LC-2-ad::Vismodegib
LC-2-ad::Oxaliplatin
OCI-M1::Gefitinib
UMC-11::AZD4547
LB647-SCLC::AZD4547
KARPAS-620::XAV939
NCI-H1993::OSI-027
DMS-114::NVP-ADW742
KARPAS-620::GSK2830371
SU8686::Ruxolitinib
LU-135::OSI-027
NALM-6::Temozolomide
LB647-SCLC::WIKI4
SU-DHL-1::PFI3
NALM-6::Pyridostatin
TE-4::AZD8055
LC-2-ad::CHIR-99021
NCI-H1993::Veliparib
EFO-21::Navitoclax
NCI-H1623::BIBR-1532
SU-DHL-1::Crizotinib
UMC-11::MK-8776
LB2241-RCC::Afuresertib
U031::ML323
U031::NU7441
NALM-6::Lenalidomide
KGN::Sepantronium bromide
NALM-6::OTX015
SN12C::Cyclophosphamide
MEL-HO::GNE-317
HPAF-II::Venetoclax
NCI-H1993::Lestaurtinib
EW-22::Savolitinib
LB2241-RCC::AMG-319
CP50-MEL-B::AZD7762
CP50-MEL-B::Picolinici-acid
NCI-H1623::Bortezomib
LB2241-RCC::GSK343
Becker::Erlotinib
SN12C::JQ1
LC-2-ad::MN-64
KGN::RO-3306
SK-OV-3::PD0325901
LC-2-ad::AZD3759
MEL-HO::Bortezomib
SU-DHL-1::Trametinib
RT-112::Navitoclax
LB647-SCLC::Entospletinib
NALM-6::Doramapimod
SIMA::Sabutoclax
CHP-134::Trametinib
KARPAS-620::Pictilisib
U031::AZ960
KGN::Serdemetan
SU8686::MIRA-1
CPC-N::MG-132
NCI-H1623::SB216763
NCI-H1623::AZD8055
A388::GSK269962A
HCC1143::Pyridostatin
NUGC-4::Talazoparib
UMC-11::Selumetinib
TE-4::Vinorelbine
CPC-N::WEHI-539
NUGC-4::Paclitaxel
LB647-SCLC::ZM447439
CAL-29::MK-2206
NB12::Refametinib
A388::AMG-319
RT-112::AZD7762
OCI-M1::Navitoclax
ChaGo-K-1::Bicalutamide
LN-18::MK-8776
LN-18::AZ6102
UMC-11::VX-11e
AU565::GSK1904529A
ChaGo-K-1::MK-8776
UMC-11::Lenalidomide
MEL-HO::PF-4708671
JHOS-3::KRAS (G12C) Inhibitor-12
LN-18::Dactolisib
ESO51::Epirubicin
NCI-H1623::Bosutinib
LN-18::Palbociclib
LB2241-RCC::Veliparib
NCI-H1993::Cyclophosphamide
ChaGo-K-1::Uprosertib
CP50-MEL-B::Sapitinib
NOS-1::Entospletinib
EFO-21::GW441756
OCI-M1::AZD8055
NB12::PLX-4720
LN-18::AZD4547
MEL-HO::Vinorelbine
HCC1143::YK-4-279
NOS-1::Sapitinib
NCI-H1623::RVX-208
KGN::GSK591
TE-4::GSK2578215A
NALM-6::Olaparib
U031::AZD5582
LB647-SCLC::GSK1904529A
Becker::PFI-1
JHOS-3::Irinotecan
HPAF-II::Temozolomide
OCI-M1::LCL161
LB647-SCLC::Lestaurtinib
NOS-1::Venetoclax
CHP-134::Dasatinib
TE-4::I-BET-762
SU8686::Pevonedistat
KP-4::SCH772984
ChaGo-K-1::LCL161
CPC-N::Venetoclax
HPAF-II::Sapitinib
LC-2-ad::PD173074
Becker::Crizotinib
AU565::Bortezomib
KGN::Olaparib
SN12C::Daporinad
CAL-29::Serdemetan
NUGC-4::Temozolomide
AU565::Taselisib
TE-4::Luminespib
ESO51::GSK591
LU-135::MG-132
CPC-N::PD0325901
LN-18::Dabrafenib
LB647-SCLC::Tanespimycin
ChaGo-K-1::PFI3
CP50-MEL-B::Vorinostat
A388::Refametinib
DMS-114::AZ6102
NUGC-4::Rucaparib
HCC1143::Tozasertib
SK-OV-3::AZD5582
SN12C::OTX015
LC-2-ad::AZ6102
LB647-SCLC::GSK2578215A
NOS-1::Paclitaxel
CP50-MEL-B::Sabutoclax
NCI-H1993::Crizotinib
SIMA::Motesanib
SN12C::Tanespimycin
LU-135::Selumetinib
UMC-11::Lapatinib
MEL-HO::CHIR-99021
NB12::Pictilisib
CHP-134::Ribociclib
CP50-MEL-B::Trametinib
DMS-114::Afuresertib
NCI-H1623::BMS-345541
RT-112::Picolinici-acid
ESO51::P22077
RT-112::AZD4547
SIMA::PRT062607
TE-4::Camptothecin
ChaGo-K-1::Sabutoclax
CPC-N::Ibrutinib
ESO51::LY2109761
KGN::AZD4547
HCC1143::CZC24832
JHOS-3::CHIR-99021
MEL-HO::Nutlin-3a (-)
EFO-21::Afuresertib
LU-135::I-BRD9
SK-OV-3::PFI3
SK-OV-3::SB216763
LB647-SCLC::BMS-345541
LU-135::Docetaxel
OCI-M1::ZM447439
UMC-11::Wnt-C59
NUGC-4::Avagacestat
NCI-H1993::NVP-ADW742
MEL-HO::Entinostat
LB2241-RCC::Tanespimycin
NB12::Vorinostat
LB647-SCLC::BI-2536
NB12::GSK591
LC-2-ad::Talazoparib
LC-2-ad::Ibrutinib
ESO51::OSI-027
CAL-29::KU-55933
NOS-1::SGC0946
ESO51::Sabutoclax
CPC-N::Linsitinib
A388::Navitoclax
DMS-114::AZD4547
LB2241-RCC::PRT062607
Becker::AGI-5198
U031::YK-4-279
ChaGo-K-1::Dabrafenib
LN-18::PFI-1
MEL-HO::MK-8776
HCC1143::Doramapimod
JHOS-3::WEHI-539
LB2241-RCC::Cyclophosphamide
DMS-114::GSK2606414
U031::Cediranib
CPC-N::Motesanib
LB2241-RCC::VE-822
NUGC-4::RVX-208
EW-22::Ruxolitinib
MEL-HO::Paclitaxel
NB12::SCH772984
A388::ZM447439
CP50-MEL-B::SGC0946
NB12::PD0325901
NOS-1::GSK2578215A
NUGC-4::SCH772984
KARPAS-620::Cyclophosphamide
UMC-11::ABT737
HCC1143::RO-3306
JHOS-3::AZD6738
EFO-21::SB216763
NCI-H1623::OSI-027
NOS-1::PD173074
KARPAS-620::Entospletinib
NCI-H1993::AZ960
A388::Sorafenib
UMC-11::Pevonedistat
KP-4::PD0325901
MEL-HO::MN-64
HCC1143::Paclitaxel
TE-4::Trametinib
LB647-SCLC::OSI-027
KGN::Afuresertib
KGN::BIBR-1532
ESO51::WIKI4
A388::Vorinostat
AU565::KU-55933
SU-DHL-1::GSK343
EFO-21::YK-4-279
UMC-11::Tanespimycin
NCI-H1623::YK-4-279
KP-4::Pevonedistat
KGN::Motesanib
SU8686::RVX-208
NUGC-4::PCI-34051
HCC1143::XAV939
LN-18::OSI-027
SIMA::GSK2830371
U031::AZD6482
KGN::Cisplatin
ESO51::LGK974
LU-135::Wnt-C59
UMC-11::Talazoparib
NUGC-4::KU-55933
NOS-1::BI-2536
KP-4::AZD8055
JHOS-3::Sorafenib
NUGC-4::Refametinib
NUGC-4::Oxaliplatin
KGN::AZD8055
LN-18::I-BRD9
LC-2-ad::KRAS (G12C) Inhibitor-12
EW-22::Bortezomib
KP-4::Uprosertib
U031::SB505124
MEL-HO::Navitoclax
AU565::GDC0810
DMS-114::Rucaparib
AU565::MG-132
SU-DHL-1::I-BET-762
DMS-114::SCH772984
KP-4::BI-2536
CAL-29::BI-2536
EW-22::Cediranib
NALM-6::Gefitinib
KARPAS-620::Veliparib
Becker::Picolinici-acid
HCC1143::Cediranib
NCI-H1623::Vorinostat
LB647-SCLC::Tretinoin
EFO-21::KRAS (G12C) Inhibitor-12
LU-135::Ruxolitinib
NCI-H1623::Gefitinib
LB2241-RCC::SB505124
KARPAS-620::SB216763
SN12C::GSK343
EFO-21::I-BET-762
NCI-H1623::Entinostat
AU565::PD0325901
Becker::Cediranib
RT-112::NU7441
NCI-H1993::MK-2206
RT-112::WZ4003
A388::MG-132
DMS-114::Vismodegib
SU-DHL-1::Elesclomol
EFO-21::Dasatinib
LN-18::Sorafenib
NALM-6::Palbociclib
LU-135::Dactolisib
SU-DHL-1::CHIR-99021
KARPAS-620::AZD7762
LN-18::Tamoxifen
CPC-N::OSI-027
TE-4::PLX-4720
LB647-SCLC::I-BRD9
SK-OV-3::Entospletinib
CP50-MEL-B::Venetoclax
OCI-M1::Crizotinib
NCI-H1623::Docetaxel
HCC1143::Bosutinib
LU-135::VX-11e
DMS-114::Vorinostat
AU565::GSK2578215A
HPAF-II::WIKI4
HCC1143::PFI-1
NCI-H1993::Venetoclax
LC-2-ad::Bosutinib
SIMA::LCL161
SIMA::Sorafenib
LB2241-RCC::Bortezomib
NUGC-4::GDC0810
EW-22::Crizotinib
SIMA::Temsirolimus
NCI-H1993::AZD3759
Becker::PD0325901
SU8686::SB216763
ChaGo-K-1::MK-1775
SU-DHL-1::PD173074
MEL-HO::RVX-208
CPC-N::I-BET-762
EFO-21::Niraparib
CPC-N::Dactolisib
CAL-29::AZ960
EFO-21::Cisplatin
JHOS-3::SB590885
LC-2-ad::Nilotinib
NCI-H1623::Temsirolimus
EW-22::EPZ004777
A388::Entospletinib
EW-22::Bleomycin (50 uM)
U031::NVP-ADW742
ChaGo-K-1::Erlotinib
KP-4::LY2109761
LU-135::KU-55933
LB647-SCLC::Fulvestrant
EW-22::Foretinib
HPAF-II::PD0325901
NCI-H1993::Alpelisib
ESO51::UMI-77
CP50-MEL-B::Leflunomide
MEL-HO::Osimertinib
LN-18::Alpelisib
ESO51::Dabrafenib
EFO-21::GSK2830371
DMS-114::I-BET-762
LB2241-RCC::BIBR-1532
A388::P22077
RT-112::Methotrexate
ChaGo-K-1::PD173074
CPC-N::Afuresertib
DMS-114::MN-64
NALM-6::Telomerase Inhibitor IX
ESO51::PFI3
MEL-HO::GSK591
NCI-H1623::AZD4547
EFO-21::P22077
KP-4::Bortezomib
SU8686::KRAS (G12C) Inhibitor-12
TE-4::Bortezomib
OCI-M1::Afatinib
NUGC-4::Picolinici-acid
SU-DHL-1::EPZ004777
KGN::JNK Inhibitor VIII
NALM-6::AZD5582
DMS-114::BI-2536
AU565::Lapatinib
Becker::GSK343
OCI-M1::Bleomycin (50 uM)
HCC1143::JNK Inhibitor VIII
EW-22::MIRA-1
A388::PD173074
NB12::EPZ5676
AU565::JQ1
U031::PD173074
KARPAS-620::AZD3759
NCI-H1623::5-Fluorouracil
DMS-114::LGK974
HPAF-II::Epirubicin
RT-112::GSK343
HCC1143::BI-2536
SIMA::WZ4003
LB647-SCLC::Docetaxel
RT-112::Bleomycin (50 uM)
SIMA::VE821
A388::Olaparib
CPC-N::5-Fluorouracil
RT-112::Gemcitabine
CPC-N::Alpelisib
UMC-11::Dasatinib
AU565::EPZ5676
DMS-114::Palbociclib
TE-4::Pevonedistat
EW-22::Daporinad
CPC-N::Cytarabine
CHP-134::P22077
SN12C::PD173074
CPC-N::Vinorelbine
KP-4::Linsitinib
KARPAS-620::Obatoclax Mesylate
RT-112::PD173074
NALM-6::Alpelisib
HPAF-II::AZ960
SU-DHL-1::Lapatinib
LB2241-RCC::KU-55933
CAL-29::Lapatinib
OCI-M1::Tamoxifen
NUGC-4::Crizotinib
SK-OV-3::Rucaparib
LU-135::MK-8776
SU-DHL-1::Serdemetan
LB2241-RCC::Wee1 Inhibitor
HCC1143::Oxaliplatin
OCI-M1::KRAS (G12C) Inhibitor-12
KARPAS-620::Sapitinib
AU565::Bosutinib
TE-4::UMI-77
UMC-11::AZ960
EW-22::GDC0810
U031::AZD7762
KP-4::EPZ5676
EFO-21::Oxaliplatin
LU-135::MIRA-1
ChaGo-K-1::Ribociclib
JHOS-3::BI-2536
JHOS-3::AZD6482
LC-2-ad::Selumetinib
EFO-21::Vinorelbine
CP50-MEL-B::GSK1904529A
NB12::Pevonedistat
ChaGo-K-1::SL0101
SN12C::Lapatinib
TE-4::Paclitaxel
ChaGo-K-1::BI-2536
NOS-1::Doramapimod
SK-OV-3::EPZ5676
CP50-MEL-B::Tamoxifen
SIMA::LGK974
JHOS-3::EPZ5676
KARPAS-620::PRT062607
ESO51::Gefitinib
ESO51::ML323
KP-4::Gefitinib
NUGC-4::Sorafenib
SIMA::RVX-208
U031::Talazoparib
SN12C::AZ6102
EW-22::SGC0946
AU565::Rucaparib
NCI-H1993::Selumetinib
JHOS-3::Serdemetan
HPAF-II::AZD3759
HCC1143::Nutlin-3a (-)
EW-22::Vorinostat
CAL-29::Vinorelbine
OCI-M1::CCT007093
CP50-MEL-B::EPZ004777
JHOS-3::MN-64
NUGC-4::OTX015
CAL-29::SB590885
JHOS-3::PD173074
UMC-11::Trametinib
LC-2-ad::Picolinici-acid
LU-135::Alpelisib
HCC1143::Obatoclax Mesylate
NUGC-4::Ibrutinib
OCI-M1::Alpelisib
TE-4::Temozolomide
U031::Nutlin-3a (-)
KP-4::Temozolomide
KP-4::KU-55933
SK-OV-3::Docetaxel
ChaGo-K-1::Savolitinib
HPAF-II::MK-1775
OCI-M1::GNE-317
ChaGo-K-1::Selumetinib
UMC-11::VE-822
LU-135::WEHI-539
NB12::GNE-317
EW-22::Vinblastine
CPC-N::PFI3
LB2241-RCC::Gefitinib
HPAF-II::Afuresertib
SIMA::EPZ5676
SIMA::Nutlin-3a (-)
CP50-MEL-B::Fulvestrant
HPAF-II::GSK1904529A
KARPAS-620::Pevonedistat
CPC-N::Wee1 Inhibitor
SU-DHL-1::Avagacestat
SU8686::Gefitinib
EW-22::Sabutoclax
EFO-21::I-BRD9
LC-2-ad::PLX-4720
OCI-M1::SB216763
CAL-29::MK-8776
SN12C::Axitinib
NCI-H1623::AZ960
LU-135::AZD7762
EW-22::KU-55933
SN12C::MN-64
LU-135::CCT007093
SN12C::VX-11e
ESO51::Trametinib
MEL-HO::Ruxolitinib
NALM-6::Pevonedistat
KARPAS-620::RVX-208
Becker::Vinblastine
CHP-134::Uprosertib
LC-2-ad::SB216763
LC-2-ad::Savolitinib
RT-112::Uprosertib
LU-135::Bosutinib
AU565::AZD7762
LC-2-ad::Cyclophosphamide
LN-18::Sapitinib
LB647-SCLC::Serdemetan
UMC-11::AZD8055
EW-22::AGI-5198
HPAF-II::Savolitinib
SU8686::Telomerase Inhibitor IX
LU-135::Entospletinib
OCI-M1::MK-1775
JHOS-3::GSK2578215A
A388::GNE-317
HCC1143::Temozolomide
NUGC-4::SN-38
EW-22::Entinostat
U031::Serdemetan
TE-4::PD173074
U031::Uprosertib
KGN::Nutlin-3a (-)
CPC-N::AZD5582
HCC1143::BMS-345541
EW-22::Refametinib
A388::AZD7762
MEL-HO::NVP-ADW742
LB2241-RCC::Venetoclax
LN-18::Oxaliplatin
CPC-N::KU-55933
LB647-SCLC::Vismodegib
SU8686::BMS-345541
LB2241-RCC::BMS-536924
KARPAS-620::Vinblastine
CPC-N::Veliparib
LB2241-RCC::Pictilisib
Becker::Osimertinib
AU565::Palbociclib
CPC-N::Fulvestrant
KARPAS-620::BMS-345541
SN12C::Cytarabine
U031::IOX2
MEL-HO::Ibrutinib
JHOS-3::Picolinici-acid
UMC-11::MIM1
EW-22::Leflunomide
NOS-1::Temsirolimus
DMS-114::Pictilisib
UMC-11::Telomerase Inhibitor IX
LB647-SCLC::CHIR-99021
Becker::Camptothecin
NB12::WEHI-539
TE-4::Savolitinib
EW-22::Linsitinib
ChaGo-K-1::Sorafenib
EW-22::GSK2830371
UMC-11::EHT-1864
CHP-134::Niraparib
NOS-1::LJI308
CAL-29::Leflunomide
TE-4::GW441756
JHOS-3::AZD3759
SN12C::ML323
A388::SB590885
SU8686::SCH772984
LC-2-ad::VE-822
LB647-SCLC::PFI-1
NALM-6::PFI-1
KP-4::Pictilisib
TE-4::Rapamycin
SN12C::Ipatasertib
SU8686::Cediranib
LB2241-RCC::I-BRD9
NCI-H1623::Cediranib
TE-4::GSK2830371
SIMA::Lestaurtinib
RT-112::SB216763
CPC-N::Tanespimycin
MEL-HO::Afatinib
KGN::Osimertinib
ChaGo-K-1::Dactolisib
RT-112::JNK Inhibitor VIII
EFO-21::Selumetinib
KARPAS-620::NVP-ADW742
CPC-N::GDC0810
JHOS-3::ZM447439
HCC1143::Afatinib
CHP-134::Lapatinib
TE-4::Sepantronium bromide
HPAF-II::EPZ5676
OCI-M1::Temozolomide
UMC-11::Doramapimod
NOS-1::PRT062607
NCI-H1623::Tanespimycin
NOS-1::AZ6102
ChaGo-K-1::GW441756
KGN::GSK343
DMS-114::PD0325901
CHP-134::OTX015
HCC1143::PFI3
HCC1143::Refametinib
DMS-114::Axitinib
DMS-114::PD173074
U031::ZM447439
JHOS-3::OSI-027
TE-4::MG-132
NUGC-4::Alpelisib
CHP-134::GSK591
JHOS-3::5-Fluorouracil
SIMA::Erlotinib
LU-135::NVP-ADW742
LB2241-RCC::Ruxolitinib
TE-4::LY2109761
CHP-134::AZD5582
A388::IOX2
CAL-29::GSK2578215A
UMC-11::I-BET-762
HCC1143::GNE-317
MEL-HO::SGC0946
AU565::I-BRD9
NCI-H1623::Linsitinib
TE-4::BI-2536
HCC1143::Nilotinib
NCI-H1993::Sepantronium bromide
NUGC-4::AZD3759
NOS-1::Methotrexate
NUGC-4::MIM1
KARPAS-620::Wnt-C59
LU-135::SB216763
U031::Rucaparib
NALM-6::Taselisib
AU565::AZ6102
OCI-M1::Palbociclib
EW-22::Lapatinib
SU8686::Paclitaxel
ESO51::Lapatinib
ChaGo-K-1::Vorinostat
KP-4::AGI-6780
EFO-21::OSI-027
NB12::AGI-5198
AU565::PFI-1
UMC-11::PD0325901
NALM-6::Ipatasertib
SU8686::Nilotinib
EW-22::AZD7762
U031::Vorinostat
NCI-H1623::Vinorelbine
Becker::PFI3
ChaGo-K-1::Foretinib
NOS-1::NVP-ADW742
NB12::Wee1 Inhibitor
NUGC-4::GSK2578215A
CPC-N::Refametinib
U031::Temozolomide
LC-2-ad::Elesclomol
KGN::Navitoclax
KGN::Talazoparib
KARPAS-620::Nutlin-3a (-)
CHP-134::Afatinib
LB2241-RCC::PLX-4720
SIMA::AZD7762
DMS-114::Dactolisib
LN-18::Niraparib
SU-DHL-1::Vismodegib
NUGC-4::Doramapimod
DMS-114::Motesanib
NB12::YK-4-279
TE-4::Doramapimod
Becker::OTX015
SIMA::AZD5582
CP50-MEL-B::NVP-ADW742
NCI-H1993::Talazoparib
TE-4::Pyridostatin
JHOS-3::WZ4003
A388::WZ4003
NB12::Taselisib
JHOS-3::AZ6102
UMC-11::Bosutinib
KARPAS-620::Methotrexate
KP-4::Tamoxifen
AU565::SB216763
CP50-MEL-B::Serdemetan
SU8686::Bosutinib
KP-4::VE-822
AU565::Lestaurtinib
DMS-114::P22077
CP50-MEL-B::Axitinib
A388::NU7441
RT-112::Bosutinib
ESO51::KRAS (G12C) Inhibitor-12
OCI-M1::SN-38
CAL-29::WZ4003
HPAF-II::Alisertib
KP-4::Vinblastine
AU565::Methotrexate
LU-135::BMS-345541
KARPAS-620::LCL161
EW-22::Motesanib
NUGC-4::Gemcitabine
LU-135::Paclitaxel
A388::GSK343
CP50-MEL-B::IOX2
LB647-SCLC::AZD6482
TE-4::Lapatinib
NUGC-4::Sepantronium bromide
NCI-H1623::EHT-1864
LB647-SCLC::Bosutinib
A388::JNK Inhibitor VIII
ESO51::JQ1
MEL-HO::Lenalidomide
LB647-SCLC::RO-3306
JHOS-3::EPZ004777
A388::Sapitinib
SK-OV-3::Doramapimod
JHOS-3::Savolitinib
CAL-29::Wee1 Inhibitor
OCI-M1::VE821
KP-4::Daporinad
U031::Refametinib
KP-4::AGI-5198
HPAF-II::Crizotinib
EW-22::Osimertinib
CAL-29::Irinotecan
MEL-HO::Alisertib
ChaGo-K-1::CCT-018159
SK-OV-3::Avagacestat
AU565::Veliparib
LB647-SCLC::NVP-ADW742
ESO51::Entinostat
CP50-MEL-B::Bicalutamide
LB647-SCLC::SCH772984
LB647-SCLC::Oxaliplatin
A388::EPZ5676
AU565::MK-1775
TE-4::Dactolisib
OCI-M1::GSK2830371
LB647-SCLC::BIBR-1532
CPC-N::Dinaciclib
SU8686::Camptothecin
SN12C::GDC0810
EFO-21::AGI-5198
SK-OV-3::Ribociclib
RT-112::Erlotinib
LB647-SCLC::Irinotecan
KP-4::Sapitinib
KP-4::Lapatinib
KP-4::Motesanib
NCI-H1993::RO-3306
NB12::Uprosertib
LC-2-ad::Crizotinib
RT-112::Olaparib
UMC-11::RO-3306
JHOS-3::IWP-2
SU8686::WZ4003
OCI-M1::I-BET-762
NOS-1::Dinaciclib
CP50-MEL-B::LY2109761
LB2241-RCC::LJI308
RT-112::Dasatinib
KP-4::Picolinici-acid
NCI-H1993::WZ4003
SN12C::SCH772984
KARPAS-620::EPZ004777
ESO51::Linsitinib
AU565::GSK2606414
NCI-H1993::AGI-6780
NB12::UMI-77
ESO51::Lenalidomide
NUGC-4::Gefitinib
NOS-1::SB590885
NUGC-4::OSI-027
KP-4::Talazoparib
NCI-H1623::Olaparib
ESO51::GSK2578215A
MEL-HO::Axitinib
A388::SGC0946
RT-112::PRIMA-1MET
RT-112::PCI-34051
SK-OV-3::MIRA-1
DMS-114::BIBR-1532
LB647-SCLC::VE-822
MEL-HO::Lapatinib
KARPAS-620::GW441756
ESO51::PCI-34051
KP-4::Obatoclax Mesylate
NOS-1::Obatoclax Mesylate
EFO-21::SB590885
MEL-HO::AGI-6780
LU-135::Picolinici-acid
EFO-21::GNE-317
LU-135::AZ960
JHOS-3::Leflunomide
JHOS-3::SB505124
LB2241-RCC::Ribociclib
CHP-134::VX-11e
HPAF-II::AZD7762
ESO51::AZD5582
OCI-M1::Talazoparib
SN12C::Gefitinib
HPAF-II::Bortezomib
OCI-M1::Alisertib
U031::Dactolisib
ESO51::Obatoclax Mesylate
EFO-21::XAV939
CHP-134::Vinorelbine
NB12::Bortezomib
HPAF-II::CZC24832
RT-112::CZC24832
CAL-29::Dasatinib
U031::Foretinib
SN12C::PRT062607
LC-2-ad::Piperlongumine
LU-135::Vinblastine
CAL-29::Ibrutinib
EFO-21::Fulvestrant
DMS-114::Obatoclax Mesylate
ESO51::Dactolisib
SK-OV-3::AZD4547
SN12C::BI-2536
HCC1143::PD173074
NCI-H1993::Dabrafenib
LC-2-ad::Dinaciclib
A388::Paclitaxel
KGN::AGI-5198
SK-OV-3::SGC0946
LC-2-ad::LY2109761
MEL-HO::SB216763
NOS-1::BIBR-1532
U031::Sapitinib
EFO-21::Erlotinib
KP-4::Savolitinib
NOS-1::Palbociclib
SK-OV-3::Axitinib
KP-4::RO-3306
SU-DHL-1::Linsitinib
JHOS-3::Doramapimod
KARPAS-620::LJI308
HCC1143::Wnt-C59
KARPAS-620::AMG-319
NCI-H1623::Pictilisib
NALM-6::Savolitinib
HPAF-II::Foretinib
CAL-29::Venetoclax
NCI-H1993::Palbociclib
JHOS-3::P22077
NCI-H1993::Avagacestat
EFO-21::Crizotinib
ChaGo-K-1::Alpelisib
MEL-HO::XAV939
JHOS-3::Olaparib
LC-2-ad::Ruxolitinib
SU8686::Crizotinib
DMS-114::MG-132
AU565::Gemcitabine
KARPAS-620::AZD8186
KGN::Wee1 Inhibitor
NCI-H1623::Trametinib
KGN::WIKI4
SN12C::Dasatinib
U031::AZ6102
HCC1143::EHT-1864
CHP-134::MK-1775
NUGC-4::YK-4-279
NUGC-4::NVP-ADW742
JHOS-3::Nilotinib
LB647-SCLC::Lenalidomide
LB647-SCLC::Erlotinib
CAL-29::Dactolisib
NB12::Rucaparib
NCI-H1993::KU-55933
SN12C::Trametinib
KGN::GDC0810
SN12C::Obatoclax Mesylate
KARPAS-620::EPZ5676
NCI-H1623::AGI-6780
KP-4::MIRA-1
CP50-MEL-B::Afatinib
CAL-29::Entinostat
AU565::OTX015
LU-135::Rucaparib
SK-OV-3::LY2109761
NCI-H1993::SB216763
DMS-114::BMS-536924
KARPAS-620::BMS-536924
ESO51::Avagacestat
LB2241-RCC::Daporinad
A388::Lapatinib
LC-2-ad::YK-4-279
CP50-MEL-B::Palbociclib
NCI-H1993::Wnt-C59
SU8686::Luminespib
OCI-M1::MK-2206
KP-4::Pyridostatin
EFO-21::Camptothecin
HCC1143::Irinotecan
NCI-H1993::ML323
CP50-MEL-B::JQ1
EW-22::Obatoclax Mesylate
U031::MN-64
A388::Tamoxifen
NCI-H1993::IWP-2
KGN::UMI-77
CP50-MEL-B::MIRA-1
TE-4::Entinostat
SU8686::Gemcitabine
RT-112::Avagacestat
NALM-6::Dasatinib
NB12::Palbociclib
LB647-SCLC::CCT007093
NCI-H1623::Dasatinib
HPAF-II::AGI-5198
UMC-11::Dinaciclib
SU-DHL-1::AMG-319
SU-DHL-1::Tretinoin
U031::Ruxolitinib
CHP-134::PRIMA-1MET
CAL-29::Doramapimod
KARPAS-620::Sepantronium bromide
KGN::Refametinib
SK-OV-3::BMS-345541
NUGC-4::Nutlin-3a (-)
LC-2-ad::Axitinib
UMC-11::Docetaxel
Becker::MK-1775
NOS-1::Nilotinib
KARPAS-620::JQ1
Becker::Ruxolitinib
UMC-11::LY2109761
KP-4::Afatinib
SK-OV-3::Vismodegib
AU565::Leflunomide
OCI-M1::Linsitinib
NOS-1::Dasatinib
HCC1143::Ribociclib
A388::PF-4708671
ChaGo-K-1::Pevonedistat
UMC-11::Obatoclax Mesylate
NOS-1::Wee1 Inhibitor
MEL-HO::Cediranib
JHOS-3::Refametinib
AU565::AMG-319
KARPAS-620::MN-64
UMC-11::PCI-34051
SN12C::Alpelisib
SU-DHL-1::Ibrutinib
LB647-SCLC::LCL161
NCI-H1623::GSK2578215A
SU8686::Veliparib
HCC1143::OSI-027
NCI-H1993::WEHI-539
CP50-MEL-B::Lapatinib
TE-4::Refametinib
EW-22::Navitoclax
HPAF-II::KU-55933
U031::EPZ004777
EFO-21::Cyclophosphamide
MEL-HO::AZD5582
OCI-M1::Veliparib
SU-DHL-1::KRAS (G12C) Inhibitor-12
SK-OV-3::GSK1904529A
OCI-M1::Lestaurtinib
NCI-H1623::AZD3759
CAL-29::Erlotinib
LB647-SCLC::Gemcitabine
SK-OV-3::Cisplatin
NCI-H1623::Erlotinib
SN12C::Sorafenib
SK-OV-3::Talazoparib
SIMA::GDC0810
SK-OV-3::Wee1 Inhibitor
KGN::KU-55933
NB12::Pyridostatin
ChaGo-K-1::AMG-319
SK-OV-3::VX-11e
NCI-H1623::Navitoclax
LB2241-RCC::Dasatinib
TE-4::EHT-1864
